Document_and_Entity_Informatio
Document and Entity Information Document Document and Entity Information | 6 Months Ended | |
Feb. 27, 2014 | Apr. 03, 2014 | |
Entity Information [Line Items] | ' | ' |
Entity Registrant Name | 'MICRON TECHNOLOGY INC | ' |
Entity Central Index Key | '0000723125 | ' |
Current Fiscal Year End Date | '--08-28 | ' |
Entity Filer Category | 'Large Accelerated Filer | ' |
Document Type | '10-Q | ' |
Document Period End Date | 27-Feb-14 | ' |
Document Fiscal Year Focus | '2014 | ' |
Document Fiscal Period Focus | 'Q2 | ' |
Amendment Flag | 'false | ' |
Entity Common Stock, Shares Outstanding | ' | 1,070,379,433 |
CONSOLIDATED_STATEMENTS_OF_OPE
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Income Statement [Abstract] | ' | ' | ' | ' |
Net sales | $4,107 | $2,078 | $8,149 | $3,912 |
Cost of goods sold | 2,704 | 1,712 | 5,465 | 3,329 |
Gross margin | 1,403 | 366 | 2,684 | 583 |
Selling, general and administrative | 177 | 123 | 353 | 242 |
Research and development | 344 | 214 | 664 | 438 |
Restructure and asset impairments | 12 | 60 | 9 | 39 |
Other operating (income) expense, net | 1 | -8 | 238 | -16 |
Operating income (loss) | 869 | -23 | 1,420 | -120 |
Interest income | 6 | 3 | 11 | 6 |
Interest expense | -83 | -56 | -184 | -113 |
Other non-operating income (expense), net | -122 | -159 | -202 | -218 |
Income (loss) from continuing operations before equity method investments, income taxes, and noncontrolling interest | 670 | -235 | 1,045 | -445 |
Income tax (provision) benefit | -63 | 9 | -143 | -4 |
Equity in net income (loss) of equity method investees | 134 | -58 | 220 | -110 |
Net income (loss) | 741 | -284 | 1,122 | -559 |
Net income attributable to noncontrolling interests | -10 | -2 | -33 | -2 |
Net income (loss) attributable to Micron | $731 | ($286) | $1,089 | ($561) |
Earnings (loss) per share: | ' | ' | ' | ' |
Basic (in dollars per share) | $0.69 | ($0.28) | $1.03 | ($0.55) |
Diluted (in dollars per share) | $0.61 | ($0.28) | $0.91 | ($0.55) |
Number of shares used in per share calculations: | ' | ' | ' | ' |
Basic (in shares) | 1,060 | 1,016 | 1,053 | 1,015 |
Diluted (in shares) | 1,201 | 1,016 | 1,199 | 1,015 |
CONSOLIDATED_STATEMENTS_OF_COM
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Net income (loss) | $741 | ($284) | $1,122 | ($559) |
Other comprehensive income (loss), net of tax | ' | ' | ' | ' |
Foreign currency translation adjustments | -10 | 2 | -4 | 9 |
Gain (loss) on derivative instruments, net | -2 | -3 | -4 | -8 |
Gain (loss) on investments, net | 1 | -3 | 2 | -1 |
Pension liability adjustments | 2 | 0 | 2 | -1 |
Other comprehensive income (loss) | -9 | -4 | -4 | -1 |
Total comprehensive income (loss) | 732 | -288 | 1,118 | -560 |
Comprehensive (income) loss attributable to noncontrolling interests | -10 | -2 | -33 | -2 |
Comprehensive income (loss) attributable to Micron | $722 | ($290) | $1,085 | ($562) |
CONSOLIDATED_BALANCE_SHEETS
CONSOLIDATED BALANCE SHEETS (USD $) | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Assets, Current [Abstract] | ' | ' |
Cash and equivalents | $4,305 | $2,880 |
Short-term investments | 199 | 221 |
Receivables | 2,826 | 2,329 |
Inventories | 2,462 | 2,649 |
Restricted cash | 0 | 556 |
Other current assets | 199 | 276 |
Total current assets | 9,991 | 8,911 |
Assets, Noncurrent [Abstract] | ' | ' |
Long-term marketable investments | 552 | 499 |
Property, plant and equipment, net | 7,859 | 7,626 |
Equity method investments | 618 | 396 |
Intangible assets, net | 367 | 386 |
Deferred tax assets | 741 | 861 |
Other noncurrent assets | 487 | 439 |
Total assets | 20,615 | 19,118 |
Liabilities, Current [Abstract] | ' | ' |
Accounts payable and accrued expenses | 2,679 | 2,115 |
Deferred income | 251 | 243 |
Equipment purchase contracts | 145 | 182 |
Current debt | 2,230 | 1,585 |
Total current liabilities | 5,305 | 4,125 |
Liabilities, Noncurrent [Abstract] | ' | ' |
Long-term debt | 4,317 | 4,452 |
Other noncurrent liabilities | 858 | 535 |
Total liabilities | 10,480 | 9,112 |
Commitments and contingencies | ' | ' |
Redeemable convertible notes | 91 | 0 |
Micron shareholders' equity: | ' | ' |
Common stock, $0.10 par value, 3,000 shares authorized, 1,070 shares issued and outstanding (1,044 as of August 29, 2013) | 107 | 104 |
Additional capital | 8,282 | 9,187 |
Retained earnings (accumulated deficit) | 836 | -212 |
Accumulated other comprehensive income | 59 | 63 |
Total Micron shareholders' equity | 9,284 | 9,142 |
Noncontrolling interests in subsidiaries | 760 | 864 |
Total equity | 10,044 | 10,006 |
Total liabilities and equity | $20,615 | $19,118 |
CONSOLIDATED_BALANCE_SHEETS_Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, except Per Share data, unless otherwise specified | ||
Liabilities and equity | ' | ' |
Common Stock, par value (in dollars per share) | $0.10 | $0.10 |
Common Stock, authorized shares (in shares) | 3,000 | 3,000 |
Common Stock, issued (in shares) | 1,070 | 1,044 |
Common Stock, outstanding (in shares) | 1,070 | 1,044 |
CONSOLIDATED_STATEMENTS_OF_CAS
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) | 6 Months Ended | |
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 |
Cash flows from operating activities | ' | ' |
Net income (loss) | $1,122 | ($559) |
Adjustments to reconcile net income (loss) to net cash provided by operating activities: | ' | ' |
Depreciation expense and amortization of intangible assets | 1,008 | 912 |
Amortization of debt discount and other costs | 94 | 58 |
Loss on restructure of debt | 166 | 31 |
Stock-based compensation | 49 | 40 |
Adjustment to gain on acquisition of Elpida | 33 | 0 |
(Gains) losses from currency hedges, net | 21 | 173 |
Equity in net (income) loss of equity method investees | -220 | 110 |
Change in operating assets and liabilities: | ' | ' |
Receivables | -458 | -3 |
Inventories | 188 | 27 |
Accounts payable and accrued expenses | 489 | -189 |
Customer prepayments | 153 | -63 |
Deferred income taxes, net | 127 | 0 |
Other | 125 | -67 |
Net cash provided by operating activities | 2,897 | 470 |
Cash flows from investing activities | ' | ' |
Expenditures for property, plant and equipment | -1,031 | -761 |
Purchases of available-for-sale securities | -359 | -430 |
Decrease in restricted cash | 556 | 0 |
Proceeds from sales and maturities of available-for-sale securities | 320 | 198 |
Other | 63 | -6 |
Net cash used for investing activities | -451 | -999 |
Cash flows from financing activities | ' | ' |
Repayments of debt | -1,987 | -587 |
Payments on equipment purchase contracts | -203 | -130 |
Cash paid to purchase common stock | -73 | -5 |
Cash paid for capped call transactions | 0 | -48 |
Proceeds from issuance of debt | 1,062 | 812 |
Proceeds from issuance of common stock under equity plans | 224 | 24 |
Cash received from noncontrolling interests | 49 | 10 |
Proceeds from equipment sale-leaseback transactions | 14 | 73 |
Cash received from capped call transactions | 0 | 24 |
Other | -92 | -42 |
Net cash provided by (used for) financing activities | -1,006 | 131 |
Effect on changes in currency exchange rates on cash and cash equivalents | -15 | 0 |
Net increase (decrease) in cash and equivalents | 1,425 | -398 |
Cash and equivalents at beginning of period | 2,880 | 2,459 |
Cash and equivalents at end of period | 4,305 | 2,061 |
Noncash investing and financing activities: | ' | ' |
Exchange of convertible notes | 756 | 0 |
Acquisition of noncontrolling interest | 127 | 0 |
Equipment acquisitions on contracts payable and capital leases | $208 | $209 |
Business_and_Basis_of_Presenta
Business and Basis of Presentation | 6 Months Ended |
Feb. 27, 2014 | |
Disclosure Text Block [Abstract] | ' |
Business and Basis of Presentation | ' |
Business and Basis of Presentation | |
Micron Technology, Inc., including its consolidated subsidiaries, (hereinafter referred to collectively as "we," "our," "us" and similar terms unless the context indicates otherwise) is one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 29, 2013. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to present fairly the financial information set forth herein. Certain reclassifications have been made to prior period amounts to conform to current period presentation. | |
Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Our second quarters of fiscal 2014 and 2013 ended on February 27, 2014 and February 28, 2013, respectively. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 29, 2013. |
Variable_Interest_Entities
Variable Interest Entities | 6 Months Ended |
Feb. 27, 2014 | |
Disclosure Text Block [Abstract] | ' |
Variable Interest Entities | ' |
Variable Interest Entities | |
We have interests in entities that are Variable Interest Entities ("VIEs"). If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. | |
Unconsolidated Variable Interest Entities | |
Inotera: Inotera Memories, Inc. ("Inotera") is a VIE because its equity is not sufficient to permit it to finance its activities without additional support from its shareholders. We have determined that we do not have the power to direct the activities of Inotera that most significantly impact its economic performance, primarily due to (1) limitations on our governance rights that require the consent of other parties for key operating decisions and (2) Inotera's dependence on Nanya Technology Corporation ("Nanya") for financing and the ability of Inotera to operate in Taiwan. Therefore, we do not consolidate Inotera and we account for our interest under the equity method. See "Equity Method Investments – Inotera" note. | |
EQUVO Entities: EQUVO HK Limited and EQUVA Capital 1 Pte. Ltd. (together, the "EQUVO Entities") are special purpose entities created to facilitate equipment sale-leaseback financing transactions between us and a consortium of financial institutions ("Financing Entities"). Neither we nor the Financing Entities have an equity interest in the EQUVO Entities. The EQUVO Entities are VIEs because their equity is not sufficient to permit them to finance their activities without additional support from the Financing Entities and because the third-party equity holder lacks characteristics of a controlling financial interest. By design, the arrangements with the EQUVO Entities are merely financing vehicles and we do not bear any significant risks from variable interests with the EQUVO Entities. Therefore, we have determined that we do not have the power to direct the activities of the EQUVO Entities that most significantly impact their economic performance and we do not consolidate the EQUVO Entities. | |
SC Hiroshima Energy Corporation: SC Hiroshima Energy Corporation ("SCHE") is an entity created to construct and operate a cogeneration, electrical power plant to support our wafer manufacturing facility in Hiroshima, Japan. SCHE is a VIE due to the nature of its tolling agreements with us and our purchase and call options for SCHE's assets. We do not have an equity ownership interest in SCHE. We do not control the operation and maintenance of the plant, which we have determined are the activities of SCHE that most significantly impacts its economic performance. Therefore, we do not consolidate SCHE. | |
Consolidated Variable Interest Entities | |
IMFT: IM Flash Technologies, LLC ("IMFT") is a VIE because all of its costs are passed to us and its other member, Intel Corporation ("Intel"), through product purchase agreements and IMFT is dependent upon us or Intel for any additional cash requirements. The primary activities of IMFT are driven by the constant introduction of product and process technology. Because we perform a significant majority of the technology development, we have the power to direct its key activities. In addition, IMFT manufactures certain products exclusively for us using our technology. We also determined that we have the obligation to absorb losses and the right to receive benefits from IMFT that could potentially be significant to it. As a result, we have determined that we have the power to direct the activities of IMFT that most significantly impact its economic performance and, therefore, we consolidate IMFT. | |
MP Mask: MP Mask Technology Center, LLC ("MP Mask") is a VIE because substantially all of its costs are passed to us and its other member, Photronics, Inc. ("Photronics"), through product purchase agreements and MP Mask is dependent upon us or Photronics for any additional cash requirements. We have tie-breaking voting rights over key operating decisions and nearly all key MP Mask activities are driven by our supply needs. We also determined that we have the obligation to absorb losses and the right to receive benefits from MP Mask that could potentially be significant to it. As a result, we have determined that we have the power to direct the activities of MP Mask that most significantly impact its economic performance and, therefore, we consolidate MP Mask. | |
For further information regarding our consolidated VIEs, see "Equity – Noncontrolling Interests in Subsidiaries" note. |
Recently_Issued_Accounting_Sta
Recently Issued Accounting Standards | 6 Months Ended |
Feb. 27, 2014 | |
Disclosure Text Block [Abstract] | ' |
Recently Issued Accounting Standards | ' |
Recently Issued Accounting Standards | |
There have been no recently issued accounting pronouncements that have had or are expected to have a material impact on our financial statements. |
Elpida_Memory_Inc
Elpida Memory, Inc. (Elpida Acquisition [Member]) | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Elpida Acquisition [Member] | ' | ||||||||
Business Acquisition [Line Items] | ' | ||||||||
Elpida Memory, Inc. | ' | ||||||||
Elpida Memory, Inc. | |||||||||
On July 31, 2013, we acquired Elpida Memory, Inc. ("Elpida") and 89% of Rexchip Electronics Corporation ("Rexchip''), now known as Micron Memory Taiwan Co., Ltd. ("MMT") for an aggregate of $949 million in cash (collectively, the "Elpida Acquisition"). In the second quarter of 2014, we purchased an additional 9.87% of MMT's outstanding common stock. (See "Equity – Noncontrolling Interest in Subsidiaries – MMT" note.) Both Elpida and MMT manufacture semiconductor memory products including mobile DRAM targeted toward mobile phones and tablets. | |||||||||
In connection with the Elpida Acquisition, we recorded net assets of $2,601 million and noncontrolling interests of $168 million. Because the fair value of the net assets acquired, less noncontrolling interests, exceeded our purchase price, we recognized a gain on the acquisition of $1,484 million. In the second quarter of 2014, the provisional amounts as of the acquisition date were adjusted, primarily for pre-petition liabilities. As a result, we recorded a charge of $33 million in the second quarter of 2014 in other non-operating expense for these measurement period adjustments to adjust the gain on the acquisition of Elpida. | |||||||||
The following unaudited pro forma financial information presents the combined results of operations as if the Elpida Acquisition had occurred on September 2, 2011. The pro forma financial information includes the accounting effects of the business combination, including adjustments to the amortization of intangible assets, depreciation of property, plant and equipment, interest expense and elimination of intercompany activities. The unaudited pro forma financial information for the quarter and six months ended February 28, 2013 includes our results for the quarter and six months ended February 28, 2013 and the results of Elpida and MMT, including the adjustments described above, for the quarter and six months ended December 31, 2012. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Elpida Acquisition occurred on September 2, 2011. | |||||||||
Quarter Ended | Six Months Ended | ||||||||
28-Feb-13 | 28-Feb-13 | ||||||||
Net sales | $ | 2,912 | $ | 5,531 | |||||
Net loss | (120 | ) | (346 | ) | |||||
Net loss attributable to Micron | (132 | ) | (369 | ) | |||||
Loss per share: | |||||||||
Basic | $ | (0.13 | ) | $ | (0.36 | ) | |||
Diluted | (0.13 | ) | (0.36 | ) |
Investments
Investments | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Disclosure Text Block [Abstract] | ' | ||||||||
Investments [Text Block] | ' | ||||||||
Investments | |||||||||
As of February 27, 2014 and August 29, 2013, the fair values, which approximated amortized costs, of available-for-sale investments were as follows: | |||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||
Money market funds | $ | 1,137 | $ | 1,188 | |||||
Corporate bonds | 456 | 414 | |||||||
Government securities | 141 | 168 | |||||||
Asset-backed securities | 123 | 97 | |||||||
Certificates of deposit | 100 | 349 | |||||||
Commercial paper | 23 | 61 | |||||||
Marketable equity securities | 1 | 6 | |||||||
$ | 1,981 | $ | 2,283 | ||||||
The table below presents the fair value of available-for-sale debt securities as of February 27, 2014, by contractual maturity: | |||||||||
Money market funds not due at a single maturity date | $ | 1,137 | |||||||
Due in 1 year or less | 292 | ||||||||
Due in 1 - 2 years | 268 | ||||||||
Due in 2 - 4 years | 266 | ||||||||
Due after 4 years | 17 | ||||||||
$ | 1,980 | ||||||||
Proceeds from the sales of available-for-sale securities were $110 million and $223 million for the second quarter and first six months of 2014, respectively, and $67 million and $160 million for the second quarter and first six months of 2013, respectively. Gross realized gains and losses for the second quarter and first six months of 2014 and 2013 were not significant. As of February 27, 2014, no available-for-sale security had been in a loss position for longer than 12 months. |
Receivables
Receivables | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Disclosure Text Block [Abstract] | ' | ||||||||
Receivables | ' | ||||||||
Receivables | |||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Trade receivables (net of allowance for doubtful accounts of $4 and $5, respectively) | $ | 2,548 | $ | 2,069 | |||||
Income and other taxes | 65 | 74 | |||||||
Other | 213 | 186 | |||||||
$ | 2,826 | $ | 2,329 | ||||||
As of February 27, 2014 and August 29, 2013, other receivables included $39 million and $34 million, respectively, due from Intel for amounts related to NAND Flash and certain emerging memory technologies product design and process development activities under cost-sharing agreements. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.) | |||||||||
Inventories
Inventories | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Disclosure Text Block [Abstract] | ' | ||||||||
Inventories | ' | ||||||||
Inventories | |||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Finished goods | $ | 829 | $ | 796 | |||||
Work in process | 1,447 | 1,719 | |||||||
Raw materials and supplies | 186 | 134 | |||||||
$ | 2,462 | $ | 2,649 | ||||||
Property_Plant_and_Equipment
Property, Plant and Equipment | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Disclosure Text Block [Abstract] | ' | ||||||||
Property, Plant and Equipment | ' | ||||||||
Property, Plant and Equipment | |||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Land | $ | 86 | $ | 86 | |||||
Buildings | 4,962 | 4,835 | |||||||
Equipment | 16,474 | 15,600 | |||||||
Construction in progress | 88 | 84 | |||||||
Software | 329 | 315 | |||||||
21,939 | 20,920 | ||||||||
Accumulated depreciation | (14,080 | ) | (13,294 | ) | |||||
$ | 7,859 | $ | 7,626 | ||||||
Depreciation expense was $486 million and $954 million for the second quarter and first six months of 2014, respectively, and $434 million and $871 million for the second quarter and first six months of 2013, respectively. Other noncurrent assets included land held for development of $55 million as of February 27, 2014 and $54 million as of August 29, 2013. |
Equity_Method_Investments
Equity Method Investments | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Equity Method Investments | ' | ||||||||||||||||
Equity Method Investments | |||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||
Investment Balance | Ownership Percentage | Investment Balance | Ownership Percentage | ||||||||||||||
Inotera(1) | $ | 566 | 35 | % | $ | 344 | 35 | % | |||||||||
Tera Probe | 41 | 40 | % | 40 | 40 | % | |||||||||||
Other | 11 | Various | 12 | Various | |||||||||||||
$ | 618 | $ | 396 | ||||||||||||||
(1) Entity is a variable interest entity. | |||||||||||||||||
As of February 27, 2014, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was our $566 million investment balance in Inotera. We may also incur losses in connection with our rights and obligations to purchase substantially all of Inotera's wafer production capacity under a supply agreement with Inotera. | |||||||||||||||||
We recognize our share of earnings or losses from our equity method investments generally on a two-month lag. Equity in net income (loss) of equity method investees, net of tax, included the following: | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Inotera | $ | 131 | $ | (55 | ) | $ | 215 | $ | (108 | ) | |||||||
Tera Probe | 4 | — | 6 | — | |||||||||||||
Other | (1 | ) | (3 | ) | (1 | ) | (2 | ) | |||||||||
$ | 134 | $ | (58 | ) | $ | 220 | $ | (110 | ) | ||||||||
Inotera | |||||||||||||||||
We have partnered with Nanya in Inotera, a Taiwan DRAM memory company, since the first quarter of 2009. As of February 27, 2014, we held a 35% ownership interest, Nanya and its affiliates held a 36% ownership interest and the remaining ownership interest in Inotera was publicly held. | |||||||||||||||||
As of February 27, 2014, the market value of our equity interest in Inotera was $1.81 billion based on the closing trading price of its shares in an active market. As of February 27, 2014 and August 29, 2013, there were gains of $45 million and $44 million, respectively, in accumulated other comprehensive income (loss) for cumulative translation adjustments from our equity investment in Inotera. | |||||||||||||||||
As of December 31, 2013, Inotera's current liabilities exceeded its current assets by $129 million, which exposes Inotera to liquidity risk. As of December 31, 2013, Inotera was not in compliance with certain loan covenants and had not been in compliance for the past several years. The terms of the loan covenants require Inotera to cure the noncompliance no later than June 30, 2014. Inotera has requested a waiver from complying with the December 31, 2013 financial covenants. For the year ended December 31, 2013, Inotera generated net income of $703 million, which has improved its liquidity. | |||||||||||||||||
Through December 2012, we had rights and obligations to purchase 50% of Inotera's wafer production capacity based on a margin-sharing formula among Nanya, Inotera and us. In the second quarter of 2013, we entered into agreements with Nanya and Inotera to amend the joint venture relationship involving Inotera. The amendments included a new supply agreement (the "Inotera Supply Agreement") with Inotera under which we were obligated to purchase for an initial period through December 2015 substantially all of Inotera's output at a purchase price based on a discount from market prices for our comparable components. The Inotera Supply Agreement contemplates annual negotiations with respect to potential successive one-year extensions, and if in any year the parties do not agree to an extension, the agreement will terminate following the end of the then-existing term plus a subsequent three-year wind-down period. Our share of Inotera's capacity would decline over the three year wind-down period. In the second quarter of 2014, we extended the initial period of the Inotera Supply Agreement through December 2016. Under the Inotera supply agreements, we purchased $714 million and $1,301 million of DRAM products in the second quarter and first six months of 2014, respectively, and $200 million and $401 million in the second quarter and first six months of 2013, respectively. | |||||||||||||||||
Pursuant to a cost-sharing arrangement with Nanya, which was effective through December 31, 2012, our research and development ("R&D") costs were reduced by $4 million and $19 million in the second quarter and first six months of 2013, respectively. Nanya ceased participating in the joint development program after December 31, 2012. | |||||||||||||||||
Tera Probe | |||||||||||||||||
In the fourth quarter of 2013, as part of the Elpida Acquisition, we acquired a 40% interest in Tera Probe, Inc. ("Tera Probe"), which provides semiconductor wafer testing and probe services to us and others. The initial net carrying value of our investment was less than our proportionate share of Tera Probe's equity and the difference is being amortized as a credit to earnings through equity in net income (loss) of equity method investees (the "Tera Probe Amortization"). As of February 27, 2014, the remaining balance of the Tera Probe Amortization was $32 million and is expected to be amortized over a weighted-average period of 6 years. As of February 27, 2014, based on the closing trading price of Tera Probe's shares in an active market, the market value of our equity interest was $42 million. Included in our cost of goods sold for the second quarter and first six months of 2014 is $31 million and $64 million, respectively, for services performed by Tera Probe. | |||||||||||||||||
Other | |||||||||||||||||
Aptina: Other equity method investments included a 30% equity interest in Aptina. The amount of cumulative loss we recognized from our investment in Aptina through the second quarter of 2012 reduced our investment balance to zero and we ceased recognizing our proportionate share of Aptina's results of operations. | |||||||||||||||||
In the second quarter and first six months of 2013, we recognized net sales of $48 million and $109 million, respectively, and cost of goods sold of $57 million and $138 million, respectively, from products sold to Aptina under a wafer supply agreement. In the third quarter of 2013, in connection with our sale of Micron Technology Italia, S.r.l. ("MIT") to LFoundry Marsica S.r.l. ("LFoundry"), we assigned to LFoundry our supply agreement with Aptina to manufacture image sensors at MIT. In 2013, we also loaned $45 million to Aptina under a short-term, interest-free, unsecured agreement which was repaid in the first six months of 2014. |
Intangible_Assets
Intangible Assets | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Intangible Assets | ' | ||||||||||||||||
Intangible Assets | |||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||
Gross | Accumulated | Gross | Accumulated | ||||||||||||||
Amount | Amortization | Amount | Amortization | ||||||||||||||
Product and process technology | $ | 660 | $ | (307 | ) | $ | 642 | $ | (269 | ) | |||||||
Customer relationships | 127 | (122 | ) | 127 | (114 | ) | |||||||||||
Other | 16 | (7 | ) | — | — | ||||||||||||
$ | 803 | $ | (436 | ) | $ | 769 | $ | (383 | ) | ||||||||
During the first six months of 2014 and 2013, we capitalized $19 million and $16 million, respectively, for product and process technology with weighted-average useful lives of 10 years. | |||||||||||||||||
Amortization expense was $31 million and $54 million for the second quarter and first six months of 2014, respectively, and $21 million and $41 million for the second quarter and first six months of 2013, respectively. Annual amortization expense is estimated to be $106 million for 2014, $74 million for 2015, $64 million for 2016, $54 million for 2017 and $44 million for 2018. | |||||||||||||||||
Accounts_Payable_and_Accrued_E
Accounts Payable and Accrued Expenses | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Disclosure Text Block [Abstract] | ' | ||||||||
Accounts Payable and Accrued Liabilities Disclosure | ' | ||||||||
Accounts Payable and Accrued Expenses | |||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Accounts payable | $ | 1,155 | $ | 1,048 | |||||
Related party payables | 714 | 374 | |||||||
Salaries, wages and benefits | 352 | 267 | |||||||
Customer advances | 156 | 140 | |||||||
Income and other taxes | 38 | 47 | |||||||
Other | 264 | 239 | |||||||
$ | 2,679 | $ | 2,115 | ||||||
As of February 27, 2014 and August 29, 2013, related party payables included $700 million and $345 million, respectively, due to Inotera primarily for the purchase of DRAM products under the Inotera Supply Agreement. As of February 27, 2014 and August 29, 2013, respectively, related party payables also included $14 million and $29 million due to Tera Probe for probe services performed. (See "Equity Method Investments" note.) | |||||||||
As of February 27, 2014 and August 29, 2013, customer advances included $61 million and $134 million, respectively, for amounts received from Intel to be applied to Intel's future purchases under a NAND Flash supply agreement. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.) As of February 27, 2014, customer advances also included $90 million for amounts received from a customer in the first quarter of 2014 under a DRAM supply agreement to be applied to purchases at market pricing through September 2016. As of February 27, 2014, other noncurrent liabilities included $135 million from the DRAM supply agreement. | |||||||||
As of February 27, 2014 and August 29, 2013, other accounts payable included $14 million and $8 million, respectively, due to Intel for NAND Flash product design and process development and licensing fees pursuant to cost-sharing agreements. (See "Equity – Noncontrolling Interests in Subsidiaries – IMFT" note.) | |||||||||
Debt
Debt | 6 Months Ended | ||||||||||||||||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||||||||||||||||
Debt | ' | ||||||||||||||||||||||||||||||
Debt | |||||||||||||||||||||||||||||||
27-Feb-14 | 29-Aug-13 | ||||||||||||||||||||||||||||||
Instrument(1) | Stated Rate | Effective Rate | Current | Long-Term | Total | Current | Long-Term | Total | |||||||||||||||||||||||
Elpida creditor installment payments; $1,392 and $1,969 principal amount | N/A | 6.25 | % | $ | 189 | $ | 926 | $ | 1,115 | $ | 527 | $ | 1,117 | $ | 1,644 | ||||||||||||||||
Capital lease obligations; | N/A | N/A | 352 | 694 | 1,046 | 407 | 845 | 1,252 | |||||||||||||||||||||||
imputed rate of 4.33% and 4.07% | |||||||||||||||||||||||||||||||
2014 convertible senior notes; | 1.875 | % | 7.88 | % | 677 | — | 677 | 465 | — | 465 | |||||||||||||||||||||
$419 and $485 principal amount | |||||||||||||||||||||||||||||||
2019 senior notes; | 1.258 | % | 1.97 | % | 92 | 370 | 462 | — | — | — | |||||||||||||||||||||
$462 principal amount | |||||||||||||||||||||||||||||||
2022 senior notes; | 5.875 | % | 6.16 | % | — | 600 | 600 | — | — | — | |||||||||||||||||||||
$600 principal amount | |||||||||||||||||||||||||||||||
2027 convertible senior notes; | 1.875 | % | 6.95 | % | — | — | — | — | 147 | 147 | |||||||||||||||||||||
$0 and $175 principal amount | |||||||||||||||||||||||||||||||
2031A convertible senior notes; | 1.5 | % | 6.55 | % | — | — | — | — | 277 | 277 | |||||||||||||||||||||
$0 and $345 principal amount | |||||||||||||||||||||||||||||||
2031B convertible senior notes;(2)(3) | 1.875 | % | 6.98 | % | 85 | — | 85 | — | 253 | 253 | |||||||||||||||||||||
$114 and $345 principal amount | |||||||||||||||||||||||||||||||
2032C convertible senior notes;(2) | 2.375 | % | 5.95 | % | — | 385 | 385 | — | 463 | 463 | |||||||||||||||||||||
$450 and $550 principal amount | |||||||||||||||||||||||||||||||
2032D convertible senior notes;(2) | 3.125 | % | 6.33 | % | — | 342 | 342 | — | 369 | 369 | |||||||||||||||||||||
$412 and $450 principal amount | |||||||||||||||||||||||||||||||
2033E convertible senior notes;(2)(3) | 1.625 | % | 4.5 | % | 275 | — | 275 | — | 272 | 272 | |||||||||||||||||||||
$300 principal amount | |||||||||||||||||||||||||||||||
2033F convertible senior notes;(2)(3) | 2.125 | % | 4.93 | % | 263 | — | 263 | — | 260 | 260 | |||||||||||||||||||||
$300 principal amount | |||||||||||||||||||||||||||||||
2043G convertible senior notes; | 3 | % | 6.77 | % | — | 631 | 631 | — | — | — | |||||||||||||||||||||
$1,025 principal amount | |||||||||||||||||||||||||||||||
Other notes payable | 2.947 | % | 3.51 | % | 297 | 369 | 666 | 186 | 449 | 635 | |||||||||||||||||||||
$ | 2,230 | $ | 4,317 | $ | 6,547 | $ | 1,585 | $ | 4,452 | $ | 6,037 | ||||||||||||||||||||
(1) We have the obligation or option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | |||||||||||||||||||||||||||||||
(2) Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on December 31, 2013 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended March 31, 2014. | |||||||||||||||||||||||||||||||
(3) As a result of these notes being convertible at the option of the holder through March 31, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||
Debt Restructure | |||||||||||||||||||||||||||||||
During the first and second quarters of 2014, we initiated a series of actions to restructure our debt as follows: | |||||||||||||||||||||||||||||||
Exchange Transactions | |||||||||||||||||||||||||||||||
• | In November 2013, we exchanged $440 million in aggregate principal amount of our 2027 Notes, 2031A Notes and 2031B Notes into 3.00% Convertible Senior Notes due 2043. | ||||||||||||||||||||||||||||||
Debt Conversions and Settlements | |||||||||||||||||||||||||||||||
• | In November 2013, we announced the termination of the conversion rights for our remaining 2027 Notes, effective on December 13, 2013; | ||||||||||||||||||||||||||||||
• | In November 2013, we called for the redemption of our remaining 2031A Notes on December 7, 2013; and | ||||||||||||||||||||||||||||||
• | In January 2014, we called for the redemption of our remaining 2014 Notes on March 3, 2014. | ||||||||||||||||||||||||||||||
During the first and second quarters of 2014, substantially all of the holders of these notes exercised their options to convert their notes and, in each case, we elected to settle the conversion amounts entirely in cash. | |||||||||||||||||||||||||||||||
Cash Repurchases | |||||||||||||||||||||||||||||||
• | In January 2014, we repurchased $164 million in aggregate principal amount of our 2031B Notes, 2032C Notes and 2032D Notes in privately-negotiated transactions for an aggregate of $407 million in cash. | ||||||||||||||||||||||||||||||
Issuance of Non-Convertible Notes | |||||||||||||||||||||||||||||||
• | In February 2014, we issued $600 million in principal amount of 5.875% senior notes due February 2022. | ||||||||||||||||||||||||||||||
Exchange Transactions: On November 12, 2013, in a series of separate non-cash transactions, we exchanged portions of our 2027 Notes, 2031A Notes and 2031B Notes (collectively, the "Exchanged Notes") into 3.00% Convertible Senior Notes due 2043 (the "2043G Notes") (collectively, the "Exchange Transactions"). In connection with the Exchange Transactions, which were accounted for as extinguishments, we issued to holders of the Exchanged Notes new 2043G Notes with an aggregate principal amount at issuance of $820 million, which accretes up to a principal amount at maturity of $1,025 million (see further discussion in "2043G Notes" below). The liability and equity components of the Exchanged Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, our accounting for the Exchanged Notes affected debt and equity. In connection with the Exchanged Notes, we recognized a loss of $38 million based on the difference between the carrying values and the fair values of the debt components of the Exchanged Notes (based on Level 2 fair value measurements), which was included in other non-operating expense for the first quarter of 2014. The table below summarizes the Exchange Transactions: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
Amounts reduced in connection with the Exchanged Notes: | |||||||||||||||||||||||||||||||
2027 Notes | $ | 80 | $ | 68 | $ | 51 | |||||||||||||||||||||||||
2031A Notes | 155 | 125 | 148 | ||||||||||||||||||||||||||||
2031B Notes | 205 | 152 | 212 | ||||||||||||||||||||||||||||
440 | 345 | 411 | |||||||||||||||||||||||||||||
Amounts added in connection with the issued notes: | |||||||||||||||||||||||||||||||
2043G Notes | 1,025 | 627 | 173 | ||||||||||||||||||||||||||||
Net increase (decrease) as a result of the Exchange Transactions | $ | 585 | $ | 282 | $ | (238 | ) | ||||||||||||||||||||||||
Debt Conversions and Settlements: During the first and second quarters of 2014, we initiated a series of actions resulting in a number of debt conversions and settlements. Those actions included the following: | |||||||||||||||||||||||||||||||
Termination of Conversion Rights of our 2027 Notes – On November 7, 2013, we announced the termination of the conversion rights for our remaining 2027 Notes, effective on December 13, 2013. During the first and second quarters of 2014, substantially all of holders of our 2027 Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. | |||||||||||||||||||||||||||||||
Redemption of our 2031A Notes – On November 7, 2013, we called for the redemption of our remaining 2031A Notes on December 7, 2013. During the first and second quarters of 2014, substantially all of holders of our 2031A Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. | |||||||||||||||||||||||||||||||
Redemption of our 2014 Notes – On January 31, 2014, we called for the redemption of our remaining 2014 Notes on March 3, 2014. During the second quarter of 2014, substantially all of the holders of our 2014 Notes exercised their option to convert their notes and, in each case, we elected to settle the conversion amount entirely in cash. | |||||||||||||||||||||||||||||||
As a result of our elections to settle the conversion amounts in cash, each of the settlement obligations became derivative debt liabilities subject to mark-to-market accounting treatment. Under the terms of the indentures for the above notes, cash settlement amounts for these derivative debt liabilities are determined based on the shares underlying the converted notes multiplied by the volume-weighted-average price of our common stock over a period of 20 consecutive trading days, beginning three days after the holder's election to convert their notes. Therefore, we reclassified the fair values of the equity components of each of the converted notes from additional capital to derivative debt liabilities within current debt in our consolidated balance sheet. In connection with the above, we used an aggregate of $728 million in cash in the second quarter of 2014 to settle conversion activities. A summary of the conversion activities for these notes is as follows: | |||||||||||||||||||||||||||||||
Debt Principal Converted | Carrying Value of Debt Converted | Equity Component Reclassified To Debt(1) | Mark-to-Market Loss(Gain)(2) | Loss on Settlement(2) | |||||||||||||||||||||||||||
Quarter ended November 28, 2013: | |||||||||||||||||||||||||||||||
2027 Notes | $ | — | $ | — | $ | 58 | $ | 22 | $ | — | |||||||||||||||||||||
2031A Notes | — | — | 115 | 15 | — | ||||||||||||||||||||||||||
— | — | 173 | 37 | — | |||||||||||||||||||||||||||
Quarter ended February 27, 2014: | |||||||||||||||||||||||||||||||
2014 Notes | 66 | 65 | 309 | (1 | ) | 1 | |||||||||||||||||||||||||
2027 Notes | 95 | 80 | — | 4 | 15 | ||||||||||||||||||||||||||
2031A Notes | 190 | 154 | 102 | 12 | 38 | ||||||||||||||||||||||||||
351 | 299 | 411 | 15 | 54 | |||||||||||||||||||||||||||
Six months ended February 27, 2014 | $ | 351 | $ | 299 | $ | 584 | $ | 52 | $ | 54 | |||||||||||||||||||||
(1) Based on Level 2 fair value measurements. | |||||||||||||||||||||||||||||||
(2) Included in non-operating expense. | |||||||||||||||||||||||||||||||
In the third quarter of 2014, we used an aggregate of $718 million in cash to settle the remaining 2014 Notes. In connection therewith, we incurred an additional aggregate $8 million of mark-to-market and settlement losses for the 2014 Notes. | |||||||||||||||||||||||||||||||
Cash Repurchases: In January 2014, we repurchased $164 million in aggregate principal amount of our 2031B Notes, 2032C Notes and 2032D Notes (collectively, the "Repurchased Notes") in privately-negotiated transactions for an aggregate of $407 million in cash. The liability and equity components of the Repurchased Notes had previously been stated separately within debt and additional capital in our consolidated balance sheet. As a result, our accounting for the Repurchased Notes reduced a component of debt and a component of equity. In connection with the Repurchased Notes, we recognized a loss of $11 million (based on Level 2 fair value measurements), which is included in other non-operating expense in the second quarter of 2014. The table below summarizes activity in the second quarter of 2014 with respect to Repurchased Notes: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
2031B Notes | $ | 26 | $ | 19 | $ | 43 | |||||||||||||||||||||||||
2032C Notes | 100 | 85 | 159 | ||||||||||||||||||||||||||||
2032D Notes | 38 | 31 | 60 | ||||||||||||||||||||||||||||
$ | 164 | $ | 135 | $ | 262 | ||||||||||||||||||||||||||
Issuance of Non-Convertible Notes: On February 5, 2014, we issued $600 million in principal amount of 5.875% Senior Notes due February 2022 (the "2022 Notes"). Issuance costs for the 2022 Notes totaled $14 million. | |||||||||||||||||||||||||||||||
The 2022 Notes contain covenants that, among other things, limit, in certain circumstances, our ability and/or the ability of our domestic restricted subsidiaries (which are generally subsidiaries in the U.S. in which we own at least 80% of the voting stock) to (1) create or incur certain liens and enter into sale and lease-back transactions, (2) create, assume, incur or guarantee certain additional secured indebtedness and unsecured indebtedness of certain of our domestic restricted subsidiaries, and (3) consolidate with or merge with or into, or convey, transfer or lease all or substantially all of our assets, to another entity. These covenants are subject to a number of limitations, exceptions and qualifications. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: Prior to February 15, 2017, we may redeem the 2022 Notes, in whole or in part, at a price equal to the principal amount of the 2022 Notes to be redeemed plus a make-whole premium as described in the indenture governing the 2022 Notes, together with accrued and unpaid interest. Additionally, we may use the net cash proceeds of one or more equity offerings to redeem up to 35% of the aggregate principal amount of the 2022 Notes at a price equal to 105.875% of the principal amount together with accrued and unpaid interest. On or after February 15, 2017, we may redeem the 2022 Notes, in whole or in part, at prices above principal amount that decline over time, as specified in the indenture, together with accrued and unpaid interest. | |||||||||||||||||||||||||||||||
Elpida Creditor Installment Payments | |||||||||||||||||||||||||||||||
In October 2013, we made the first Elpida creditor installment payment of $534 million from funds that had been held in a current restricted cash account since the acquisition date. The remaining payments are due at the end of each calendar year from 2014 through 2019. | |||||||||||||||||||||||||||||||
2043G Notes | |||||||||||||||||||||||||||||||
In connection with the Exchange Transactions, on November 12, 2013, we issued $1,025 million principal amount of 2043G Convertible Senior Notes (the "2043G Notes"). Each $1,000 principal amount at maturity had an original issue price of $800. An amount equal to the difference between the original issue price and the principal amount at maturity will accrete in accordance with a schedule set forth in the indenture. The initial conversion rate for the 2043G Notes is 34.2936 shares of common stock per $1,000 principal amount at maturity, equivalent to an initial conversion price of approximately $29.16 per share of common stock. | |||||||||||||||||||||||||||||||
Upon issuance of the 2043G Notes, we recorded $627 million of debt, $173 million of additional capital and $5 million of deferred debt issuance costs (included in other noncurrent assets). The amount recorded as debt was based on the fair value of the debt component as a standalone instrument and was determined using an average interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance (Level 2 fair value measurements). We recorded a debt discount of $398 million for the difference between the debt recorded at inception and the principal amount at maturity. Holders of the 2043G Notes have the right to require us to repurchase all or a portion of their notes on November 15, 2028 at the accreted principal amount, which is scheduled to be $917 million at such date. We have the option to pay cash, issue shares of common stock or any combination thereof, for the aggregate amount due upon conversion. It is our current intent to settle in cash the principal amount of the 2043G Notes upon conversion. As a result, the dilutive effect of the 2043G Notes in earnings per share is computed under the treasury stock method. | |||||||||||||||||||||||||||||||
Conversion Rights: Holders may convert their 2043G Notes under the following circumstances: (1) if the 2043G Notes are called for redemption; (2) during any calendar quarter if the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the conversion price (approximately $37.91 per share) of the 2043G Notes; (3) if the trading price of the 2043G Notes is less than 98% of the product of the closing price of our common stock and the conversion rate of the 2043G Notes during the periods specified in the indenture; (4) if specified distributions or corporate events occur, as set forth in the indenture; or (5) at any time after August 15, 2043. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: Prior to November 20, 2018, we may redeem for cash the 2043G Notes if the closing price of our common stock is more than 130% of the conversion price for at least 20 trading days in the 30 consecutive trading days ending within five trading days prior to the date on which we provide notice of redemption. The redemption price would equal the principal amount at maturity plus accrued and unpaid interest. On or after November 20, 2018, we may redeem for cash the 2043G Notes without regard to the closing price of our common stock. The redemption price would equal the accreted principal amount plus accrued and unpaid interest. If we redeem the 2043G Notes prior to November 20, 2018, we are required to pay in cash a make-whole premium as specified in the indenture. | |||||||||||||||||||||||||||||||
Cash Repurchase at the Option of the Holder: Holders of the 2043G Notes may require us to repurchase for cash all or a portion of the 2043G Notes on November 15, 2028. The repurchase price is equal to the accreted principal amount at such date plus accrued and unpaid interest. Holders of the 2043G Notes may also require us to repurchase for cash all or a portion of their 2043G Notes at a repurchase price equal to the accreted principal amount plus accrued and unpaid interest upon a change in control or a termination of trading, as defined in the indenture. | |||||||||||||||||||||||||||||||
2019 Notes | |||||||||||||||||||||||||||||||
On December 20, 2013, we issued $462 million in principal amount of 1.258% Secured Notes due January 2019 (the "2019 Notes"). The 2019 Notes mature on January 15, 2019 and are collateralized by certain equipment which had a carrying value of $240 million as of February 27, 2014. The principal amount of the 2019 Notes is payable in 10 consecutive semi-annual installments payable in January and July of each year, commencing in July 2014. The Export-Import Bank of the United States ("Ex-Im Bank") guaranteed payment of all regularly scheduled installment payments of principal of, and interest on, the 2019 Notes. We paid $23 million to Ex-Im Bank for its guarantee upon issuance of the 2019 Notes. | |||||||||||||||||||||||||||||||
The 2019 Notes contains covenants which are customary for financings of this type, including negative covenants that limit or restrict our ability to create liens or dispose of the equipment securing the 2019 Notes. Events of default also include, among others, the occurrence of any event or circumstance that, in the reasonable judgment of Ex-Im Bank, is likely materially and adversely to affect our ability to perform any payment obligation, or any of our other material obligations under the indenture, the 2019 Notes or under any other related transaction documents to which Ex-Im Bank is a party. | |||||||||||||||||||||||||||||||
Cash Redemption at Our Option: At any time prior to the maturity date of the 2019 Notes, we may redeem the 2019 Notes, in whole or in part, at a price equal to the principal amount of the 2019 Notes to be redeemed plus a make-whole premium as described in the indenture, together with accrued and unpaid interest. | |||||||||||||||||||||||||||||||
Other Notes Payable | |||||||||||||||||||||||||||||||
On February 27, 2014, in connection with our acquisition of an additional 9.87% interest in MMT, we recorded a $127 million note payable to the seller in monthly installments, without interest, from March 2014 through December 2014. | |||||||||||||||||||||||||||||||
Convertible Notes With Debt and Equity Components | |||||||||||||||||||||||||||||||
Accounting standards for convertible debt instruments that may be fully or partially settled in cash upon conversion require the debt and equity components to be separately accounted for in a manner that reflects a nonconvertible borrowing rate when interest expense is recognized in subsequent periods. The amount initially recorded as debt is based on the fair value of the debt component as a standalone instrument, determined using an average interest rate for similar nonconvertible debt issued by entities credit ratings similar to ours at the time of issuance. The difference between the debt recorded at inception and its principal amount is accreted to principal through interest expense through the estimated life of the note. | |||||||||||||||||||||||||||||||
The terms of certain of our convertible notes give holders the right to require us to repurchase all or a portion of their notes at a date or dates earlier than the contractual maturity of the notes or upon the occurrence of certain events or circumstances. In these cases, we amortize any initial debt discount or imputed interest over the period from issuance of the notes through the earliest date that holders can require us to repurchase all or a portion of their notes. As a result, the period of amortization can be significantly shorter than the contractual maturity. (See "Holder Put Date" in the table below.) | |||||||||||||||||||||||||||||||
As of February 27, 2014, the trading price of our common stock was higher than the initial conversion prices of all of our outstanding convertible notes, except for the 2043G Notes. As a result, the conversion values were in excess of principal amounts for such notes. The following table sets forth, as of February 27, 2014, a summary of certain features of our convertible notes: | |||||||||||||||||||||||||||||||
Holder Put Date | Outstanding Principal | Shares Issuable Upon Conversion | Initial Conversion Price Per Share | Conversion Price Per Share Threshold(1) | Conversion Value | ||||||||||||||||||||||||||
in Excess of Principal(2) | |||||||||||||||||||||||||||||||
2031B Notes | Aug-20 | $ | 114 | 12 | $ | 9.5 | $ | 12.35 | $ | 176 | |||||||||||||||||||||
2032C Notes | May-19 | 450 | 47 | 9.63 | 12.52 | 681 | |||||||||||||||||||||||||
2032D Notes | May-21 | 412 | 41 | 9.98 | 12.97 | 587 | |||||||||||||||||||||||||
2033E Notes | Feb-18 | 300 | 27 | 10.93 | 14.21 | 364 | |||||||||||||||||||||||||
2033F Notes | Feb-20 | 300 | 27 | 10.93 | 14.21 | 364 | |||||||||||||||||||||||||
2043G Notes(3) | Nov-28 | 1,025 | 35 | 29.16 | 37.91 | — | |||||||||||||||||||||||||
$ | 2,601 | 189 | $ | 2,172 | |||||||||||||||||||||||||||
(1) | Holders have the right to convert all or a portion of their notes at a date or dates earlier than the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the initial conversion price. | ||||||||||||||||||||||||||||||
(2) | Based on our closing share price of $24.19 as of February 27, 2014. | ||||||||||||||||||||||||||||||
(3) | The original principal amount of $820 million accretes up to $917 million in November 2028 and $1,025 million at maturity in 2043. | ||||||||||||||||||||||||||||||
Contractual Maturities | |||||||||||||||||||||||||||||||
The table below sets forth the contractual maturities of the Elpida creditor installment payments, convertible notes and other notes payable as of February 27, 2014: | |||||||||||||||||||||||||||||||
Remainder of 2014 | $ | 883 | |||||||||||||||||||||||||||||
2015 | 515 | ||||||||||||||||||||||||||||||
2016 | 441 | ||||||||||||||||||||||||||||||
2017 | 410 | ||||||||||||||||||||||||||||||
2018 | 609 | ||||||||||||||||||||||||||||||
2019 and thereafter | 3,443 | ||||||||||||||||||||||||||||||
Discounts | (800 | ) | |||||||||||||||||||||||||||||
$ | 5,501 | ||||||||||||||||||||||||||||||
Contingencies
Contingencies | 6 Months Ended |
Feb. 27, 2014 | |
Disclosure Text Block [Abstract] | ' |
Contingencies | ' |
Contingencies | |
We have accrued a liability and charged operations for the estimated costs of adjudication or settlement of various asserted and unasserted claims existing as of the balance sheet date, including those described below. We are currently a party to other legal actions arising from the normal course of business, none of which is expected to have a material adverse effect on our business, results of operations or financial condition. | |
Rambus | |
On May 5, 2004, Rambus, Inc. ("Rambus") filed a complaint in the Superior Court of the State of California (San Francisco County) against us and other DRAM suppliers which alleged that the defendants harmed Rambus by engaging in concerted and unlawful efforts affecting Rambus DRAM by eliminating competition and stifling innovation in the market for computer memory technology and computer memory chips. Rambus' complaint alleged various causes of action under California state law including, among other things, a conspiracy to restrict output and fix prices, a conspiracy to monopolize, intentional interference with prospective economic advantage, and unfair competition. Rambus sought a judgment for damages of approximately $3.9 billion, joint and several liability, trebling of damages awarded, punitive damages, a permanent injunction enjoining the defendants from the conduct alleged in the complaint, interest, and attorneys' fees and costs. Trial began on June 20, 2011, and the case went to the jury on September 21, 2011. On November 16, 2011, the jury found for us on all claims. On April 2, 2012, Rambus filed a notice of appeal to the California 1st District Court of Appeal. | |
We were engaged in litigation with Rambus relating to certain of Rambus' patents and certain of our claims and defenses. Our lawsuits with Rambus related to patent matters were pending in the U.S. District Court for the District of Delaware, U.S. District Court for the Northern District of California, Germany, France, and Italy. | |
In December 2013, we settled all pending litigation between us and Rambus, including all antitrust and patent matters. We also entered into a 7-year term patent cross-license agreement with Rambus that allows us to avoid costs of patent-related litigation during the term. We agreed to pay Rambus up to $10 million per quarter over seven years, for a total of $280 million, beginning in the second quarter of 2014. The primary benefits we received from these arrangements were (1) the settlement and termination of all existing litigation, (2) the avoidance of future litigation expenses and (3) the avoidance of future management and customer disruptions. As a result, other operating expense for the first quarter of 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement. | |
Patent Matters | |
As is typical in the semiconductor and other high technology industries, from time to time others have asserted, and may in the future assert, that our products or manufacturing processes infringe their intellectual property rights. | |
On September 1, 2011, HSM Portfolio LLC and Technology Properties Limited LLC filed a patent infringement action in the U.S. District Court for the District of Delaware against us and seventeen other defendants, including Elpida Memory, Inc. and Elpida Memory (USA) Inc. (collectively “Elpida”). On August 22, 2013, the plaintiffs filed a third amended complaint. The third amended complaint alleges that certain of our DRAM and image sensor products infringe four U.S. patents and that certain Elpida DRAM products infringe two U.S. patents and seeks damages, attorneys' fees, and costs. Trial currently is scheduled for February 8, 2016. On March 23, 2012, Elpida filed a Notice of Filing and Hearing on Petition Under Chapter 15 of the U.S. Bankruptcy Code and Issuance of Provisional Relief that included an order of the U.S. Bankruptcy Court for the District of Delaware staying judicial proceedings against Elpida. Accordingly, the plaintiffs' case against Elpida is stayed. | |
On December 5, 2011, the Board of Trustees for the University of Illinois (the "University") filed a patent infringement action against us in the U.S. District Court for the Central District of Illinois. The complaint alleges that unspecified semiconductor products of ours infringe three U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. We have filed three petitions for inter-partes review by the Patent and Trademark Office, challenging the validity of each of the patents in suit. The Patent Trial and Appeal Board (“PTAB”) held a hearing in connection with the three petitions on December 9, 2013. On March 10, 2014, the PTAB issued written decisions finding that each and every claim in the three patents in suit is invalid, and cancelled all claims. The University has a right to appeal the PTAB rulings to the U.S. Court of Appeals for the Federal Circuit. | |
On April 27, 2012, Semcon Tech, LLC filed a patent infringement action against us in the U.S. District Court for the District of Delaware. The complaint alleges that our use of various chemical mechanical planarization systems purchased from Applied Materials and others infringes a single U.S. patent and seeks injunctive relief, damages, attorneys' fees, and costs. On September 24, 2013, the Court entered an order staying our case pending the resolution of co-pending cases brought by Semcon Tech, LLC against Applied Materials and Ebara Technologies, Inc. Subsequently these cases were resolved, and on February 21, 2014, the Court lifted the stay of the case against us. Trial currently is for August 21, 2015. | |
On December 7, 2007, Tessera, Inc. filed a patent infringement against Elpida Memory, Inc., Elpida Memory (USA) Inc. (collectively "Elpida"), and numerous other defendants, in the United States District Court for the Eastern District of Texas. The complaint alleges that certain Elpida products infringe four U.S. patents and seeks injunctive relief, damages, attorneys' fees, and costs. Prior to answering the complaint, Elpida and other defendants filed motions to stay the case pending final resolution of a case before the International Trade Commission ("ITC") against Elpida and other respondents, alleging infringement of the same patents asserted in the Eastern District of Texas case (In The Matter of Certain Semiconductor Chips with Minimized Chip Package Size and Products Containing Same (III), ITC No. 337-TA-630 (the "ITC Action")). On February 25, 2008, the Eastern District of Texas Court granted the defendants' motion to stay the action. On December 29, 2009, the ITC issued a Notice of Final Determination in the ITC Action finding no violation by Elpida. Tessera Inc. subsequently appealed the matter to the U.S. Court of Appeals for the Federal Circuit. On May 23, 2011, the Federal Circuit affirmed the ITC's Final Determination. The Eastern District of Texas case currently remains stayed. | |
Among other things, the above lawsuits pertain to certain of our DDR, DDR2, DDR3, SDR SDRAM, PSRAM, RLDRAM, LPSDR, NAND Flash, image sensor products and certain other memory products we manufacture, which account for a significant portion of our net sales. | |
We are unable to predict the outcome of assertions of infringement made against us and therefore cannot estimate the range of possible loss. A court determination that our products or manufacturing processes infringe the intellectual property rights of others could result in significant liability and/or require us to make material changes to our products and/or manufacturing processes. Any of the foregoing could have a material adverse effect on our business, results of operations or financial condition. | |
Antitrust Matters | |
At least sixty-eight purported class action price-fixing lawsuits have been filed against us and other DRAM suppliers in various federal and state courts in the United States and in Puerto Rico on behalf of indirect purchasers alleging a conspiracy to increase DRAM prices in violation of federal and state antitrust laws and state unfair competition law, and/or unjust enrichment relating to the sale and pricing of DRAM products during the period from April 1999 through at least June 2002. The complaints seek joint and several damages, trebled, in addition to restitution, costs and attorneys' fees. A number of these cases were removed to federal court and transferred to the U.S. District Court for the Northern District of California for consolidated pre-trial proceedings. In July, 2006, the Attorneys General for approximately forty U.S. states and territories filed suit in the U.S. District Court for the Northern District of California. The complaints allege, among other things, violations of the Sherman Act, Cartwright Act, and certain other states' consumer protection and antitrust laws and seek joint and several damages, trebled, as well as injunctive and other relief. On October 3, 2008, the California Attorney General filed a similar lawsuit in California Superior Court, purportedly on behalf of local California government entities, alleging, among other things, violations of the Cartwright Act and state unfair competition law. On June 23, 2010, we executed a settlement agreement resolving these purported class-action indirect purchaser cases and the pending cases of the Attorneys General relating to alleged DRAM price-fixing in the United States. Subject to certain conditions, including final court approval of the class settlements, we agreed to pay approximately $67 million in aggregate in three equal installments over a two-year period. We paid the full amount into an escrow account by the end of the first quarter of 2013 in accordance with the settlement agreement. | |
On June 21, 2010, the Brazil Secretariat of Economic Law of the Ministry of Justice ("SDE") announced that it had initiated an investigation relating to alleged anticompetitive activities within the DRAM industry. The SDE's Notice of Investigation names various DRAM manufacturers and certain executives, including us, and focuses on the period from July 1998 to June 2002. | |
We are unable to predict the outcome of these matters and therefore cannot estimate the range of possible loss, except as noted in the above discussion of the U.S. indirect purchaser cases. The final resolution of these alleged violations of antitrust laws could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition. | |
Securities Matters | |
On July 12, 2013, seven former shareholders of Elpida Memory, Inc. ("Elpida") filed a complaint against Messrs. Sakamoto, Adachi, Gomi, Shirai, Tsay-Jiu, Wataki, Kinoshita, and Takahasi in their capacity as members of the board of directors of Elpida as of February 2013. The complaint alleges that the defendants engaged in various acts and misrepresentations to hide the financial condition of Elpida and deceive shareholders prior to Elpida filing a petition for corporate reorganization on February 27, 2013. The plaintiffs seek joint and several damages equal to the market value of shares owned by each of the plaintiffs on February 23, 2013, along with attorneys’ fees and interest. At a hearing on September 25, 2013, the plaintiffs withdrew the complaint against Mr. Tsay-Jiu. | |
We are unable to predict the outcome of this matter and therefore cannot estimate the range of possible loss. The final resolution of this matter could result in significant liability and could have a material adverse effect on our business, results of operations or financial condition. | |
Qimonda | |
On January 20, 2011, Dr. Michael Jaffé, administrator for Qimonda AG ("Qimonda") insolvency proceedings, filed suit against Micron Technology, Inc. (“Micron Technology”) and Micron Semiconductor B.V., our Netherlands subsidiary (“Micron B.V.”), in the District Court of Munich, Civil Chamber. The complaint seeks to void under Section 133 of the German Insolvency Act a share purchase agreement between Micron B.V. and Qimonda signed in fall 2008 pursuant to which Micron B.V. purchased substantially all of Qimonda's shares of Inotera Memories, Inc. (the “Inotera Shares”) and seeks an order requiring us to retransfer those shares to the Qimonda estate. The complaint also seeks, among other things, to recover damages for the alleged value of the joint venture relationship with Inotera and to terminate under Sections 103 or 133 of the German Insolvency Code a patent cross-license between us and Qimonda entered into at the same time as the share purchase agreement. | |
Following a series of hearings with pleadings, arguments and witnesses on behalf of the Qimonda estate, on March 13, 2014, the Court issued judgments: (i) ordering Micron B.V. to pay approximately $1 million in respect of certain Inotera shares sold in connection with the original share purchase; (ii) ordering Micron B.V. to disclose certain information with respect to any Inotera Shares sold by it to third parties; (iii) ordering Micron B.V. to disclose the benefits derived by it from ownership of the Inotera Shares, including in particular, any profits distributed on such shares and all other benefits; (iv) denying Qimonda’s claims against Micron Technology for any damages relating to the joint venture relationship with Inotera; and (v) determining that Qimonda's obligations under the patent cross-license agreement are cancelled. In addition, the Court issued interlocutory judgments ordering, among other things: (i) that Micron B.V. transfer to the Qimonda estate the Inotera Shares still owned by it and pay to the Qimonda estate compensation in an amount to be specified for any Inotera Shares sold to third parties; and (ii) that Micron B.V. pay the Qimonda estate as compensation an amount to be specified for benefits derived by it from ownership of the Inotera Shares. The interlocutory judgments have no immediate, enforceable effect on us, and, accordingly, we expect to be able to continue to operate with full control of the Inotera Shares subject to further developments in the case. All of these judgments are immediately appealable, and we have until April 28, 2014 to file a notice of appeal. | |
We are unable to predict the outcome of the matter and therefore cannot estimate the range of possible loss. The final resolution of this lawsuit could result in the loss of the Inotera shares or equivalent monetary damages, unspecified damages based on the benefits derived by Micron B.V. from the ownership of the Inotera Shares, and/or the termination of the patent cross-license, which could have a material adverse effect on our business, results of operation or financial condition. As of February 27, 2014, the Inotera Shares had a carrying value for purposes of our financial reporting of $312 million and a market value of $1,002 million. | |
Other | |
In the normal course of business, we are a party to a variety of agreements pursuant to which we may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations and the unique facts and circumstances involved in each particular agreement. Historically, our payments under these types of agreements have not had a material adverse effect on our business, results of operations or financial condition. |
Redeemable_Convertible_Notes
Redeemable Convertible Notes | 6 Months Ended |
Feb. 27, 2014 | |
Disclosure Text Block [Abstract] | ' |
Convertible Debt Equity Disclosure [Text Block] | ' |
Redeemable Convertible Notes | |
Under the terms of the indentures of the 2031B and 2033E and 2033F Notes, upon conversion, we would be required to pay cash equal to the lesser of (1) the aggregate principal amount or (2) the conversion value of the notes being converted (we could pay cash, shares of common stock or a combination thereof, at our option, for the remainder, if any, of our conversion obligation). Therefore, the 2031B, 2033E and 2033F Notes were classified as current debt. Since these notes were convertible at the option of the holder and the principal amount of any converted notes would be required to be paid in cash, the aggregate difference of $91 million between the principal amount and the carrying value was classified as redeemable convertible notes in the mezzanine section of the accompanying consolidated balance sheet as of February 27, 2014. |
Equity
Equity | 6 Months Ended | |||||||||||||||||||||||||||
Feb. 27, 2014 | ||||||||||||||||||||||||||||
Disclosure Text Block [Abstract] | ' | |||||||||||||||||||||||||||
Equity | ' | |||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||
Changes in the components of equity were as follows: | ||||||||||||||||||||||||||||
Six Months Ended February 27, 2014 | Six Months Ended February 28, 2013 | |||||||||||||||||||||||||||
Attributable to Micron | Noncontrolling Interests | Total Equity | Attributable to Micron | Noncontrolling Interests | Total Equity | |||||||||||||||||||||||
Beginning balance | $ | 9,142 | $ | 864 | $ | 10,006 | $ | 7,700 | $ | 717 | $ | 8,417 | ||||||||||||||||
Net income (loss) | 1,089 | 33 | 1,122 | (561 | ) | 2 | (559 | ) | ||||||||||||||||||||
Other comprehensive income (loss) | (4 | ) | — | (4 | ) | (1 | ) | — | (1 | ) | ||||||||||||||||||
Comprehensive income (loss) | 1,085 | 33 | 1,118 | (562 | ) | 2 | (560 | ) | ||||||||||||||||||||
Contribution from noncontrolling interests | — | 49 | 49 | — | 10 | 10 | ||||||||||||||||||||||
Distributions to noncontrolling interests | — | (19 | ) | (19 | ) | — | — | — | ||||||||||||||||||||
Acquisition of noncontrolling interests in MMT | 31 | (167 | ) | (136 | ) | — | — | — | ||||||||||||||||||||
Capital and other transactions attributable to Micron | (974 | ) | — | (974 | ) | 93 | — | 93 | ||||||||||||||||||||
Ending balance | $ | 9,284 | $ | 760 | $ | 10,044 | $ | 7,231 | $ | 729 | $ | 7,960 | ||||||||||||||||
Micron Shareholders' Equity | ||||||||||||||||||||||||||||
Capped Calls | ||||||||||||||||||||||||||||
Issued and Outstanding Capped Calls: We have entered into a series of capped call transactions intended to reduce the effect of potential dilution upon conversion of our convertible notes which may be settled in shares or cash, at our election. The capped call transactions are considered capital transactions and the related cost was recorded as a charge to additional capital. | ||||||||||||||||||||||||||||
The following table presents information related to the issued and outstanding capped calls as of February 27, 2014. | ||||||||||||||||||||||||||||
Capped Calls | Strike Price(1) | Cap Price Range | Common Shares Covered | Value at Expiration(2) | ||||||||||||||||||||||||
Expiration Dates | Low | High | Minimum | Maximum | ||||||||||||||||||||||||
2031 | Jul-14 | - | Feb-16 | $ | 9.5 | $ | 11.4 | $ | 13.17 | 73 | $ | — | $ | 207 | ||||||||||||||
2032C | May-16 | - | Nov-17 | 9.8 | 14.26 | 15.69 | 56 | — | 307 | |||||||||||||||||||
2032D | Nov-16 | - | May-18 | 10.16 | 14.62 | 16.04 | 44 | — | 244 | |||||||||||||||||||
2033E | Jan-18 | - | Feb-18 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
2033F | Jan-20 | - | Feb-20 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
227 | $ | — | $ | 954 | ||||||||||||||||||||||||
(1) | Initial strike prices are subject to certain adjustments. | |||||||||||||||||||||||||||
(2) | Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchased would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration. | |||||||||||||||||||||||||||
Accumulated Other Comprehensive Income (Loss) | ||||||||||||||||||||||||||||
The changes in accumulated other comprehensive income (loss) by component in the first six months of 2014 were as follows: | ||||||||||||||||||||||||||||
Cumulative Foreign Currency Translation Adjustments | Gains (Losses) on Derivative Instruments, Net | Gains (Losses) on Investments, Net | Pension Liability Adjustments | Total | ||||||||||||||||||||||||
August 29, 2013 | $ | 44 | $ | 21 | $ | — | $ | (2 | ) | $ | 63 | |||||||||||||||||
Other comprehensive income before reclassifications | (4 | ) | (2 | ) | 4 | 1 | (1 | ) | ||||||||||||||||||||
Amount reclassified out of accumulated other comprehensive income | — | (1 | ) | (2 | ) | 1 | (2 | ) | ||||||||||||||||||||
Tax effects | — | (1 | ) | — | — | (1 | ) | |||||||||||||||||||||
Other comprehensive income (loss) | (4 | ) | (4 | ) | 2 | 2 | (4 | ) | ||||||||||||||||||||
February 27, 2014 | $ | 40 | $ | 17 | $ | 2 | $ | — | $ | 59 | ||||||||||||||||||
Noncontrolling Interests in Subsidiaries | ||||||||||||||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | ||||||||||||||||||||||||||
Noncontrolling Interest Balance | Noncontrolling Interest Percentage | Noncontrolling Interest Balance | Noncontrolling Interest Percentage | |||||||||||||||||||||||||
IMFT(1) | $ | 640 | 49 | % | $ | 601 | 49 | % | ||||||||||||||||||||
MP Mask(1) | 93 | 49.99 | % | 92 | 49.99 | % | ||||||||||||||||||||||
MMT | 21 | 1.24 | % | 155 | 11.11 | % | ||||||||||||||||||||||
Other | 6 | Various | 16 | Various | ||||||||||||||||||||||||
$ | 760 | $ | 864 | |||||||||||||||||||||||||
(1) Entity is a variable interest entity. | ||||||||||||||||||||||||||||
IMFT | ||||||||||||||||||||||||||||
Since its inception in 2006 through February 27, 2014, we have owned 51% of IMFT, a venture between us and Intel to manufacture NAND Flash memory products and certain emerging memory technologies, for the exclusive use of the members. IMFT is governed by a Board of Managers and the number of managers appointed by each member to the board varies based on the members' respective ownership interests, which is based on cumulative contributions to IMFT. The IMFT joint venture agreement extends through 2024 and includes certain buy-sell rights, commencing in 2015, pursuant to which Intel may elect to sell to us, or we may elect to purchase from Intel, Intel's interest in IMFT. If Intel elects to sell to us, we would set the closing date of the transaction within two years following such election and could elect to receive financing of the purchase price from Intel for one to two years from the closing date. | ||||||||||||||||||||||||||||
IMFT manufactures NAND Flash memory products using designs and technology we develop with Intel. We generally share with Intel the cost of product design, other NAND Flash R&D costs and R&D cost of certain emerging memory technologies. Our R&D expenses were reduced by reimbursements from Intel of $35 million and $64 million for the second quarter and first six months of 2014, respectively, and $34 million and $66 million for the second quarter and first six months of 2013, respectively. | ||||||||||||||||||||||||||||
We sell a portion of our products to Intel through our IMFT joint venture at long-term negotiated prices approximating cost. Sales of NAND Flash products to Intel under this arrangement were $104 million and $205 million for the second quarter and first six months of 2014, respectively, and $91 million and $190 million for the second quarter and first six months of 2013, respectively. Receivables from Intel for IMFT sales of NAND Flash products as of February 27, 2014 and August 29, 2013, were $62 million and $68 million, respectively. | ||||||||||||||||||||||||||||
The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances: | ||||||||||||||||||||||||||||
As of | February 27, | August 29, 2013 | ||||||||||||||||||||||||||
2014 | ||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||
Cash and equivalents | $ | 112 | $ | 62 | ||||||||||||||||||||||||
Receivables | 70 | 76 | ||||||||||||||||||||||||||
Inventories | 47 | 49 | ||||||||||||||||||||||||||
Other current assets | 5 | 4 | ||||||||||||||||||||||||||
Total current assets | 234 | 191 | ||||||||||||||||||||||||||
Property, plant and equipment, net | 1,348 | 1,382 | ||||||||||||||||||||||||||
Other noncurrent assets | 42 | 46 | ||||||||||||||||||||||||||
Total assets | $ | 1,624 | $ | 1,619 | ||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||
Accounts payable and accrued expenses | $ | 93 | $ | 88 | ||||||||||||||||||||||||
Deferred income | 8 | 9 | ||||||||||||||||||||||||||
Equipment purchase contracts | 11 | 78 | ||||||||||||||||||||||||||
Current debt | 6 | 6 | ||||||||||||||||||||||||||
Total current liabilities | 118 | 181 | ||||||||||||||||||||||||||
Long-term debt | 10 | 13 | ||||||||||||||||||||||||||
Other noncurrent liabilities | 114 | 118 | ||||||||||||||||||||||||||
Total liabilities | $ | 242 | $ | 312 | ||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. | ||||||||||||||||||||||||||||
Our ability to access IMFT's cash and other assets through cash dividends, loans or advances, including to finance our other operations, is subject to agreement by Intel. Creditors of IMFT have recourse only to its assets and do not have recourse to any other of our assets. | ||||||||||||||||||||||||||||
The following table presents IMFT's distributions to and contributions from its shareholders: | ||||||||||||||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||||||||||||||
February 27, | February 28, | February 27, | February 28, | |||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||
IMFT distributions to Micron | $ | 10 | $ | — | $ | 10 | $ | — | ||||||||||||||||||||
IMFT distributions to Intel | 10 | — | 10 | — | ||||||||||||||||||||||||
Micron contributions to IMFT | — | 10 | 51 | 10 | ||||||||||||||||||||||||
Intel contributions to IMFT | — | 10 | 49 | 10 | ||||||||||||||||||||||||
MP Mask | ||||||||||||||||||||||||||||
In 2006, we formed a joint venture with Photronics to produce photomasks for leading-edge and advanced next generation semiconductors. At inception and through February 27, 2014, we owned 50.01% and Photronics owned 49.99% of MP Mask. In connection with the formation of the joint venture, we received $72 million in 2006 in exchange for entering into a license agreement with Photronics, which is being recognized over the term of the 10-year agreement. Deferred income and other noncurrent liabilities included an aggregate of $16 million and $19 million as of February 27, 2014 and August 29, 2013, respectively, related to this agreement. We purchase a substantial majority of the reticles produced by MP Mask pursuant to a supply arrangement. | ||||||||||||||||||||||||||||
Total MP Mask assets and liabilities included in our consolidated balance sheets were as follows: | ||||||||||||||||||||||||||||
As of | February 27, | August 29, 2013 | ||||||||||||||||||||||||||
2014 | ||||||||||||||||||||||||||||
Current assets | $ | 37 | $ | 26 | ||||||||||||||||||||||||
Noncurrent assets (primarily property, plant and equipment) | 209 | 182 | ||||||||||||||||||||||||||
Current liabilities | 40 | 25 | ||||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. | ||||||||||||||||||||||||||||
Creditors of MP Mask have recourse only to the assets of MP Mask and do not have recourse to any other of our assets. | ||||||||||||||||||||||||||||
MMT | ||||||||||||||||||||||||||||
As a result of the acquisition of Elpida and MMT on July 31, 2013, noncontrolling interests in subsidiaries in our consolidated balance sheet included an approximate 11.11% ownership interest in MMT. In the second quarter of 2014, we purchased an additional 9.87% of MMT's outstanding common stock for $136 million. The purchase of substantially all of the shares was financed with a short-term loan from a seller. (See "Debt – Other Notes Payable" note.) As a result of the purchase of MMT shares, noncontrolling interest decreased by $167 million and additional capital increased by $31 million in the second quarter of 2014. |
Derivative_Instruments
Derivative Instruments | 6 Months Ended | ||||||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||||||
Derivative Financial Instruments | ' | ||||||||||||||||||||
Derivative Instruments | |||||||||||||||||||||
We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates and variable interest rates. We also have convertible note settlement obligations which became derivative instruments as a result of our elections to settle conversions in cash. We do not use derivative instruments for speculative purpose. | |||||||||||||||||||||
Derivative Instruments without Hedge Accounting Designation | |||||||||||||||||||||
Currency Derivatives: We use derivative instruments to manage a portion of our exposure to changes in currency exchange rates from our monetary assets and liabilities. Our primary objective in entering into currency derivatives is to reduce the volatility that changes in currency exchange rates have on our earnings. | |||||||||||||||||||||
To hedge our exposures to monetary assets and liabilities, we generally utilize a rolling hedge strategy with currency forward contracts that mature within 35 days. At the end of each reporting period, monetary assets and liabilities held or denominated in currencies other than the U.S. dollar are remeasured in U.S. dollars and the associated outstanding forward contracts are marked-to-market. Currency forward contracts are valued at fair values based on the middle of bid and ask prices of dealers or exchange quotations (Level 2 fair value measurements). In connection with the currency exchange rate risk associated with our acquisition of Elpida and the MMT shares in July 2013, we entered into currency exchange transactions (the "Elpida Acquisition Hedges"). The Elpida Acquisition Hedges were not designated for hedge accounting and were remeasured at fair value each period. We recorded losses from the Elpida Acquisition Hedges of $120 million and $178 million in the second quarter and first six months of 2013, respectively. To mitigate the risk that increases in exchange rates have on Elpida creditor installment payments due in December 2014 and December 2015, we entered into forward contracts to purchase 20 billion yen on November 28, 2014 and 10 billion yen on November 27, 2015. | |||||||||||||||||||||
Realized and unrealized gains and losses on currency derivatives without hedge accounting designation as well as the change in the underlying monetary assets and liabilities due to changes in currency exchange rates are included in other non-operating income (expense). | |||||||||||||||||||||
Interest Rate Swaps: We are party to interest rate swap contracts that mature in August 2017 to hedge against the variability of future interest payments due on floating-rate debt, which effectively converts the floating-rate debt to fixed-rate debt. Our primary objective of entering into interest rate swap contracts is to reduce the volatility that changes in interest rates on floating-rate debt have on interest expense. As of February 27, 2014, the principle balance on the floating-rate debt was $273 million. We designated 80% of the swaps as cash flow hedges and the remaining 20% were not designated for hedge accounting treatment. The fair values of the interest rate swaps are calculated by discounting the expected future cash flows based on inputs that are readily available in publicly quoted markets (Level 2 fair value measurements). Changes in the fair value of the undesignated portion are included in interest expense. | |||||||||||||||||||||
Convertible Notes Settlement Obligations: In connection with our debt restructure activities in the first six months of 2014, our settlement obligations for the 2014 Notes, 2027 Notes and 2031A Notes became derivative instruments for an approximate 30-day period ending on their respective settlement dates. The settlement dates varied through the first, second and third quarters of 2014. The fair values of the underlying conversion options were initially determined using the Black-Scholes option valuation model (Level 2 fair value measurements). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. Subsequent measurements of our convertible notes settlement obligations were based on the volume-weighted-average stock price (Level 1 fair value measurements). Changes in fair values of the derivative settlement obligations were included in other non-operating income (expense). | |||||||||||||||||||||
Total gross notional amounts and fair values for derivative instruments without hedge accounting designation were as follows: | |||||||||||||||||||||
Notional Amount(1) | Fair Value of | ||||||||||||||||||||
Current Assets(2) | Noncurrent Assets(3) | (Current Liabilities)(4) | (Noncurrent Liabilities)(5) | ||||||||||||||||||
As of February 27, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 321 | $ | — | $ | — | $ | (6 | ) | $ | (3 | ) | |||||||||
Singapore dollar | 321 | 1 | — | — | — | ||||||||||||||||
Shekel | 66 | — | — | — | — | ||||||||||||||||
Euro | 8 | — | — | — | — | ||||||||||||||||
Interest rate swap contracts | 55 | — | — | — | — | ||||||||||||||||
$ | 771 | ||||||||||||||||||||
Convertible notes settlement obligations | 26 | — | — | (265 | ) | — | |||||||||||||||
$ | 1 | $ | — | $ | (271 | ) | $ | (3 | ) | ||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 336 | $ | 1 | $ | 3 | $ | — | $ | — | |||||||||||
Singapore dollar | 218 | — | — | — | — | ||||||||||||||||
Shekel | 78 | — | — | (1 | ) | — | |||||||||||||||
Euro | 217 | 1 | — | (1 | ) | — | |||||||||||||||
Interest rate swap contracts | 62 | — | — | — | — | ||||||||||||||||
Currency options – New Taiwan dollar | 351 | — | — | — | — | ||||||||||||||||
$ | 1,262 | $ | 2 | $ | 3 | $ | (2 | ) | $ | — | |||||||||||
-1 | Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in millions of shares. | ||||||||||||||||||||
(2) | Included in receivables – other. | ||||||||||||||||||||
(3) | Included in other noncurrent assets. | ||||||||||||||||||||
(4) | Included in accounts payable and accrued expenses – other for forward, option and interest rate swap contracts and in current debt for convertible notes settlement obligations. | ||||||||||||||||||||
(5) | Included in other noncurrent liabilities. | ||||||||||||||||||||
Net losses for derivative instruments without hedge accounting designation were as follows: | |||||||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||||||
February 27, | February 28, | February 27, | February 28, | Location | |||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
Convertible notes settlement obligations | $ | (15 | ) | $ | — | $ | (52 | ) | $ | — | Other non-operating income (expense) | ||||||||||
Foreign exchange contracts | (7 | ) | (122 | ) | (21 | ) | (173 | ) | Other non-operating income (expense) | ||||||||||||
Derivative Instruments with Cash Flow Hedge Accounting Designation | |||||||||||||||||||||
Currency Derivatives: We utilize currency forward contracts that generally mature within 12 months and currency options that generally mature from 12 to 18 months to hedge our exposure to changes in cash flows from changes in currency exchange rates for certain capital expenditures and forecasted operating cash flows. Currency forward contracts are valued at their fair values based on market-based observable inputs including currency exchange spot and forward rates, interest rate and credit risk spread (Level 2 fair value measurements). Currency options are valued at their fair value using a modified Black-Scholes option valuation model using inputs of the current spot rate, strike price, risk-free interest rate, maturity, volatility and credit-risk spread (Level 2 fair value measurements). | |||||||||||||||||||||
Interest Rate Swaps: As noted above in “Derivative Instruments without Hedge Designation – Interest Rate Swaps,” we are party to interest rate swap contracts that mature in August 2017 to hedge against the variability in future interest payments due on $273 million of floating-rate debt and we designated 80% of the swaps as cash flow hedges. | |||||||||||||||||||||
For derivative instruments designated as cash flow hedges, the effective portion of the realized and unrealized gain or loss on the derivatives is included as a component of accumulated other comprehensive income (loss). For derivative instruments designated as cash flow hedges, the amounts in accumulated other comprehensive income (loss) are reclassified into earnings in the same line items of the consolidated statements of operation and in the same periods in which the underlying transactions affect earnings. The ineffective or excluded portion of the realized and unrealized gain or loss is included in other non-operating income (expense). Total gross notional amounts and fair values for derivative instruments with cash flow hedge accounting designation were as follows: | |||||||||||||||||||||
Notional Amount | Fair Value of Current Liabilities (1) | ||||||||||||||||||||
(in U.S. Dollars) | |||||||||||||||||||||
As of February 27, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Euro | $ | 2 | $ | — | |||||||||||||||||
Yen | 8 | (1 | ) | ||||||||||||||||||
Currency options – Yen | 3 | — | |||||||||||||||||||
Interest swap contracts | 218 | (1 | ) | ||||||||||||||||||
$ | 231 | $ | (2 | ) | |||||||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 6 | $ | (1 | ) | ||||||||||||||||
Euro | 6 | — | |||||||||||||||||||
Currency options – Yen | 21 | (2 | ) | ||||||||||||||||||
Interest swap contracts | 250 | — | |||||||||||||||||||
$ | 283 | $ | (3 | ) | |||||||||||||||||
(1) | Included in accounts payable and accrued expenses – other. | ||||||||||||||||||||
For the first six months of 2014, we recognized $2 million of net pre-tax losses in accumulated other comprehensive income (loss) from the effective portion of cash flow hedges. For the second quarter and first six months of 2013, we recognized $6 million and $10 million, respectively, of net pre-tax losses in accumulated other comprehensive income (loss) from the effective portion of cash flow hedges. The ineffective and excluded portions of cash flow hedges recognized in other non-operating income (expense) were not significant for the second quarters and first six months of 2014 and 2013. The amounts reclassified from accumulated other comprehensive income (loss) for the second quarters and first six months of 2014 and 2013 were not significant. As of February 27, 2014, the amount of pre-tax net cash flow hedge gains included in accumulated other comprehensive income (loss) expected to be reclassified into earnings in the next 12 months was $7 million. | |||||||||||||||||||||
Derivative Counterparty Credit Risk and Master Netting Arrangements | |||||||||||||||||||||
Our derivative instruments expose us to credit risk to the extent the counterparties may be unable to meet the terms of the derivative instrument. As of February 27, 2014, our maximum exposure to loss due to credit risk if counterparties fail completely to perform according to the terms of the contracts was generally equal to the fair value of our assets for these contracts as listed in the tables below. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading risk across multiple major financial institutions. In addition, we monitor the potential risk of loss with any one counterparty resulting from this type of credit risk on an ongoing basis. | |||||||||||||||||||||
We also seek to enter into master netting arrangements with our counterparties to mitigate credit risk in derivative hedge transactions. These master netting arrangements allow us and our counterparties to net settle amounts owed to each other. Derivative assets and liabilities that can be net settled under these arrangements have been presented in our consolidated balance sheet on a net basis. As of February 27, 2014, amounts netted were not significant. |
Fair_Value_Measurements
Fair Value Measurements | 6 Months Ended | ||||||||||||||||||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||||||||||||||||||
Fair Value Measurements | ' | ||||||||||||||||||||||||||||||||
Fair Value Measurements | |||||||||||||||||||||||||||||||||
Accounting standards establish three levels of inputs that may be used to measure fair value: quoted prices in active markets for identical assets or liabilities (referred to as Level 1), inputs other than Level 1 that are observable for the asset or liability either directly or indirectly (referred to as Level 2) and unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities (referred to as Level 3). | |||||||||||||||||||||||||||||||||
Fair Value Measurements on a Recurring Basis | |||||||||||||||||||||||||||||||||
All marketable debt and equity investments are classified as available-for-sale and are carried at fair value. Assets measured at fair value on a recurring basis were as follows: | |||||||||||||||||||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||
Money market funds | $ | 1,137 | $ | — | $ | — | $ | 1,137 | $ | 1,188 | $ | — | $ | — | $ | 1,188 | |||||||||||||||||
Certificates of deposit | — | 81 | — | 81 | — | 38 | — | 38 | |||||||||||||||||||||||||
Government securities | — | 5 | — | 5 | — | — | — | — | |||||||||||||||||||||||||
Commercial paper | — | — | — | — | — | 35 | — | 35 | |||||||||||||||||||||||||
1,137 | 86 | — | 1,223 | 1,188 | 73 | — | 1,261 | ||||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||||||
Corporate bonds | — | 124 | — | 124 | — | 112 | — | 112 | |||||||||||||||||||||||||
Government securities | — | 39 | — | 39 | — | 72 | — | 72 | |||||||||||||||||||||||||
Commercial paper | — | 23 | — | 23 | — | 26 | — | 26 | |||||||||||||||||||||||||
Certificates of deposit | — | 10 | — | 10 | — | 9 | — | 9 | |||||||||||||||||||||||||
Asset-backed securities | — | 3 | — | 3 | — | 2 | — | 2 | |||||||||||||||||||||||||
— | 199 | — | 199 | — | 221 | — | 221 | ||||||||||||||||||||||||||
Long-term marketable investments: | |||||||||||||||||||||||||||||||||
Corporate bonds | — | 332 | — | 332 | — | 302 | — | 302 | |||||||||||||||||||||||||
Asset-backed securities | — | 120 | — | 120 | — | 95 | — | 95 | |||||||||||||||||||||||||
Government securities | — | 97 | — | 97 | — | 96 | — | 96 | |||||||||||||||||||||||||
Certificates of deposit | — | 2 | — | 2 | — | — | — | — | |||||||||||||||||||||||||
Marketable equity securities | 1 | — | — | 1 | 6 | — | — | 6 | |||||||||||||||||||||||||
1 | 551 | — | 552 | 6 | 493 | — | 499 | ||||||||||||||||||||||||||
Restricted cash: | |||||||||||||||||||||||||||||||||
Certificates of deposit | — | 7 | — | 7 | — | 302 | — | 302 | |||||||||||||||||||||||||
— | 7 | — | 7 | — | 302 | — | 302 | ||||||||||||||||||||||||||
$ | 1,138 | $ | 843 | $ | — | $ | 1,981 | $ | 1,194 | $ | 1,089 | $ | — | $ | 2,283 | ||||||||||||||||||
Government securities consist of securities issued directly by or deemed to be guaranteed by government entities such as U.S. and non U.S. agency securities, government bonds and treasury securities. Level 2 securities are valued using information obtained from pricing services, which obtain quoted market prices for similar instruments, non-binding market consensus prices that are corroborated by observable market data, or various other methodologies, to determine the appropriate value at the measurement date. We perform supplemental analysis to validate information obtained from our pricing services. As of February 27, 2014, no adjustments were made to such pricing information. | |||||||||||||||||||||||||||||||||
Fair Value Measurements on a Nonrecurring Basis | |||||||||||||||||||||||||||||||||
In connection with the Exchange Transactions, we determined the fair value for the debt component of the Exchanged Notes as if it were a stand-alone instrument using an interest rate for similar nonconvertible debt issued by entities with credit ratings comparable to ours at the time of issuance. | |||||||||||||||||||||||||||||||||
In connection with the debt conversions and settlements in the first and second quarters of 2014, substantially all of the holders elected to convert their then outstanding 2014, 2031A and 2027 Notes. As a result of our elections to settle the conversion amounts in cash, each of the settlement obligations became derivative debt liabilities subject to mark-to-market accounting treatment for a period of approximately 30 days beginning on the date we notified the holder of our intention to settle the obligation in cash through the settlement date. The fair values of the underlying derivative settlement obligations were initially determined using the Black-Scholes option valuation model (Level 2 fair value measurements). The Black-Scholes model requires the input of assumptions, including the stock price, expected stock-price volatility, estimated option life, risk-free interest rate and dividend rate. The subsequent measurements and final settlement amounts of our convertible notes settlement obligations were based on the value-weighted average stock price (Level 1 fair value measurements). Changes in fair values of the derivative settlement obligations were included in other non-operating income (expense), net. | |||||||||||||||||||||||||||||||||
Fair Value of Financial Instruments | |||||||||||||||||||||||||||||||||
Amounts reported as cash and equivalents, receivables, and accounts payable and accrued expenses approximate fair value. The estimated fair value and carrying value of debt instruments (carrying value excludes the equity components of our convertible notes classified in equity) were as follows: | |||||||||||||||||||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||||||||||||||||||
Fair | Carrying | Fair | Carrying | ||||||||||||||||||||||||||||||
Value | Value | Value | Value | ||||||||||||||||||||||||||||||
Convertible notes | $ | 5,693 | $ | 2,658 | $ | 4,167 | $ | 2,506 | |||||||||||||||||||||||||
Elpida creditor installment payments and other notes | 2,907 | 2,843 | 2,269 | 2,279 | |||||||||||||||||||||||||||||
The fair values of our convertible debt instruments were determined based on inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including our stock price and interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2). The fair value of our other debt instruments was estimated based on discounted cash flows using inputs that are observable in the market or that could be derived from, or corroborated with, observable market data, including interest rates based on similar debt issued by parties with credit ratings similar to ours (Level 2). |
Equity_Plans
Equity Plans | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Equity Plans | ' | ||||||||||||||||
Equity Plans | |||||||||||||||||
As of February 27, 2014, we had an aggregate of 123 million shares of common stock reserved for the issuance of stock options and restricted stock awards, of which 66 million shares were subject to outstanding awards and 57 million shares were available for future awards. Awards are subject to terms and conditions as determined by our Board of Directors. | |||||||||||||||||
Stock Options | |||||||||||||||||
We granted 9 million and 11 million stock options during the second quarter and first six months of 2014, respectively, with weighted-average grant-date fair values per share of $9.58 and $9.17, respectively. We granted 13 million and 17 million stock options during the second quarter and first six months of 2013, respectively, with weighted-average grant-date fair values per share of $3.35 and $3.27, respectively. | |||||||||||||||||
The fair values of option awards were estimated at each grant date using the Black-Scholes option valuation model. The Black-Scholes model requires the input of assumptions, including the expected stock-price volatility and estimated option life. The expected volatilities utilized were based on implied volatilities from traded options on our stock and on historical volatility. The expected lives of options granted were based, in part, on historical experience and on the terms and conditions of the options. The risk-free interest rates utilized were based on the U.S. Treasury yield in effect at each grant date. No dividends were assumed in estimated option values. Assumptions used in the Black-Scholes model are presented below: | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Average expected life in years | 4.8 | 5.1 | 4.8 | 5.1 | |||||||||||||
Weighted-average expected volatility | 46 | % | 59 | % | 47 | % | 60 | % | |||||||||
Weighted-average risk-free interest rate | 1.6 | % | 0.7 | % | 1.6 | % | 0.7 | % | |||||||||
Restricted Stock and Restricted Stock Units ("Restricted Stock Awards") | |||||||||||||||||
As of February 27, 2014, there were 12 million shares of Restricted Stock Awards outstanding, of which 1 million were performance-based Restricted Stock Awards. For service-based Restricted Stock Awards, restrictions generally lapse in one-fourth increments during each year of employment after the grant date. For performance-based Restricted Stock Awards, vesting is contingent upon meeting certain performance goals. Restricted Stock Awards granted for the second quarters and first six months of 2014 and 2013 were as follows: | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Service-based awards in shares | 4 | 3 | 5 | 5 | |||||||||||||
Performance-based awards in shares | — | — | 1 | 1 | |||||||||||||
Weighted-average grant-date fair values per share | $ | 23.24 | $ | 6.69 | $ | 21.22 | $ | 6.2 | |||||||||
Stock-based Compensation Expense | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Stock-based compensation expense by caption: | |||||||||||||||||
Cost of goods sold | $ | 8 | $ | 7 | $ | 15 | $ | 13 | |||||||||
Selling, general and administrative | 13 | 9 | 24 | 18 | |||||||||||||
Research and development | 6 | 5 | 10 | 9 | |||||||||||||
$ | 27 | $ | 21 | $ | 49 | $ | 40 | ||||||||||
Stock-based compensation expense by type of award: | |||||||||||||||||
Stock options | $ | 14 | $ | 14 | $ | 28 | $ | 27 | |||||||||
Restricted stock awards | 13 | 7 | 21 | 13 | |||||||||||||
$ | 27 | $ | 21 | $ | 49 | $ | 40 | ||||||||||
As of February 27, 2014, $295 million of total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards was expected to be recognized through the second quarter of 2018, resulting in a weighted-average period of 1.5 years. Stock-based compensation expense in the above presentation does not reflect any significant income tax benefits, which is consistent with our treatment of income or loss from our U.S. operations. (See "Income Taxes" note.) |
Restucture_and_Asset_Impairmen
Restucture and Asset Impairments | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Restructure and Asset Impairments | ' | ||||||||||||||||
Restructure and Asset Impairments | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Loss (gain) on impairment of MIT assets | $ | (5 | ) | $ | 62 | $ | (5 | ) | $ | 62 | |||||||
Gain on termination of lease to Transform | — | — | — | (25 | ) | ||||||||||||
Other | 17 | (2 | ) | 14 | 2 | ||||||||||||
$ | 12 | $ | 60 | $ | 9 | $ | 39 | ||||||||||
On May 3, 2013, we sold MIT, a wholly-owned subsidiary, including its 200mm wafer fabrication facility assets in Avezzano, Italy, to LFoundry. In exchange for the shares of MIT, we received consideration from LFoundry valued at $35 million, substantially all of which was under a 7-year, non-interest bearing term note. Under the terms of the agreements, we assigned to LFoundry our supply agreement with Aptina for CMOS image sensors manufactured at the Avezzano facility. In the second quarter of 2013, we recorded an impairment loss of $62 million to write down the assets and liabilities to their estimated fair values in connection with the sale of MIT. | |||||||||||||||||
Since the second quarter of 2010, we have held an equity method investment in Transform Solar Pty Ltd. ("Transform"), a developer, manufacturer and marketer of photovoltaic technology and solar panels. In May 2012, the Board of Directors of Transform approved a liquidation plan and in connection therewith, Transform terminated a lease to a portion of our manufacturing facilities in Boise, Idaho and we recognized a gain of $25 million in the first quarter of 2013. |
Other_Operating_Income_Expense
Other Operating (Income) Expense, Net | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Other Operating (Income) Expense, Net | ' | ||||||||||||||||
Other Operating (Income) Expense, Net | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Rambus settlement | $ | — | $ | — | $ | 233 | $ | — | |||||||||
(Gain) loss on disposition of property, plant and equipment | 1 | (10 | ) | 9 | (15 | ) | |||||||||||
Other | — | 2 | (4 | ) | (1 | ) | |||||||||||
$ | 1 | $ | (8 | ) | $ | 238 | $ | (16 | ) | ||||||||
On December 9, 2013, we settled all pending litigation between us and Rambus, including all antitrust and patent matters. As a result, other operating expense for the first quarter of 2014 included a $233 million charge to accrue a liability, which reflects the discounted value of amounts due under this arrangement. (See "Contingencies" note.) |
Other_NonOperating_Income_Expe
Other Non-Operating Income (Expense), Net | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Other Non-Operating Income Expense, Net [Text Block] | ' | ||||||||||||||||
Other Non-Operating Income (Expense), Net | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
27-Feb-14 | 28-Feb-13 | 27-Feb-14 | 28-Feb-13 | ||||||||||||||
Loss on restructure of debt | $ | (80 | ) | $ | (31 | ) | $ | (155 | ) | $ | (31 | ) | |||||
Adjustment to gain on acquisition of Elpida | (33 | ) | — | (33 | ) | — | |||||||||||
Gain (loss) from changes in currency exchange rates | (14 | ) | (127 | ) | (20 | ) | (186 | ) | |||||||||
Other | 5 | (1 | ) | 6 | (1 | ) | |||||||||||
$ | (122 | ) | $ | (159 | ) | $ | (202 | ) | $ | (218 | ) | ||||||
Loss on restructure of debt for the second quarter and first six months of 2014 resulted from a series of transactions with holders of our 2014 Notes, 2027 Notes, 2031A Notes, 2031B Notes, 2032C Notes and 2032D Notes. Loss on restructure of debt for the second quarter of 2013 included a $31 million charge associated with a cash repurchase of $464 million of aggregate principal amount of our 2014 Notes. | |||||||||||||||||
In the second quarter of 2014, the provisional amounts recorded in connection with our acquisition of Elpida were adjusted, primarily for pre-petition liabilities. As a result, other non-operating expense for the second quarter of 2014 includes these measurement period adjustments of $33 million. (See "Elpida Memory, Inc." note.) | |||||||||||||||||
Other non-operating expense for the second quarter and first six months of 2013 included currency losses of $120 million and $178 million from changes in the market value of our Elpida Acquisition Hedges. (See "Derivative Instruments" note.) |
Income_Taxes
Income Taxes | 6 Months Ended |
Feb. 27, 2014 | |
Disclosure Text Block [Abstract] | ' |
Income Taxes | ' |
Income Taxes | |
Income taxes for the second quarter and first six months of 2014 included $55 million and $128 million, respectively, related to the utilization of deferred tax assets as a result of Elpida's operations. Income taxes for the second quarter of 2013 included tax benefits related to two non-U.S. jurisdictions of $10 million for the favorable resolution of certain prior year tax matters, which was previously reserved as an uncertain tax position, and $9 million for a favorable change in tax law applicable to prior years. Remaining taxes for the second quarters and first six months of 2014 and 2013 primarily reflect taxes on our non-U.S. operations. We have a full valuation allowance for our net deferred tax asset associated with our U.S. operations. The provision (benefit) for taxes on U.S. operations for the second quarters and first six months of 2014 and 2013 was substantially offset by changes in the valuation allowance. | |
We currently operate in several tax jurisdictions where we have arrangements that allow us to compute our tax provision at rates below the local statutory rates that expire in whole or in part at various dates through 2026. These arrangements benefitted our tax provision for the second quarter and first six months of 2014 by $68 million ($0.06 per diluted share) and by $144 million ($0.12 per diluted share), respectively. These arrangements benefitted our tax provision for the second quarter and first six months of 2013 by $36 million ($0.04 per diluted share) and by $47 million ($0.05 per diluted share), respectively. |
Earnings_Per_Share
Earnings Per Share | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Earnings Per Share | ' | ||||||||||||||||
Earnings Per Share | |||||||||||||||||
Basic earnings per share is computed based on the weighted-average number of common shares outstanding. Diluted earnings per share is computed based on the weighted-average number of common shares outstanding plus the dilutive effects of equity awards and convertible notes. Potential common shares that would increase earnings per share amounts or decrease loss per share amounts are antidilutive and are therefore excluded from diluted earnings per share calculations. Antidilutive potential common shares that could dilute basic earnings per share in the future were 45 million and 41 million for the second quarter and first six months of 2014, respectively, and 384 million for the second quarter and first six months of 2013. | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Net income (loss) available to Micron shareholders – Basic and Diluted | $ | 731 | $ | (286 | ) | $ | 1,089 | $ | (561 | ) | |||||||
Weighted-average common shares outstanding – Basic | 1,060 | 1,016 | 1,053 | 1,015 | |||||||||||||
Net effect of dilutive equity awards and convertible notes | 141 | — | 146 | — | |||||||||||||
Weighted-average common shares outstanding – Diluted | 1,201 | 1,016 | 1,199 | 1,015 | |||||||||||||
Earnings (loss) per share: | |||||||||||||||||
Basic | $ | 0.69 | $ | (0.28 | ) | $ | 1.03 | $ | (0.55 | ) | |||||||
Diluted | 0.61 | (0.28 | ) | 0.91 | (0.55 | ) | |||||||||||
Segment_Information
Segment Information | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Disclosure Text Block [Abstract] | ' | ||||||||||||||||
Segment Information | ' | ||||||||||||||||
Segment Information | |||||||||||||||||
Segment information reported herein is consistent with how it is reviewed and evaluated by our chief operating decision makers. Factors used to identify our segments include, among others, products, technologies and customers. We have the following four reportable segments: | |||||||||||||||||
DRAM Solutions Group ("DSG"): Includes DRAM products sold to the PC, consumer electronics, networking and server markets. | |||||||||||||||||
Wireless Solutions Group ("WSG"): Includes DRAM, NAND Flash and NOR Flash products, including multi-chip packages, sold to the mobile device market. | |||||||||||||||||
NAND Solutions Group ("NSG"): Includes high-volume NAND Flash products sold into data storage, personal music players, and the high-density computing market, as well as NAND Flash products sold to Intel through our IMFT joint venture. | |||||||||||||||||
Embedded Solutions Group ("ESG"): Includes DRAM, NAND Flash and NOR Flash products sold into automotive and industrial applications, as well as NOR and NAND Flash sold to consumer electronics, networking, PC and server markets. | |||||||||||||||||
Our other operations do not meet the quantitative thresholds of a reportable segment and are reported under All Other. | |||||||||||||||||
Certain operating expenses directly associated with the activities of a specific reportable segment are charged to that segment. Other indirect operating expenses (income) are generally allocated to the reportable segments based on their respective percentage of cost of goods sold or forecasted wafer production. The unallocated amount in the first six months of 2014 related to the Rambus settlement. | |||||||||||||||||
We do not identify or report internally our assets or capital expenditures by segment, nor do we allocate gains and losses from equity method investments, interest, other non-operating income or expense items or taxes to operating segments. There are no differences in the accounting policies for segment reporting and our consolidated results of operations. | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Net sales: | |||||||||||||||||
DSG | $ | 1,888 | $ | 756 | $ | 3,673 | $ | 1,356 | |||||||||
WSG | 910 | 213 | 1,964 | 476 | |||||||||||||
NSG | 902 | 713 | 1,708 | 1,330 | |||||||||||||
ESG | 365 | 282 | 731 | 560 | |||||||||||||
All Other | 42 | 114 | 73 | 190 | |||||||||||||
$ | 4,107 | $ | 2,078 | $ | 8,149 | $ | 3,912 | ||||||||||
Operating income (loss): | |||||||||||||||||
DSG | $ | 520 | $ | (46 | ) | $ | 952 | $ | (158 | ) | |||||||
WSG | 185 | (87 | ) | 361 | (151 | ) | |||||||||||
NSG | 77 | 64 | 172 | 77 | |||||||||||||
ESG | 59 | 65 | 125 | 143 | |||||||||||||
All Other | 28 | (19 | ) | 43 | (31 | ) | |||||||||||
Unallocated | — | — | (233 | ) | — | ||||||||||||
$ | 869 | $ | (23 | ) | $ | 1,420 | $ | (120 | ) | ||||||||
Certain_Concentrations
Certain Concentrations | 6 Months Ended | ||||||
Feb. 27, 2014 | |||||||
Disclosure Text Block [Abstract] | ' | ||||||
Certain Concentrations | ' | ||||||
Certain Concentrations | |||||||
Market Concentrations: Markets with a concentration of net sales were as follows: | |||||||
Six Months Ended | |||||||
27-Feb-14 | 28-Feb-13 | ||||||
Computing (including desktop PCs, servers, notebooks and workstations) | 35 | % | 25 | % | |||
Mobile | 25 | % | 10 | % | |||
Consumer electronics | 15 | % | 20 | % | |||
Solid state drives | 10 | % | 15 | % | |||
Networking and storage | < 10% | 10 | % | ||||
Customer Concentrations: Customer concentrations for the first six months of 2014 included net sales to Apple Inc. ("Apple") of 11% of our total net sales. Substantially all of our sales to Apple are included in the WSG and DSG segments. |
Business_and_Basis_of_Presenta1
Business and Basis of Presentation (Policies) | 6 Months Ended |
Feb. 27, 2014 | |
Policy Text Block [Abstract] | ' |
Basis of Presentation | ' |
Micron Technology, Inc., including its consolidated subsidiaries, (hereinafter referred to collectively as "we," "our," "us" and similar terms unless the context indicates otherwise) is one of the world's leading providers of advanced semiconductor solutions. Through our worldwide operations, we manufacture and market a full range of DRAM, NAND Flash and NOR Flash memory, as well as other innovative memory technologies, packaging solutions and semiconductor systems for use in leading-edge computing, consumer, networking, automotive, industrial, embedded and mobile products. The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America consistent in all material respects with those applied in our Annual Report on Form 10-K for the year ended August 29, 2013. In the opinion of our management, the accompanying unaudited consolidated financial statements contain all necessary adjustments, consisting of a normal recurring nature, to present fairly the financial information set forth herein. | |
Reclassification | ' |
Certain reclassifications have been made to prior period amounts to conform to current period presentation. | |
Fiscal Period | ' |
Our fiscal year is the 52 or 53-week period ending on the Thursday closest to August 31. Our second quarters of fiscal 2014 and 2013 ended on February 27, 2014 and February 28, 2013, respectively. All period references are to our fiscal periods unless otherwise indicated. These interim financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the year ended August 29, 2013. |
Variable_Interest_Entities_Pol
Variable Interest Entities (Policies) | 6 Months Ended |
Feb. 27, 2014 | |
Policy Text Block [Abstract] | ' |
Variable Interest Entities | ' |
We have interests in entities that are Variable Interest Entities ("VIEs"). If we are the primary beneficiary of a VIE, we are required to consolidate it. To determine if we are the primary beneficiary, we evaluate whether we have the power to direct the activities that most significantly impact the VIE's economic performance and the obligation to absorb losses or the right to receive benefits of the VIE that could potentially be significant to the VIE. Our evaluation includes identification of significant activities and an assessment of our ability to direct those activities based on governance provisions and arrangements to provide or receive product and process technology, product supply, operations services, equity funding, financing and other applicable agreements and circumstances. Our assessments of whether we are the primary beneficiary of our VIEs require significant assumptions and judgments. |
Elpida_Memories_Inc_Tables
Elpida Memories, Inc. (Tables) (Elpida Acquisition [Member]) | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Elpida Acquisition [Member] | ' | ||||||||
Business Acquisition [Line Items] | ' | ||||||||
Business Acquisition, Pro Forma Information [Table Text Block] | ' | ||||||||
The following unaudited pro forma financial information presents the combined results of operations as if the Elpida Acquisition had occurred on September 2, 2011. The pro forma financial information includes the accounting effects of the business combination, including adjustments to the amortization of intangible assets, depreciation of property, plant and equipment, interest expense and elimination of intercompany activities. The unaudited pro forma financial information for the quarter and six months ended February 28, 2013 includes our results for the quarter and six months ended February 28, 2013 and the results of Elpida and MMT, including the adjustments described above, for the quarter and six months ended December 31, 2012. The unaudited pro forma financial information below is not necessarily indicative of either future results of operations or results that might have been achieved had the Elpida Acquisition occurred on September 2, 2011. | |||||||||
Quarter Ended | Six Months Ended | ||||||||
28-Feb-13 | 28-Feb-13 | ||||||||
Net sales | $ | 2,912 | $ | 5,531 | |||||
Net loss | (120 | ) | (346 | ) | |||||
Net loss attributable to Micron | (132 | ) | (369 | ) | |||||
Loss per share: | |||||||||
Basic | $ | (0.13 | ) | $ | (0.36 | ) | |||
Diluted | (0.13 | ) | (0.36 | ) | |||||
Investments_Tables
Investments (Tables) | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Table Text Block [Abstract] | ' | ||||||||
Schedule of Available-for-sale Securities Reconciliation [Table Text Block] | ' | ||||||||
As of February 27, 2014 and August 29, 2013, the fair values, which approximated amortized costs, of available-for-sale investments were as follows: | |||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||
Money market funds | $ | 1,137 | $ | 1,188 | |||||
Corporate bonds | 456 | 414 | |||||||
Government securities | 141 | 168 | |||||||
Asset-backed securities | 123 | 97 | |||||||
Certificates of deposit | 100 | 349 | |||||||
Commercial paper | 23 | 61 | |||||||
Marketable equity securities | 1 | 6 | |||||||
$ | 1,981 | $ | 2,283 | ||||||
Investments Classified by Contractual Maturity Date [Table Text Block] | ' | ||||||||
The table below presents the fair value of available-for-sale debt securities as of February 27, 2014, by contractual maturity: | |||||||||
Money market funds not due at a single maturity date | $ | 1,137 | |||||||
Due in 1 year or less | 292 | ||||||||
Due in 1 - 2 years | 268 | ||||||||
Due in 2 - 4 years | 266 | ||||||||
Due after 4 years | 17 | ||||||||
$ | 1,980 | ||||||||
Receivables_Tables
Receivables (Tables) | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Table Text Block [Abstract] | ' | ||||||||
Schedule of Receivables | ' | ||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Trade receivables (net of allowance for doubtful accounts of $4 and $5, respectively) | $ | 2,548 | $ | 2,069 | |||||
Income and other taxes | 65 | 74 | |||||||
Other | 213 | 186 | |||||||
$ | 2,826 | $ | 2,329 | ||||||
Inventories_Tables
Inventories (Tables) | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Table Text Block [Abstract] | ' | ||||||||
Schedule Of Inventory | ' | ||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Finished goods | $ | 829 | $ | 796 | |||||
Work in process | 1,447 | 1,719 | |||||||
Raw materials and supplies | 186 | 134 | |||||||
$ | 2,462 | $ | 2,649 | ||||||
Property_Plant_and_Equipment_T
Property, Plant and Equipment (Tables) | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Table Text Block [Abstract] | ' | ||||||||
Schedule of Property, Plant and Equipment | ' | ||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Land | $ | 86 | $ | 86 | |||||
Buildings | 4,962 | 4,835 | |||||||
Equipment | 16,474 | 15,600 | |||||||
Construction in progress | 88 | 84 | |||||||
Software | 329 | 315 | |||||||
21,939 | 20,920 | ||||||||
Accumulated depreciation | (14,080 | ) | (13,294 | ) | |||||
$ | 7,859 | $ | 7,626 | ||||||
Equity_Method_Investments_Tabl
Equity Method Investments (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||
Equity Method Investments | ' | ||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||
Investment Balance | Ownership Percentage | Investment Balance | Ownership Percentage | ||||||||||||||
Inotera(1) | $ | 566 | 35 | % | $ | 344 | 35 | % | |||||||||
Tera Probe | 41 | 40 | % | 40 | 40 | % | |||||||||||
Other | 11 | Various | 12 | Various | |||||||||||||
$ | 618 | $ | 396 | ||||||||||||||
(1) Entity is a variable interest entity. | |||||||||||||||||
As of February 27, 2014, substantially all of our maximum exposure to loss from our VIEs that were not consolidated was our $566 million investment balance in Inotera. We may also incur losses in connection with our rights and obligations to purchase substantially all of Inotera's wafer production capacity under a supply agreement with Inotera. | |||||||||||||||||
We recognize our share of earnings or losses from our equity method investments generally on a two-month lag. Equity in net income (loss) of equity method investees, net of tax, included the following: | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Inotera | $ | 131 | $ | (55 | ) | $ | 215 | $ | (108 | ) | |||||||
Tera Probe | 4 | — | 6 | — | |||||||||||||
Other | (1 | ) | (3 | ) | (1 | ) | (2 | ) | |||||||||
$ | 134 | $ | (58 | ) | $ | 220 | $ | (110 | ) | ||||||||
Intangible_Assets_Tables
Intangible Assets (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||
Schedule Of Finite Lived Intangible Assets By Major Class | ' | ||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||
Gross | Accumulated | Gross | Accumulated | ||||||||||||||
Amount | Amortization | Amount | Amortization | ||||||||||||||
Product and process technology | $ | 660 | $ | (307 | ) | $ | 642 | $ | (269 | ) | |||||||
Customer relationships | 127 | (122 | ) | 127 | (114 | ) | |||||||||||
Other | 16 | (7 | ) | — | — | ||||||||||||
$ | 803 | $ | (436 | ) | $ | 769 | $ | (383 | ) | ||||||||
Accounts_Payable_and_Accrued_E1
Accounts Payable and Accrued Expenses (Tables) | 6 Months Ended | ||||||||
Feb. 27, 2014 | |||||||||
Table Text Block [Abstract] | ' | ||||||||
Accounts Payable And Accrued Liabilities Schedule | ' | ||||||||
As of | February 27, | August 29, | |||||||
2014 | 2013 | ||||||||
Accounts payable | $ | 1,155 | $ | 1,048 | |||||
Related party payables | 714 | 374 | |||||||
Salaries, wages and benefits | 352 | 267 | |||||||
Customer advances | 156 | 140 | |||||||
Income and other taxes | 38 | 47 | |||||||
Other | 264 | 239 | |||||||
$ | 2,679 | $ | 2,115 | ||||||
Debt_Tables
Debt (Tables) | 6 Months Ended | ||||||||||||||||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Debt | ' | ||||||||||||||||||||||||||||||
27-Feb-14 | 29-Aug-13 | ||||||||||||||||||||||||||||||
Instrument(1) | Stated Rate | Effective Rate | Current | Long-Term | Total | Current | Long-Term | Total | |||||||||||||||||||||||
Elpida creditor installment payments; $1,392 and $1,969 principal amount | N/A | 6.25 | % | $ | 189 | $ | 926 | $ | 1,115 | $ | 527 | $ | 1,117 | $ | 1,644 | ||||||||||||||||
Capital lease obligations; | N/A | N/A | 352 | 694 | 1,046 | 407 | 845 | 1,252 | |||||||||||||||||||||||
imputed rate of 4.33% and 4.07% | |||||||||||||||||||||||||||||||
2014 convertible senior notes; | 1.875 | % | 7.88 | % | 677 | — | 677 | 465 | — | 465 | |||||||||||||||||||||
$419 and $485 principal amount | |||||||||||||||||||||||||||||||
2019 senior notes; | 1.258 | % | 1.97 | % | 92 | 370 | 462 | — | — | — | |||||||||||||||||||||
$462 principal amount | |||||||||||||||||||||||||||||||
2022 senior notes; | 5.875 | % | 6.16 | % | — | 600 | 600 | — | — | — | |||||||||||||||||||||
$600 principal amount | |||||||||||||||||||||||||||||||
2027 convertible senior notes; | 1.875 | % | 6.95 | % | — | — | — | — | 147 | 147 | |||||||||||||||||||||
$0 and $175 principal amount | |||||||||||||||||||||||||||||||
2031A convertible senior notes; | 1.5 | % | 6.55 | % | — | — | — | — | 277 | 277 | |||||||||||||||||||||
$0 and $345 principal amount | |||||||||||||||||||||||||||||||
2031B convertible senior notes;(2)(3) | 1.875 | % | 6.98 | % | 85 | — | 85 | — | 253 | 253 | |||||||||||||||||||||
$114 and $345 principal amount | |||||||||||||||||||||||||||||||
2032C convertible senior notes;(2) | 2.375 | % | 5.95 | % | — | 385 | 385 | — | 463 | 463 | |||||||||||||||||||||
$450 and $550 principal amount | |||||||||||||||||||||||||||||||
2032D convertible senior notes;(2) | 3.125 | % | 6.33 | % | — | 342 | 342 | — | 369 | 369 | |||||||||||||||||||||
$412 and $450 principal amount | |||||||||||||||||||||||||||||||
2033E convertible senior notes;(2)(3) | 1.625 | % | 4.5 | % | 275 | — | 275 | — | 272 | 272 | |||||||||||||||||||||
$300 principal amount | |||||||||||||||||||||||||||||||
2033F convertible senior notes;(2)(3) | 2.125 | % | 4.93 | % | 263 | — | 263 | — | 260 | 260 | |||||||||||||||||||||
$300 principal amount | |||||||||||||||||||||||||||||||
2043G convertible senior notes; | 3 | % | 6.77 | % | — | 631 | 631 | — | — | — | |||||||||||||||||||||
$1,025 principal amount | |||||||||||||||||||||||||||||||
Other notes payable | 2.947 | % | 3.51 | % | 297 | 369 | 666 | 186 | 449 | 635 | |||||||||||||||||||||
$ | 2,230 | $ | 4,317 | $ | 6,547 | $ | 1,585 | $ | 4,452 | $ | 6,037 | ||||||||||||||||||||
(1) We have the obligation or option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | |||||||||||||||||||||||||||||||
(2) Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on December 31, 2013 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended March 31, 2014. | |||||||||||||||||||||||||||||||
(3) As a result of these notes being convertible at the option of the holder through March 31, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||
Schedule Of Convertible Debt Instruments With Debt And Equity Components [Text Block] | ' | ||||||||||||||||||||||||||||||
Holder Put Date | Outstanding Principal | Shares Issuable Upon Conversion | Initial Conversion Price Per Share | Conversion Price Per Share Threshold(1) | Conversion Value | ||||||||||||||||||||||||||
in Excess of Principal(2) | |||||||||||||||||||||||||||||||
2031B Notes | Aug-20 | $ | 114 | 12 | $ | 9.5 | $ | 12.35 | $ | 176 | |||||||||||||||||||||
2032C Notes | May-19 | 450 | 47 | 9.63 | 12.52 | 681 | |||||||||||||||||||||||||
2032D Notes | May-21 | 412 | 41 | 9.98 | 12.97 | 587 | |||||||||||||||||||||||||
2033E Notes | Feb-18 | 300 | 27 | 10.93 | 14.21 | 364 | |||||||||||||||||||||||||
2033F Notes | Feb-20 | 300 | 27 | 10.93 | 14.21 | 364 | |||||||||||||||||||||||||
2043G Notes(3) | Nov-28 | 1,025 | 35 | 29.16 | 37.91 | — | |||||||||||||||||||||||||
$ | 2,601 | 189 | $ | 2,172 | |||||||||||||||||||||||||||
(1) | Holders have the right to convert all or a portion of their notes at a date or dates earlier than the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the initial conversion price. | ||||||||||||||||||||||||||||||
(2) | Based on our closing share price of $24.19 as of February 27, 2014. | ||||||||||||||||||||||||||||||
(3) | The original principal amount of $820 million accretes up to $917 million in November 2028 and $1,025 million at maturity in 2043. | ||||||||||||||||||||||||||||||
Schedule of Maturities of Long-term Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
The table below sets forth the contractual maturities of the Elpida creditor installment payments, convertible notes and other notes payable as of February 27, 2014: | |||||||||||||||||||||||||||||||
Remainder of 2014 | $ | 883 | |||||||||||||||||||||||||||||
2015 | 515 | ||||||||||||||||||||||||||||||
2016 | 441 | ||||||||||||||||||||||||||||||
2017 | 410 | ||||||||||||||||||||||||||||||
2018 | 609 | ||||||||||||||||||||||||||||||
2019 and thereafter | 3,443 | ||||||||||||||||||||||||||||||
Discounts | (800 | ) | |||||||||||||||||||||||||||||
$ | 5,501 | ||||||||||||||||||||||||||||||
Exchanged [Member] | ' | ||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Extinguishment of Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
The table below summarizes the Exchange Transactions: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
Amounts reduced in connection with the Exchanged Notes: | |||||||||||||||||||||||||||||||
2027 Notes | $ | 80 | $ | 68 | $ | 51 | |||||||||||||||||||||||||
2031A Notes | 155 | 125 | 148 | ||||||||||||||||||||||||||||
2031B Notes | 205 | 152 | 212 | ||||||||||||||||||||||||||||
440 | 345 | 411 | |||||||||||||||||||||||||||||
Amounts added in connection with the issued notes: | |||||||||||||||||||||||||||||||
2043G Notes | 1,025 | 627 | 173 | ||||||||||||||||||||||||||||
Net increase (decrease) as a result of the Exchange Transactions | $ | 585 | $ | 282 | $ | (238 | ) | ||||||||||||||||||||||||
Conversion And Settlement [Member] | ' | ||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Extinguishment of Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
A summary of the conversion activities for these notes is as follows: | |||||||||||||||||||||||||||||||
Debt Principal Converted | Carrying Value of Debt Converted | Equity Component Reclassified To Debt(1) | Mark-to-Market Loss(Gain)(2) | Loss on Settlement(2) | |||||||||||||||||||||||||||
Quarter ended November 28, 2013: | |||||||||||||||||||||||||||||||
2027 Notes | $ | — | $ | — | $ | 58 | $ | 22 | $ | — | |||||||||||||||||||||
2031A Notes | — | — | 115 | 15 | — | ||||||||||||||||||||||||||
— | — | 173 | 37 | — | |||||||||||||||||||||||||||
Quarter ended February 27, 2014: | |||||||||||||||||||||||||||||||
2014 Notes | 66 | 65 | 309 | (1 | ) | 1 | |||||||||||||||||||||||||
2027 Notes | 95 | 80 | — | 4 | 15 | ||||||||||||||||||||||||||
2031A Notes | 190 | 154 | 102 | 12 | 38 | ||||||||||||||||||||||||||
351 | 299 | 411 | 15 | 54 | |||||||||||||||||||||||||||
Six months ended February 27, 2014 | $ | 351 | $ | 299 | $ | 584 | $ | 52 | $ | 54 | |||||||||||||||||||||
(1) Based on Level 2 fair value measurements. | |||||||||||||||||||||||||||||||
(2) Included in non-operating expense. | |||||||||||||||||||||||||||||||
Repurchase [Member] | ' | ||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ||||||||||||||||||||||||||||||
Schedule of Extinguishment of Debt [Table Text Block] | ' | ||||||||||||||||||||||||||||||
The table below summarizes activity in the second quarter of 2014 with respect to Repurchased Notes: | |||||||||||||||||||||||||||||||
Principal Amount | Carrying Value of Debt | Equity | |||||||||||||||||||||||||||||
2031B Notes | $ | 26 | $ | 19 | $ | 43 | |||||||||||||||||||||||||
2032C Notes | 100 | 85 | 159 | ||||||||||||||||||||||||||||
2032D Notes | 38 | 31 | 60 | ||||||||||||||||||||||||||||
$ | 164 | $ | 135 | $ | 262 | ||||||||||||||||||||||||||
Equity_Tables
Equity (Tables) | 6 Months Ended | |||||||||||||||||||||||||||
Feb. 27, 2014 | ||||||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | |||||||||||||||||||||||||||
Schedule of Stockholders Equity [Table Text Block] | ' | |||||||||||||||||||||||||||
Changes in the components of equity were as follows: | ||||||||||||||||||||||||||||
Six Months Ended February 27, 2014 | Six Months Ended February 28, 2013 | |||||||||||||||||||||||||||
Attributable to Micron | Noncontrolling Interests | Total Equity | Attributable to Micron | Noncontrolling Interests | Total Equity | |||||||||||||||||||||||
Beginning balance | $ | 9,142 | $ | 864 | $ | 10,006 | $ | 7,700 | $ | 717 | $ | 8,417 | ||||||||||||||||
Net income (loss) | 1,089 | 33 | 1,122 | (561 | ) | 2 | (559 | ) | ||||||||||||||||||||
Other comprehensive income (loss) | (4 | ) | — | (4 | ) | (1 | ) | — | (1 | ) | ||||||||||||||||||
Comprehensive income (loss) | 1,085 | 33 | 1,118 | (562 | ) | 2 | (560 | ) | ||||||||||||||||||||
Contribution from noncontrolling interests | — | 49 | 49 | — | 10 | 10 | ||||||||||||||||||||||
Distributions to noncontrolling interests | — | (19 | ) | (19 | ) | — | — | — | ||||||||||||||||||||
Acquisition of noncontrolling interests in MMT | 31 | (167 | ) | (136 | ) | — | — | — | ||||||||||||||||||||
Capital and other transactions attributable to Micron | (974 | ) | — | (974 | ) | 93 | — | 93 | ||||||||||||||||||||
Ending balance | $ | 9,284 | $ | 760 | $ | 10,044 | $ | 7,231 | $ | 729 | $ | 7,960 | ||||||||||||||||
Schedule of Options Indexed to Issuer's Equity [Table Text Block] | ' | |||||||||||||||||||||||||||
The following table presents information related to the issued and outstanding capped calls as of February 27, 2014. | ||||||||||||||||||||||||||||
Capped Calls | Strike Price(1) | Cap Price Range | Common Shares Covered | Value at Expiration(2) | ||||||||||||||||||||||||
Expiration Dates | Low | High | Minimum | Maximum | ||||||||||||||||||||||||
2031 | Jul-14 | - | Feb-16 | $ | 9.5 | $ | 11.4 | $ | 13.17 | 73 | $ | — | $ | 207 | ||||||||||||||
2032C | May-16 | - | Nov-17 | 9.8 | 14.26 | 15.69 | 56 | — | 307 | |||||||||||||||||||
2032D | Nov-16 | - | May-18 | 10.16 | 14.62 | 16.04 | 44 | — | 244 | |||||||||||||||||||
2033E | Jan-18 | - | Feb-18 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
2033F | Jan-20 | - | Feb-20 | 10.93 | 14.51 | 14.51 | 27 | — | 98 | |||||||||||||||||||
227 | $ | — | $ | 954 | ||||||||||||||||||||||||
(1) | Initial strike prices are subject to certain adjustments. | |||||||||||||||||||||||||||
(2) | Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchased would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration. | |||||||||||||||||||||||||||
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] | ' | |||||||||||||||||||||||||||
The changes in accumulated other comprehensive income (loss) by component in the first six months of 2014 were as follows: | ||||||||||||||||||||||||||||
Cumulative Foreign Currency Translation Adjustments | Gains (Losses) on Derivative Instruments, Net | Gains (Losses) on Investments, Net | Pension Liability Adjustments | Total | ||||||||||||||||||||||||
August 29, 2013 | $ | 44 | $ | 21 | $ | — | $ | (2 | ) | $ | 63 | |||||||||||||||||
Other comprehensive income before reclassifications | (4 | ) | (2 | ) | 4 | 1 | (1 | ) | ||||||||||||||||||||
Amount reclassified out of accumulated other comprehensive income | — | (1 | ) | (2 | ) | 1 | (2 | ) | ||||||||||||||||||||
Tax effects | — | (1 | ) | — | — | (1 | ) | |||||||||||||||||||||
Other comprehensive income (loss) | (4 | ) | (4 | ) | 2 | 2 | (4 | ) | ||||||||||||||||||||
February 27, 2014 | $ | 40 | $ | 17 | $ | 2 | $ | — | $ | 59 | ||||||||||||||||||
Schedule Of Noncontrolling Interests in Subsidiaries [Table Text Block] | ' | |||||||||||||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | ||||||||||||||||||||||||||
Noncontrolling Interest Balance | Noncontrolling Interest Percentage | Noncontrolling Interest Balance | Noncontrolling Interest Percentage | |||||||||||||||||||||||||
IMFT(1) | $ | 640 | 49 | % | $ | 601 | 49 | % | ||||||||||||||||||||
MP Mask(1) | 93 | 49.99 | % | 92 | 49.99 | % | ||||||||||||||||||||||
MMT | 21 | 1.24 | % | 155 | 11.11 | % | ||||||||||||||||||||||
Other | 6 | Various | 16 | Various | ||||||||||||||||||||||||
$ | 760 | $ | 864 | |||||||||||||||||||||||||
(1) Entity is a variable interest entity. | ||||||||||||||||||||||||||||
IM Flash Technologies, LLC [Member] | ' | |||||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | |||||||||||||||||||||||||||
Total IMFT and MP Mask assets and liabilities | ' | |||||||||||||||||||||||||||
The following table presents the assets and liabilities of IMFT included in our consolidated balance sheets, excluding intercompany balances: | ||||||||||||||||||||||||||||
As of | February 27, | August 29, 2013 | ||||||||||||||||||||||||||
2014 | ||||||||||||||||||||||||||||
Assets | ||||||||||||||||||||||||||||
Cash and equivalents | $ | 112 | $ | 62 | ||||||||||||||||||||||||
Receivables | 70 | 76 | ||||||||||||||||||||||||||
Inventories | 47 | 49 | ||||||||||||||||||||||||||
Other current assets | 5 | 4 | ||||||||||||||||||||||||||
Total current assets | 234 | 191 | ||||||||||||||||||||||||||
Property, plant and equipment, net | 1,348 | 1,382 | ||||||||||||||||||||||||||
Other noncurrent assets | 42 | 46 | ||||||||||||||||||||||||||
Total assets | $ | 1,624 | $ | 1,619 | ||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||
Accounts payable and accrued expenses | $ | 93 | $ | 88 | ||||||||||||||||||||||||
Deferred income | 8 | 9 | ||||||||||||||||||||||||||
Equipment purchase contracts | 11 | 78 | ||||||||||||||||||||||||||
Current debt | 6 | 6 | ||||||||||||||||||||||||||
Total current liabilities | 118 | 181 | ||||||||||||||||||||||||||
Long-term debt | 10 | 13 | ||||||||||||||||||||||||||
Other noncurrent liabilities | 114 | 118 | ||||||||||||||||||||||||||
Total liabilities | $ | 242 | $ | 312 | ||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. | ||||||||||||||||||||||||||||
IMFT's distributions to, and contributions from, shareholders | ' | |||||||||||||||||||||||||||
The following table presents IMFT's distributions to and contributions from its shareholders: | ||||||||||||||||||||||||||||
Quarter Ended | Six Months Ended | |||||||||||||||||||||||||||
February 27, | February 28, | February 27, | February 28, | |||||||||||||||||||||||||
2014 | 2013 | 2014 | 2013 | |||||||||||||||||||||||||
IMFT distributions to Micron | $ | 10 | $ | — | $ | 10 | $ | — | ||||||||||||||||||||
IMFT distributions to Intel | 10 | — | 10 | — | ||||||||||||||||||||||||
Micron contributions to IMFT | — | 10 | 51 | 10 | ||||||||||||||||||||||||
Intel contributions to IMFT | — | 10 | 49 | 10 | ||||||||||||||||||||||||
MP Mask Technology Center LLC [Member] | ' | |||||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | |||||||||||||||||||||||||||
Total IMFT and MP Mask assets and liabilities | ' | |||||||||||||||||||||||||||
Total MP Mask assets and liabilities included in our consolidated balance sheets were as follows: | ||||||||||||||||||||||||||||
As of | February 27, | August 29, 2013 | ||||||||||||||||||||||||||
2014 | ||||||||||||||||||||||||||||
Current assets | $ | 37 | $ | 26 | ||||||||||||||||||||||||
Noncurrent assets (primarily property, plant and equipment) | 209 | 182 | ||||||||||||||||||||||||||
Current liabilities | 40 | 25 | ||||||||||||||||||||||||||
Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. |
Derivative_Instruments_Tables
Derivative Instruments (Tables) | 6 Months Ended | ||||||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||||||
Schedule of Other Derivatives Not Designated as Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] | ' | ||||||||||||||||||||
Total gross notional amounts and fair values for derivative instruments without hedge accounting designation were as follows: | |||||||||||||||||||||
Notional Amount(1) | Fair Value of | ||||||||||||||||||||
Current Assets(2) | Noncurrent Assets(3) | (Current Liabilities)(4) | (Noncurrent Liabilities)(5) | ||||||||||||||||||
As of February 27, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 321 | $ | — | $ | — | $ | (6 | ) | $ | (3 | ) | |||||||||
Singapore dollar | 321 | 1 | — | — | — | ||||||||||||||||
Shekel | 66 | — | — | — | — | ||||||||||||||||
Euro | 8 | — | — | — | — | ||||||||||||||||
Interest rate swap contracts | 55 | — | — | — | — | ||||||||||||||||
$ | 771 | ||||||||||||||||||||
Convertible notes settlement obligations | 26 | — | — | (265 | ) | — | |||||||||||||||
$ | 1 | $ | — | $ | (271 | ) | $ | (3 | ) | ||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 336 | $ | 1 | $ | 3 | $ | — | $ | — | |||||||||||
Singapore dollar | 218 | — | — | — | — | ||||||||||||||||
Shekel | 78 | — | — | (1 | ) | — | |||||||||||||||
Euro | 217 | 1 | — | (1 | ) | — | |||||||||||||||
Interest rate swap contracts | 62 | — | — | — | — | ||||||||||||||||
Currency options – New Taiwan dollar | 351 | — | — | — | — | ||||||||||||||||
$ | 1,262 | $ | 2 | $ | 3 | $ | (2 | ) | $ | — | |||||||||||
-1 | Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in millions of shares. | ||||||||||||||||||||
(2) | Included in receivables – other. | ||||||||||||||||||||
(3) | Included in other noncurrent assets. | ||||||||||||||||||||
(4) | Included in accounts payable and accrued expenses – other for forward, option and interest rate swap contracts and in current debt for convertible notes settlement obligations. | ||||||||||||||||||||
(5) | Included in other noncurrent liabilities. | ||||||||||||||||||||
Net losses for derivative instruments without hedge accounting designation were as follows: | |||||||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||||||
February 27, | February 28, | February 27, | February 28, | Location | |||||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||||||
Convertible notes settlement obligations | $ | (15 | ) | $ | — | $ | (52 | ) | $ | — | Other non-operating income (expense) | ||||||||||
Foreign exchange contracts | (7 | ) | (122 | ) | (21 | ) | (173 | ) | Other non-operating income (expense) | ||||||||||||
Schedule of Cash Flow Hedging Instruments, Statements of Financial Performance and Financial Position, Location [Table Text Block] | ' | ||||||||||||||||||||
Total gross notional amounts and fair values for derivative instruments with cash flow hedge accounting designation were as follows: | |||||||||||||||||||||
Notional Amount | Fair Value of Current Liabilities (1) | ||||||||||||||||||||
(in U.S. Dollars) | |||||||||||||||||||||
As of February 27, 2014 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Euro | $ | 2 | $ | — | |||||||||||||||||
Yen | 8 | (1 | ) | ||||||||||||||||||
Currency options – Yen | 3 | — | |||||||||||||||||||
Interest swap contracts | 218 | (1 | ) | ||||||||||||||||||
$ | 231 | $ | (2 | ) | |||||||||||||||||
As of August 29, 2013 | |||||||||||||||||||||
Currency forward contracts: | |||||||||||||||||||||
Yen | $ | 6 | $ | (1 | ) | ||||||||||||||||
Euro | 6 | — | |||||||||||||||||||
Currency options – Yen | 21 | (2 | ) | ||||||||||||||||||
Interest swap contracts | 250 | — | |||||||||||||||||||
$ | 283 | $ | (3 | ) | |||||||||||||||||
(1) | Included in accounts payable and accrued expenses – other. |
Fair_Value_Measurements_Tables
Fair Value Measurements (Tables) | 6 Months Ended | ||||||||||||||||||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||||||||||||||||||
Assets measured at fair value on a recurring basis | ' | ||||||||||||||||||||||||||||||||
Assets measured at fair value on a recurring basis were as follows: | |||||||||||||||||||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | Total | ||||||||||||||||||||||||||
Cash equivalents: | |||||||||||||||||||||||||||||||||
Money market funds | $ | 1,137 | $ | — | $ | — | $ | 1,137 | $ | 1,188 | $ | — | $ | — | $ | 1,188 | |||||||||||||||||
Certificates of deposit | — | 81 | — | 81 | — | 38 | — | 38 | |||||||||||||||||||||||||
Government securities | — | 5 | — | 5 | — | — | — | — | |||||||||||||||||||||||||
Commercial paper | — | — | — | — | — | 35 | — | 35 | |||||||||||||||||||||||||
1,137 | 86 | — | 1,223 | 1,188 | 73 | — | 1,261 | ||||||||||||||||||||||||||
Short-term investments: | |||||||||||||||||||||||||||||||||
Corporate bonds | — | 124 | — | 124 | — | 112 | — | 112 | |||||||||||||||||||||||||
Government securities | — | 39 | — | 39 | — | 72 | — | 72 | |||||||||||||||||||||||||
Commercial paper | — | 23 | — | 23 | — | 26 | — | 26 | |||||||||||||||||||||||||
Certificates of deposit | — | 10 | — | 10 | — | 9 | — | 9 | |||||||||||||||||||||||||
Asset-backed securities | — | 3 | — | 3 | — | 2 | — | 2 | |||||||||||||||||||||||||
— | 199 | — | 199 | — | 221 | — | 221 | ||||||||||||||||||||||||||
Long-term marketable investments: | |||||||||||||||||||||||||||||||||
Corporate bonds | — | 332 | — | 332 | — | 302 | — | 302 | |||||||||||||||||||||||||
Asset-backed securities | — | 120 | — | 120 | — | 95 | — | 95 | |||||||||||||||||||||||||
Government securities | — | 97 | — | 97 | — | 96 | — | 96 | |||||||||||||||||||||||||
Certificates of deposit | — | 2 | — | 2 | — | — | — | — | |||||||||||||||||||||||||
Marketable equity securities | 1 | — | — | 1 | 6 | — | — | 6 | |||||||||||||||||||||||||
1 | 551 | — | 552 | 6 | 493 | — | 499 | ||||||||||||||||||||||||||
Restricted cash: | |||||||||||||||||||||||||||||||||
Certificates of deposit | — | 7 | — | 7 | — | 302 | — | 302 | |||||||||||||||||||||||||
— | 7 | — | 7 | — | 302 | — | 302 | ||||||||||||||||||||||||||
$ | 1,138 | $ | 843 | $ | — | $ | 1,981 | $ | 1,194 | $ | 1,089 | $ | — | $ | 2,283 | ||||||||||||||||||
Estimated fair value and carrying value of debt instruments | ' | ||||||||||||||||||||||||||||||||
The estimated fair value and carrying value of debt instruments (carrying value excludes the equity components of our convertible notes classified in equity) were as follows: | |||||||||||||||||||||||||||||||||
As of | February 27, 2014 | August 29, 2013 | |||||||||||||||||||||||||||||||
Fair | Carrying | Fair | Carrying | ||||||||||||||||||||||||||||||
Value | Value | Value | Value | ||||||||||||||||||||||||||||||
Convertible notes | $ | 5,693 | $ | 2,658 | $ | 4,167 | $ | 2,506 | |||||||||||||||||||||||||
Elpida creditor installment payments and other notes | 2,907 | 2,843 | 2,269 | 2,279 | |||||||||||||||||||||||||||||
Equity_Plans_Tables
Equity Plans (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||
Assumptions used in Black-Scholes option valuation model | ' | ||||||||||||||||
Assumptions used in the Black-Scholes model are presented below: | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Average expected life in years | 4.8 | 5.1 | 4.8 | 5.1 | |||||||||||||
Weighted-average expected volatility | 46 | % | 59 | % | 47 | % | 60 | % | |||||||||
Weighted-average risk-free interest rate | 1.6 | % | 0.7 | % | 1.6 | % | 0.7 | % | |||||||||
Schedule of restricted stock awards activity | ' | ||||||||||||||||
Restricted Stock Awards granted for the second quarters and first six months of 2014 and 2013 were as follows: | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Service-based awards in shares | 4 | 3 | 5 | 5 | |||||||||||||
Performance-based awards in shares | — | — | 1 | 1 | |||||||||||||
Weighted-average grant-date fair values per share | $ | 23.24 | $ | 6.69 | $ | 21.22 | $ | 6.2 | |||||||||
Stock-based compensation expense | ' | ||||||||||||||||
Stock-based Compensation Expense | |||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Stock-based compensation expense by caption: | |||||||||||||||||
Cost of goods sold | $ | 8 | $ | 7 | $ | 15 | $ | 13 | |||||||||
Selling, general and administrative | 13 | 9 | 24 | 18 | |||||||||||||
Research and development | 6 | 5 | 10 | 9 | |||||||||||||
$ | 27 | $ | 21 | $ | 49 | $ | 40 | ||||||||||
Stock-based compensation expense by type of award: | |||||||||||||||||
Stock options | $ | 14 | $ | 14 | $ | 28 | $ | 27 | |||||||||
Restricted stock awards | 13 | 7 | 21 | 13 | |||||||||||||
$ | 27 | $ | 21 | $ | 49 | $ | 40 | ||||||||||
Restucture_and_Asset_Impairmen1
Restucture and Asset Impairments Restructure and Asset Impairments (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Restructuring and Related Activities [Abstract] | ' | ||||||||||||||||
Schedule of Restructuring and Related Costs [Table Text Block] | ' | ||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Loss (gain) on impairment of MIT assets | $ | (5 | ) | $ | 62 | $ | (5 | ) | $ | 62 | |||||||
Gain on termination of lease to Transform | — | — | — | (25 | ) | ||||||||||||
Other | 17 | (2 | ) | 14 | 2 | ||||||||||||
$ | 12 | $ | 60 | $ | 9 | $ | 39 | ||||||||||
Other_Operating_Income_Expense1
Other Operating (Income) Expense, Net (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||
Schedule of Other operating (income) expense, net | ' | ||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Rambus settlement | $ | — | $ | — | $ | 233 | $ | — | |||||||||
(Gain) loss on disposition of property, plant and equipment | 1 | (10 | ) | 9 | (15 | ) | |||||||||||
Other | — | 2 | (4 | ) | (1 | ) | |||||||||||
$ | 1 | $ | (8 | ) | $ | 238 | $ | (16 | ) | ||||||||
Other_NonOperating_Income_Expe1
Other Non-Operating Income (Expense), Net (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Other Income and Expenses [Abstract] | ' | ||||||||||||||||
Schedule of Other Nonoperating Income (Expense) [Table Text Block] | ' | ||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
27-Feb-14 | 28-Feb-13 | 27-Feb-14 | 28-Feb-13 | ||||||||||||||
Loss on restructure of debt | $ | (80 | ) | $ | (31 | ) | $ | (155 | ) | $ | (31 | ) | |||||
Adjustment to gain on acquisition of Elpida | (33 | ) | — | (33 | ) | — | |||||||||||
Gain (loss) from changes in currency exchange rates | (14 | ) | (127 | ) | (20 | ) | (186 | ) | |||||||||
Other | 5 | (1 | ) | 6 | (1 | ) | |||||||||||
$ | (122 | ) | $ | (159 | ) | $ | (202 | ) | $ | (218 | ) |
Earnings_Per_Share_Tables
Earnings Per Share (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||
Basic and diluted earnings per share | ' | ||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Net income (loss) available to Micron shareholders – Basic and Diluted | $ | 731 | $ | (286 | ) | $ | 1,089 | $ | (561 | ) | |||||||
Weighted-average common shares outstanding – Basic | 1,060 | 1,016 | 1,053 | 1,015 | |||||||||||||
Net effect of dilutive equity awards and convertible notes | 141 | — | 146 | — | |||||||||||||
Weighted-average common shares outstanding – Diluted | 1,201 | 1,016 | 1,199 | 1,015 | |||||||||||||
Earnings (loss) per share: | |||||||||||||||||
Basic | $ | 0.69 | $ | (0.28 | ) | $ | 1.03 | $ | (0.55 | ) | |||||||
Diluted | 0.61 | (0.28 | ) | 0.91 | (0.55 | ) | |||||||||||
Segment_Information_Tables
Segment Information (Tables) | 6 Months Ended | ||||||||||||||||
Feb. 27, 2014 | |||||||||||||||||
Table Text Block [Abstract] | ' | ||||||||||||||||
Segment Information | ' | ||||||||||||||||
Quarter Ended | Six Months Ended | ||||||||||||||||
February 27, | February 28, | February 27, | February 28, | ||||||||||||||
2014 | 2013 | 2014 | 2013 | ||||||||||||||
Net sales: | |||||||||||||||||
DSG | $ | 1,888 | $ | 756 | $ | 3,673 | $ | 1,356 | |||||||||
WSG | 910 | 213 | 1,964 | 476 | |||||||||||||
NSG | 902 | 713 | 1,708 | 1,330 | |||||||||||||
ESG | 365 | 282 | 731 | 560 | |||||||||||||
All Other | 42 | 114 | 73 | 190 | |||||||||||||
$ | 4,107 | $ | 2,078 | $ | 8,149 | $ | 3,912 | ||||||||||
Operating income (loss): | |||||||||||||||||
DSG | $ | 520 | $ | (46 | ) | $ | 952 | $ | (158 | ) | |||||||
WSG | 185 | (87 | ) | 361 | (151 | ) | |||||||||||
NSG | 77 | 64 | 172 | 77 | |||||||||||||
ESG | 59 | 65 | 125 | 143 | |||||||||||||
All Other | 28 | (19 | ) | 43 | (31 | ) | |||||||||||
Unallocated | — | — | (233 | ) | — | ||||||||||||
$ | 869 | $ | (23 | ) | $ | 1,420 | $ | (120 | ) | ||||||||
Certain_Concentrations_Certain
Certain Concentrations Certain Concentrations (Tables) | 6 Months Ended | ||||||
Feb. 27, 2014 | |||||||
Risks and Uncertainties [Abstract] | ' | ||||||
Schedule of market concentration risk [Table Text Block] | ' | ||||||
Markets with a concentration of net sales were as follows: | |||||||
Six Months Ended | |||||||
27-Feb-14 | 28-Feb-13 | ||||||
Computing (including desktop PCs, servers, notebooks and workstations) | 35 | % | 25 | % | |||
Mobile | 25 | % | 10 | % | |||
Consumer electronics | 15 | % | 20 | % | |||
Solid state drives | 10 | % | 15 | % | |||
Networking and storage | < 10% | 10 | % | ||||
Elpida_Memories_Inc_Details
Elpida Memories, Inc. (Details) (USD $) | 3 Months Ended | 6 Months Ended | 3 Months Ended | 0 Months Ended | 3 Months Ended | 12 Months Ended | 0 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Jul. 31, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Jul. 31, 2013 |
Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Elpida Acquisition [Member] | Elpida Acquisition [Member] | Elpida Acquisition [Member] | Elpida Acquisition [Member] | |||||
Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | |||||||||
Business Acquisition [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash paid for the Elpida Acquisition | ' | ' | ' | ' | ' | $949 | ' | ' | ' |
Rexchip Share Purchase Agreement [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Ownership percentage after stock transactions during period (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | 89.00% |
Minority interest decrease from purchase of interest, change in ownership percentage (in ten thousandths) | ' | ' | ' | ' | 9.87% | ' | ' | ' | ' |
Total net assets acquired | ' | ' | ' | ' | ' | 2,601 | ' | ' | ' |
Noncontrolling interests in Elpida | ' | ' | ' | ' | ' | 168 | ' | ' | ' |
Gain on acquisition of Elpida | ' | ' | ' | ' | ' | ' | ' | 1,484 | ' |
Adjustment to gain on acquisition of Elpida | -33 | 0 | -33 | 0 | ' | ' | -33 | ' | ' |
Business Acquisition, Pro Forma Information [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Net sales | ' | 2,912 | ' | 5,531 | ' | ' | ' | ' | ' |
Net loss | ' | -120 | ' | -346 | ' | ' | ' | ' | ' |
Net loss attributable to Micron | ' | ($132) | ' | ($369) | ' | ' | ' | ' | ' |
Loss per share: [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Basic (in dollars per share) | ' | ($0.13) | ' | ($0.36) | ' | ' | ' | ' | ' |
Diluted (in dollars per share) | ' | ($0.13) | ' | ($0.36) | ' | ' | ' | ' | ' |
Investments_Details
Investments (Details) (USD $) | 3 Months Ended | 6 Months Ended | |||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | $1,981 | ' | $1,981 | ' | $2,283 |
Available-for-sale Securities, Debt Maturities, Fair Value [Abstract] | ' | ' | ' | ' | ' |
Money market funds not due at a single maturity date | 1,137 | ' | 1,137 | ' | ' |
Due in 1 year or less | 292 | ' | 292 | ' | ' |
Due in 1-2 years | 268 | ' | 268 | ' | ' |
Due in 2-4 years | 266 | ' | 266 | ' | ' |
Due after 4 years | 17 | ' | 17 | ' | ' |
Debt Securities, Fair Value | 1,980 | ' | 1,980 | ' | ' |
Available-for-sale Securities, Gross Realized Gain (Loss), Disclosures [Abstract] | ' | ' | ' | ' | ' |
Proceeds from the sale of available-for-sale securities | 110 | 67 | 223 | 160 | ' |
Money market funds [Member] | ' | ' | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | 1,137 | ' | 1,137 | ' | 1,188 |
Corporate bonds [Member] | ' | ' | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | 456 | ' | 456 | ' | 414 |
Government securities [Member] | ' | ' | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | 141 | ' | 141 | ' | 168 |
Asset-backed securities [Member] | ' | ' | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | 123 | ' | 123 | ' | 97 |
Certificates of deposit [Member] | ' | ' | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | 100 | ' | 100 | ' | 349 |
Commercial paper [Member] | ' | ' | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | 23 | ' | 23 | ' | 61 |
Marketable equity securities [Member] | ' | ' | ' | ' | ' |
Schedule of Available-for-sale Securities [Line Items] | ' | ' | ' | ' | ' |
Fair value of available-for-sale investments | $1 | ' | $1 | ' | $6 |
Receivables_Details
Receivables (Details) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Receivables [Abstract] | ' | ' |
Trade receivables (net of allowance for doubtful accounts of $4 and $5, respectively) | $2,548 | $2,069 |
Income and other taxes | 65 | 74 |
Other | 213 | 186 |
Receivables | 2,826 | 2,329 |
Allowance for doubtful accounts | 4 | 5 |
Intel [Member] | Collaborative Arrangement Process Design and Process Development [Member] | ' | ' |
Receivables [Abstract] | ' | ' |
Other | $39 | $34 |
Inventories_Details
Inventories (Details) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Inventory, Net, Items Net of Reserve Alternative [Abstract] | ' | ' |
Finished goods | $829 | $796 |
Work in process | 1,447 | 1,719 |
Raw materials and supplies | 186 | 134 |
Inventories | $2,462 | $2,649 |
Property_Plant_and_Equipment_D
Property, Plant and Equipment (Details) (USD $) | 3 Months Ended | 6 Months Ended | |||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' | ' | ' |
Property, plant and equipment, gross | $21,939 | ' | $21,939 | ' | $20,920 |
Accumulated depreciation | -14,080 | ' | -14,080 | ' | -13,294 |
Property, plant and equipment, net | 7,859 | ' | 7,859 | ' | 7,626 |
Depreciation [Abstract] | ' | ' | ' | ' | ' |
Depreciation expense | 486 | 434 | 954 | 871 | ' |
Land [Member] | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' | ' | ' |
Property, plant and equipment, gross | 86 | ' | 86 | ' | 86 |
Buildings [Member] | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' | ' | ' |
Property, plant and equipment, gross | 4,962 | ' | 4,962 | ' | 4,835 |
Equipment [Member] | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' | ' | ' |
Property, plant and equipment, gross | 16,474 | ' | 16,474 | ' | 15,600 |
Construction in progress [Member] | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' | ' | ' |
Property, plant and equipment, gross | 88 | ' | 88 | ' | 84 |
Software [Member] | ' | ' | ' | ' | ' |
Property, Plant and Equipment, Net, by Type [Abstract] | ' | ' | ' | ' | ' |
Property, plant and equipment, gross | 329 | ' | 329 | ' | 315 |
Other noncurrent assets [Member] | ' | ' | ' | ' | ' |
Property, Plant and Equipment Assets Held-for-sale or held-for-development Disclosure [Abstract] | ' | ' | ' | ' | ' |
Land held for development | $55 | ' | $55 | ' | $54 |
Equity_Method_Investments_Deta
Equity Method Investments (Details) (USD $) | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | ||||||||||||||||||||||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Feb. 28, 2013 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Dec. 31, 2013 | Dec. 31, 2012 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Mar. 01, 2012 | |||
Nanya [Member] | Nanya [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Inotera [Member] | Tera Probe [Member] | Tera Probe [Member] | Tera Probe [Member] | Tera Probe [Member] | Tera Probe [Member] | Tera Probe [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | Other [Member] | |||||||||
Collaborative Arrangement Process Design and Process Development [Member] | Collaborative Arrangement Process Design and Process Development [Member] | Nanya [Member] | Inventories [Member] | Inventories [Member] | Inventories [Member] | Inventories [Member] | Elpida Acquisition [Member] | Aptina [Member] | Aptina [Member] | ||||||||||||||||||||||||||
Schedule of Equity Method Investments [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Investment Balance | $618 | ' | $618 | ' | $396 | ' | ' | $566 | [1] | ' | $566 | [1] | ' | ' | ' | $344 | [1] | ' | ' | ' | ' | ' | $41 | ' | $41 | ' | $40 | ' | $11 | ' | $11 | ' | $12 | ' | $0 |
Ownership Percentage (in hundredths) | ' | ' | ' | ' | ' | ' | ' | 35.00% | [1] | ' | 35.00% | [1] | ' | ' | ' | 35.00% | [1] | ' | ' | ' | ' | ' | 40.00% | ' | 40.00% | ' | 40.00% | ' | ' | ' | ' | ' | ' | 30.00% | ' |
Equity in net income (loss) of equity method investees, net of tax | 134 | -58 | 220 | -110 | ' | ' | ' | 131 | -55 | 215 | -108 | ' | ' | ' | ' | ' | ' | ' | ' | 4 | 0 | 6 | 0 | ' | ' | -1 | -3 | -1 | -2 | ' | ' | ' | |||
Inotera's investment balance which comprises most of the entity's maximum exposure to loss from unconsolidated VIEs | ' | ' | ' | ' | ' | ' | ' | 566 | ' | 566 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Percentage interest held by a third party (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 36.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Market value of equity interests | ' | ' | ' | ' | ' | ' | ' | 1,810 | ' | 1,810 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 42 | ' | 42 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Amount in accumulated other comprehensive income (loss) for cumulative translation adjustments on its investment | ' | ' | ' | ' | ' | ' | ' | 45 | ' | 45 | ' | ' | ' | 44 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Equity Method Investment, Summarized Financial Information [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Inotera current liabilities that exceed current assets | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 129 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Inotera net income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 703 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Percentage of Inotera's wafer production previously obligated to purchase (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 50.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Purchases of DRAM products from Inotera | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 714 | 200 | 1,301 | 401 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Equity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Ownership percentage after stock transactions during period (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40.00% | ' | ' | ' | ' | ' | ' | ' | |||
R&D expenses reduced by reimbursements from third party | 344 | 214 | 664 | 438 | ' | -4 | -19 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Difference between cost of Tera Probe investment and underlying equity | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $32 | ' | $32 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
Weighted-average period for remaining basis difference amortization (in years) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '6 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||
[1] | Entity is a variable interest entity. |
Equity_Method_Investments_2_De
Equity Method Investments - 2 (Details) (USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended | 3 Months Ended | 6 Months Ended | |
In Millions, unless otherwise specified | Feb. 28, 2013 | Feb. 28, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 |
Aptina [Member] | Aptina [Member] | Aptina [Member] | Aptina [Member] | Tera Probe [Member] | Tera Probe [Member] | |
Short-term interest free loan to Aptina [Member] | Short-term interest free loan to Aptina [Member] | Cost of Goods Sold [Member] | Cost of Goods Sold [Member] | |||
Related Party Transaction [Line Items] | ' | ' | ' | ' | ' | ' |
Manufacturing process services provided by Tera Probe | ' | ' | ' | ' | $31 | $64 |
Revenues from transactions with related party | 48 | 109 | ' | ' | ' | ' |
Cost of goods sold from transactions with related party | 57 | 138 | ' | ' | ' | ' |
Amount loaned to Aptina | ' | ' | ' | 45 | ' | ' |
Repayments received from Aptina | ' | ' | $45 | ' | ' | ' |
Intangible_Assets_Details
Intangible Assets (Details) (USD $) | 3 Months Ended | 6 Months Ended | |||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 |
Intangible Assets [Abstract] | ' | ' | ' | ' | ' |
Finite-lived intangible assets, gross | $803 | ' | $803 | ' | $769 |
Finite-lived intangible assets, accumulated amortization | -436 | ' | -436 | ' | -383 |
Amortization expense for intangible assets | 31 | 21 | 54 | 41 | ' |
Finite-Lived Intangible Assets, Future Amortization Expense [Abstract] | ' | ' | ' | ' | ' |
Annual amortization for 2014 | 106 | ' | 106 | ' | ' |
Annual amortization for 2015 | 74 | ' | 74 | ' | ' |
Annual amortization for 2016 | 64 | ' | 64 | ' | ' |
Annual amortization for 2017 | 54 | ' | 54 | ' | ' |
Annual amortization for 2018 | 44 | ' | 44 | ' | ' |
Product and process technology [Member] | ' | ' | ' | ' | ' |
Intangible Assets [Abstract] | ' | ' | ' | ' | ' |
Finite-lived intangible assets, gross | 660 | ' | 660 | ' | 642 |
Finite-lived intangible assets, accumulated amortization | -307 | ' | -307 | ' | -269 |
Product and process technology intangible asset capitalized during period | ' | ' | 19 | 16 | ' |
Product and process technology intangible asset capitalized during period, weighted-average useful lives (in years) | ' | ' | '10 years | '10 years | ' |
Customer relationships [Member] | ' | ' | ' | ' | ' |
Intangible Assets [Abstract] | ' | ' | ' | ' | ' |
Finite-lived intangible assets, gross | 127 | ' | 127 | ' | 127 |
Finite-lived intangible assets, accumulated amortization | -122 | ' | -122 | ' | -114 |
Other [Member] | ' | ' | ' | ' | ' |
Intangible Assets [Abstract] | ' | ' | ' | ' | ' |
Finite-lived intangible assets, gross | 16 | ' | 16 | ' | 0 |
Finite-lived intangible assets, accumulated amortization | ($7) | ' | ($7) | ' | $0 |
Accounts_Payable_and_Accrued_E2
Accounts Payable and Accrued Expenses (Details) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Accounts payable | $1,155 | $1,048 |
Related party payables | 714 | 374 |
Salaries, wages and benefits | 352 | 267 |
Customer advances | 156 | 140 |
Income and other taxes | 38 | 47 |
Other | 264 | 239 |
Total accounts payable and accrued expenses | 2,679 | 2,115 |
Other Liabilities, Noncurrent [Abstract] | ' | ' |
Other noncurrent liabilities | 858 | 535 |
DRAM [Member] | ' | ' |
Customer advances | 90 | ' |
DRAM [Member] | Customer advances [Member] | ' | ' |
Other Liabilities, Noncurrent [Abstract] | ' | ' |
Other noncurrent liabilities | 135 | ' |
Intel [Member] | ' | ' |
Other | 14 | 8 |
Intel [Member] | NAND Flash [Member] | ' | ' |
Customer advances | 61 | 134 |
Inotera [Member] | ' | ' |
Related party payables | 700 | 345 |
Tera Probe [Member] | ' | ' |
Related party payables | $14 | $29 |
Debt_Schedule_of_Longterm_Debt
Debt - Schedule of Long-term Debt (Details) (USD $) | 6 Months Ended | 3 Months Ended | 1 Months Ended | 6 Months Ended | 6 Months Ended | 6 Months Ended | 6 Months Ended | 6 Months Ended | 6 Months Ended | 6 Months Ended | 3 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||
Share data in Millions, except Per Share data, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Oct. 31, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 28, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Nov. 12, 2013 | Aug. 29, 2013 | Nov. 12, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Dec. 20, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 05, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | |||||||||||||||||||
Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Reorganization obligation [Member] | Capital Lease Obligations [Member] | Capital Lease Obligations [Member] | Capital Lease Obligations [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Convertible Debt [Member] | Secured Debt [Member] | Secured Debt [Member] | Secured Debt [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Loans Payable [Member] | |||||||||||||||||||||||
2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2031B convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2032D convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033E convertible senior notes [Member] | 2033F convertible senior note [Member] | 2033F convertible senior note [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | 2043G convertible senior notes [Member] | Convertible Senior Notes As Of Feb 27, 2014 excluding 2014 Notes [Member] | 2019 Notes [Member] | 2019 Notes [Member] | 2019 Notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | 2022 senior notes [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | |||||||||||||||||||||||||||||||||
integer | Other noncurrent assets [Member] | integer | Scenario, Optional Redemption Using Equity Offering Proceeds [Member] | Scenario, Optional Redemption Using Equity Offering Proceeds [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Maximum [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Instrument [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Stated interest rate (in hundred thousandths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1.88% | ' | 1.88% | ' | 1.50% | ' | 1.88% | ' | 2.38% | ' | 3.13% | ' | 1.63% | ' | 2.13% | ' | 3.00% | ' | ' | ' | ' | 1.26% | ' | ' | 5.88% | ' | ' | ' | ' | 2.95% | ' | ' | ' | |||||||||||||||||||
Effective interest rate (in ten thousandths) | ' | ' | ' | ' | ' | 6.25% | ' | 4.33% | ' | 4.07% | 7.88% | ' | 6.95% | ' | 6.55% | ' | 6.98% | ' | 5.95% | ' | 6.33% | ' | 4.50% | ' | 4.93% | ' | 6.77% | ' | ' | ' | ' | 1.97% | ' | ' | 6.16% | ' | ' | ' | ' | 3.51% | ' | ' | ' | |||||||||||||||||||
Current debt | $2,230,000,000 | ' | $1,585,000,000 | ' | ' | $189,000,000 | $527,000,000 | $352,000,000 | $407,000,000 | ' | $677,000,000 | [1] | $465,000,000 | [1] | $0 | [1] | $0 | [1] | $0 | [1] | $0 | [1] | $85,000,000 | [1],[2],[3] | $0 | [1] | $0 | [1],[3] | $0 | [1] | $0 | [1],[3] | $0 | [1] | $275,000,000 | [1],[2],[3] | $0 | [1] | $263,000,000 | [1],[2],[3] | $0 | [1] | $0 | [1] | ' | $0 | [1] | ' | ' | $92,000,000 | ' | $0 | $0 | ' | $0 | ' | ' | $297,000,000 | $186,000,000 | ' | ' | |
Long-term debt | 4,317,000,000 | ' | 4,452,000,000 | ' | ' | 926,000,000 | 1,117,000,000 | 694,000,000 | 845,000,000 | ' | 0 | [1] | 0 | [1] | 0 | [1] | 147,000,000 | [1] | 0 | [1] | 277,000,000 | [1] | 0 | [1],[2],[3] | 253,000,000 | [1] | 385,000,000 | [1],[3] | 463,000,000 | [1] | 342,000,000 | [1],[3] | 369,000,000 | [1] | 0 | [1],[2],[3] | 272,000,000 | [1] | 0 | [1],[2],[3] | 260,000,000 | [1] | 631,000,000 | [1] | ' | 0 | [1] | ' | ' | 370,000,000 | ' | 0 | 600,000,000 | ' | 0 | ' | ' | 369,000,000 | 449,000,000 | ' | ' | |
Long-term Debt, Gross | 6,547,000,000 | ' | 6,037,000,000 | ' | ' | 1,115,000,000 | 1,644,000,000 | 1,046,000,000 | 1,252,000,000 | ' | 677,000,000 | [1] | 465,000,000 | [1] | 0 | [1] | 147,000,000 | [1] | 0 | [1] | 277,000,000 | [1] | 85,000,000 | [1],[2],[3] | 253,000,000 | [1] | 385,000,000 | [1],[3] | 463,000,000 | [1] | 342,000,000 | [1],[3] | 369,000,000 | [1] | 275,000,000 | [1],[2],[3] | 272,000,000 | [1] | 263,000,000 | [1],[2],[3] | 260,000,000 | [1] | 631,000,000 | [1] | 627,000,000 | 0 | [1] | ' | ' | 462,000,000 | ' | 0 | 600,000,000 | ' | 0 | ' | ' | 666,000,000 | 635,000,000 | 127,000,000 | ' | |
Stated principal amount of debt instrument | ' | ' | ' | ' | ' | 1,392,000,000 | 1,969,000,000 | ' | ' | ' | 419,000,000 | 485,000,000 | 0 | 175,000,000 | 0 | 345,000,000 | 114,000,000 | 345,000,000 | 450,000,000 | 550,000,000 | 412,000,000 | 450,000,000 | 300,000,000 | 300,000,000 | 300,000,000 | 300,000,000 | 1,025,000,000 | [4] | 1,025,000,000 | 0 | ' | 2,601,000,000 | 462,000,000 | 462,000,000 | 0 | 600,000,000 | 600,000,000 | 0 | ' | ' | ' | ' | ' | ' | ||||||||||||||||||
Debt instrument, amount of collateral | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 240,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Debt instrument, number of semi-annual installment payments | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Debt instrument, fees paid for third party credit enhancement | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 23,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Payments of debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 14,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Debt instrument, domestic restricted subsidiaries based on ownership percentage by parent (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 80.00% | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Debt instrument, redemption price, percentage of principal redeemed (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 35.00% | ' | ' | ' | ' | |||||||||||||||||||
Debt Instrument, Redemption Price, Percentage | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 105.88% | ' | ' | ' | ' | ' | |||||||||||||||||||
Repayments of debt | 1,987,000,000 | 587,000,000 | ' | ' | 534,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Convertible Debt [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Debt instrument, earliest put date of holders | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31-Aug-20 | ' | 31-May-19 | ' | 31-May-21 | ' | 28-Feb-18 | ' | 28-Feb-20 | ' | 30-Nov-28 | [4] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||
shares issuable upon conversion | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 12 | ' | 47 | ' | 41 | ' | 27 | ' | 27 | ' | 35 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Initial conversion price per share (in dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $9.50 | ' | $9.63 | ' | $9.98 | ' | $10.93 | ' | $10.93 | ' | $29.16 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Conversion price per share threshold (dollars per share) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $12.35 | [5] | ' | $12.52 | [5] | ' | $12.97 | [5] | ' | $14.21 | [5] | ' | $14.21 | [5] | ' | $37.91 | [5] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||
Conversion value in excess of principal | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 176,000,000 | [6] | ' | 681,000,000 | [6] | ' | 587,000,000 | [6] | ' | 364,000,000 | [6] | ' | 364,000,000 | [6] | ' | 0 | [6] | ' | ' | ' | 2,172,000,000 | [6] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||
Share Price (in dollars per share) | $24.19 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Convertible Debt Issuances [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Debt Instrument, Discounted Issue Price Per Debenture | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 800 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Conversion rate (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 34.2936 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Principal amount per debenture used In coversion rate | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Additional paid in capital equity component of convertible debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 173,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Unamortized deferred debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 5,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Debt Instrument, Unamortized Discount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 398,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 800,000,000 | |||||||||||||||||||
Debt instrument, scheduled accreted principal amount on the date holders can require Micron to repurchase all or a portion of the notes | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 917,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Conversion rights, minimum number of trading days (in days) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Conversion rights, consecutive trading period (in days) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Conversion rights, threshold percentage of applicable conversion price (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 130.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Conversion rights, maximum percentage of product of stock price and conversion rate (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 98.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Minority interest decrease from purchase of interest, change in ownership percentage (in ten thousandths) | ' | ' | ' | 9.87% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 9.87% | ' | |||||||||||||||||||
Long-term Debt (excluding capital leases), Fiscal Year Maturity [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||
Remainder of 2014 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 883,000,000 | |||||||||||||||||||
2015 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 515,000,000 | |||||||||||||||||||
2016 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 441,000,000 | |||||||||||||||||||
2017 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 410,000,000 | |||||||||||||||||||
2018 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 609,000,000 | |||||||||||||||||||
2019 and thereafter | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3,443,000,000 | |||||||||||||||||||
Discounts | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -398,000,000 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -800,000,000 | |||||||||||||||||||
Long-term Debt, gross excluding capital leases | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $5,501,000,000 | |||||||||||||||||||
[1] | (1) We have the obligation or option to pay cash for the aggregate amount due upon conversion for all of our convertible notes. Since it is our current intent to settle in cash the principal amount of all of our convertible notes upon conversion, the dilutive effect of such notes on earnings per share is computed under the treasury stock method. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | (3) As a result of these notes being convertible at the option of the holder through March 31, 2014, and because the terms of these notes would require us to pay cash for the principal amount of any converted notes, amounts are classified as current. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | (2) Since the closing price of our common stock for at least 20 trading days in the 30 trading day period ending on December 31, 2013 exceeded 130% of the initial conversion price per share, holders have the right to convert their notes at any time during the calendar quarter ended March 31, 2014. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[4] | (3)B The original principal amount of $820 million accretes up to $917 million in November 2028 and $1,025 million at maturity in 2043. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[5] | (1)B Holders have the right to convert all or a portion of their notes at a date or dates earlier than the contractual maturity if, during any calendar quarter, the closing price of our common stock for at least 20 trading days in the 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is more than 130% of the initial conversion price. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[6] | (2)B Based on our closing share price of $24.19 as of FebruaryB 27, 2014. |
Debt_Extinguishment_of_Debt_De
Debt - Extinguishment of Debt (Details) (USD $) | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 0 Months Ended | 3 Months Ended | 0 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 1 Months Ended | 3 Months Ended | 1 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 28, 2013 | Nov. 12, 2013 | Nov. 28, 2013 | Nov. 12, 2013 | Nov. 12, 2013 | Nov. 12, 2013 | Nov. 12, 2013 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | 29-May-14 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Nov. 28, 2013 | Feb. 27, 2014 | Nov. 28, 2013 | Jan. 31, 2014 | Feb. 27, 2014 | Jan. 31, 2014 | Jan. 31, 2014 | Jan. 31, 2014 | ||||||||||||||||||||||||
Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | 2014 convertible senior notes [Member] | Exchanged [Member] | Exchanged [Member] | Exchanged [Member] | Exchanged [Member] | Exchanged [Member] | Exchanged [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Conversion And Settlement [Member] | Repurchase [Member] | Repurchase [Member] | Repurchase [Member] | Repurchase [Member] | Repurchase [Member] | ||||||||||||||||||||||||||||||
Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Other Non-Operating Income Expense Net [Member] | 2043G convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031B convertible senior notes [Member] | integer | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2014 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2027 convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | 2031A convertible senior notes [Member] | Other Non-Operating Income Expense Net [Member] | 2031B convertible senior notes [Member] | 2032C convertible senior notes [Member] | 2032D convertible senior notes [Member] | |||||||||||||||||||||||||||||||||||
Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Level 2 [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Scenario, Forecast [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Other Non-Operating Income Expense Net [Member] | Level 2 [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||
Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | Convertible notes settlement obligations [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Extinguishment of Debt [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Repayments of convertible debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $728 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $718 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $407 | ' | ' | ' | ' | ||||||||||||||||||||||||
Debt instrument, scheduled accreted principal amount on the date holders can require Micron to repurchase all or a portion of the notes | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 820 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Extinguishment of Debt, Principal Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | 464 | 440 | ' | ' | 80 | 155 | 205 | 351 | 0 | 351 | ' | ' | ' | ' | ' | ' | 66 | ' | ' | ' | 95 | 0 | ' | ' | ' | ' | 190 | 0 | ' | ' | ' | ' | 164 | ' | 26 | 100 | 38 | ||||||||||||||||||||||||
Extinguishment of Debt, Carrying Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 345 | ' | ' | 68 | 125 | 152 | 299 | 0 | 299 | ' | ' | ' | ' | ' | ' | 65 | ' | ' | ' | 80 | 0 | ' | ' | ' | ' | 154 | 0 | ' | ' | ' | ' | 135 | ' | 19 | 85 | 31 | ||||||||||||||||||||||||
Equity component of convertible debt derecognized | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 411 | ' | ' | 51 | 148 | 212 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 262 | ' | 43 | 159 | 60 | ||||||||||||||||||||||||
Debt Instrument, Face Amount | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1,025 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Long-term Debt, Gross | 6,547 | ' | 6,547 | ' | 6,037 | ' | ' | ' | ' | ' | ' | ' | 627 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Additional paid in capital equity component of convertible debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 173 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Net Principal | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 585 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Net Debt Component | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 282 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Debt Instrument, Increase (Decrease), Net Equity Component | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | -238 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Debt Instrument, Convertible, Derivative Reclassification | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 411 | [1] | 173 | [1] | 584 | [1] | ' | ' | ' | ' | ' | ' | 309 | [1] | ' | ' | ' | 0 | [1] | 58 | [1] | ' | ' | ' | ' | 102 | [1] | 115 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||
(Gains) losses from currency hedges, net | ' | ' | 21 | 173 | ' | 15 | 0 | 52 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 15 | [2] | 37 | [2] | 52 | [2] | ' | ' | -1 | [2] | ' | ' | ' | ' | ' | 4 | [2] | 22 | [2] | ' | ' | ' | ' | 12 | [2] | 15 | [2] | ' | ' | ' | ' | ' | ||||||||||||||||
Loss on settlement for restructure of debt | ' | ' | ' | ' | ' | ' | ' | ' | ' | 31 | ' | 38 | ' | ' | ' | ' | ' | ' | ' | 54 | [2] | 0 | [2] | 54 | [2] | ' | ' | ' | ' | 1 | [2] | ' | ' | ' | ' | 15 | [2] | 0 | [2] | ' | ' | ' | ' | 38 | [2] | 0 | [2] | ' | ' | ' | 11 | ' | ' | ' | ||||||||||||||||
Loss on restructure of debt and derivative mark-to-market, net | $80 | $31 | $155 | $31 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $8 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Debt Instrument, Convertible, Settlement Trading Days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
Debt Instrument Convertible Number Of Days Between Conversion Date and Start Date of Settlement Trading Days Period | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '3 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||
[1] | (1) Based on Level 2 fair value measurements. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | (2) Included in non-operating expense. |
Contingencies_Details
Contingencies (Details) (USD $) | 3 Months Ended | 6 Months Ended | 1 Months Ended | 3 Months Ended | 6 Months Ended | 6 Months Ended | 0 Months Ended | 1 Months Ended | 6 Months Ended | 29 Months Ended | 6 Months Ended | 0 Months Ended | |||||||||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Dec. 31, 2013 | Nov. 28, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Mar. 10, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Jun. 23, 2010 | Jul. 31, 2006 | Feb. 27, 2014 | Nov. 29, 2012 | Feb. 27, 2014 | Feb. 27, 2014 | Mar. 13, 2014 |
Rambus Settlement [Member] | Rambus Settlement [Member] | Rambus Settlement [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Patent Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Antitrust Matters [Member] | Securities Matter [Member] | Commercial Matters [Member] | Commercial Matters [Member] | |||||
HSM Portfolio LLC and Technology Properties LLC [Member] | HSM Portfolio LLC and Technology Properties LLC [Member] | Board Of Trustees For The University Of Illinois [Member] | Board Of Trustees For The University Of Illinois [Member] | Semcon Tech, LLC [Member] | Tessera, Inc. [Member] | Rambus DRAM Complaint [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | DRAM Purported Class Action Price-fixing Lawsuit [Member] | Former Shareholders of Elpida Memory, Inc [Member] | Qimonda AG Inotera Share Purchase Proceedings [Member] | Qimonda AG Inotera Share Purchase Proceedings [Member] | ||||||||
integer | Elpida Company [Member] | integer | Subsequent Event [Member] | integer | Elpida Company [Member] | integer | integer | integer | Elpida Company [Member] | Inotera [Member] | Subsequent Event [Member] | ||||||||||
integer | Scenario, Forecast [Member] | integer | integer | Scenario, Forecast [Member] | |||||||||||||||||
integer | Inotera [Member] | ||||||||||||||||||||
Loss Contingencies [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Approximation of damages claimed | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $3,900 | ' | ' | ' | ' | ' | ' | ' |
Settlement agreement execution date | ' | ' | ' | ' | ' | ' | 'December 31, 2013 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 'June 23, 2010 | ' | ' | ' | ' |
Patent License Agreement, Term of Agreement | ' | ' | ' | ' | '7 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Settlement Agreement, Maximum Quarterly Installment Payment | ' | ' | ' | ' | 10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Settlement agreement number of years for installment payments (in years) | ' | ' | ' | ' | '7 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | '2 years | ' | ' | ' | ' | ' | ' |
Settlement agreement amount | ' | ' | ' | ' | 280 | ' | ' | ' | ' | ' | ' | ' | ' | ' | 67 | ' | ' | ' | ' | ' | ' |
Rambus settlement | 0 | 0 | 233 | 0 | ' | 233 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of other defendants | ' | ' | ' | ' | ' | ' | ' | 17 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Allegedly number of patents infringed | ' | ' | ' | ' | ' | ' | ' | 4 | 2 | 3 | ' | 1 | 4 | ' | ' | ' | ' | ' | ' | ' | ' |
Number Of Petitions Submitted For Inter-Partes Review | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of patents found to be invalid by the Patent and Trademark Office | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Number of lawsuits filed | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 68 | ' | ' | ' | ' |
Approximate number of U.S. states and territories filing suit | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 40 | ' | ' | ' | ' | ' |
Settlement agreement number of installment payments | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 3 | ' | ' | ' | ' | ' | ' |
Amount paid into an escrow account in connection with settlement | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 67 | ' | ' | ' |
Number of Plaintiffs | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7 | ' | ' |
Loss Contingency, Damages Awarded, Value | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 |
Equity method investment carrying value of shares acquired from Qimonda | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 312 | ' |
Equity method investment quoted market value of shares acquired from Qimonda | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1,002 | ' |
Redeemable_Convertible_Notes_D
Redeemable Convertible Notes (Details) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Debt Instrument [Line Items] | ' | ' |
Redeemable convertible notes | $91 | $0 |
Convertible Debt 2031B, 2033E and 2033F [Member] | ' | ' |
Debt Instrument [Line Items] | ' | ' |
Redeemable convertible notes | $91 | ' |
Equity_Changes_in_Components_o
Equity - Changes in Components of Equity (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | ' | ' | $10,006 | $8,417 |
Net income (loss) | 741 | -284 | 1,122 | -559 |
Other comprehensive income (loss) | -9 | -4 | -4 | -1 |
Comprehensive income (loss) | 732 | -288 | 1,118 | -560 |
Contributions from noncontrolling interests | ' | ' | 49 | 10 |
Distributions to noncontrolling interests | ' | ' | -19 | 0 |
Acquisition of noncontrolling interest in MMT | ' | ' | -136 | 0 |
Capital and other transactions attributable to Micron | ' | ' | -974 | 93 |
Ending Balance | 10,044 | 7,960 | 10,044 | 7,960 |
Attributable to Micron [Member] | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | ' | ' | 9,142 | 7,700 |
Net income (loss) | ' | ' | 1,089 | -561 |
Other comprehensive income (loss) | ' | ' | -4 | -1 |
Comprehensive income (loss) | ' | ' | 1,085 | -562 |
Contributions from noncontrolling interests | ' | ' | 0 | 0 |
Distributions to noncontrolling interests | ' | ' | 0 | 0 |
Acquisition of noncontrolling interest in MMT | ' | ' | 31 | 0 |
Capital and other transactions attributable to Micron | ' | ' | -974 | 93 |
Ending Balance | 9,284 | 7,231 | 9,284 | 7,231 |
Noncontrolling Interests [Member] | ' | ' | ' | ' |
Increase (Decrease) in Stockholders' Equity [Roll Forward] | ' | ' | ' | ' |
Beginning Balance | ' | ' | 864 | 717 |
Net income (loss) | ' | ' | 33 | 2 |
Other comprehensive income (loss) | ' | ' | 0 | 0 |
Comprehensive income (loss) | ' | ' | 33 | 2 |
Contributions from noncontrolling interests | ' | ' | 49 | 10 |
Distributions to noncontrolling interests | ' | ' | -19 | 0 |
Acquisition of noncontrolling interest in MMT | ' | ' | -167 | 0 |
Capital and other transactions attributable to Micron | ' | ' | 0 | 0 |
Ending Balance | $760 | $729 | $760 | $729 |
Equity_Capped_Calls_Details
Equity - Capped Calls (Details) (Call Option [Member], Purchased options [Member], Convertible Debt [Member], USD $) | 6 Months Ended | |
Share data in Millions, except Per Share data, unless otherwise specified | Feb. 27, 2014 | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuer's equity, shares (in shares) | 227 | |
Minimum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuers equity settlement proceeds | 0 | [1] |
Maximum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuers equity settlement proceeds | 954,000,000 | [1] |
2031A and 2031B convertible senior notes [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuer's equity, strike price (in dollars per share) | 9.5 | [2] |
Option indexed to issuer's equity, shares (in shares) | 73 | |
2031A and 2031B convertible senior notes [Member] | Minimum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 11.4 | |
Option indexed to issuers equity settlement proceeds | 0 | [1] |
2031A and 2031B convertible senior notes [Member] | Maximum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 13.17 | |
Option indexed to issuers equity settlement proceeds | 207,000,000 | [1] |
2032C convertible senior notes [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuer's equity, strike price (in dollars per share) | 9.8 | [2] |
Option indexed to issuer's equity, shares (in shares) | 56 | |
2032C convertible senior notes [Member] | Minimum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 14.26 | |
Option indexed to issuers equity settlement proceeds | 0 | [1] |
2032C convertible senior notes [Member] | Maximum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 15.69 | |
Option indexed to issuers equity settlement proceeds | 307,000,000 | [1] |
2032D convertible senior notes [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuer's equity, strike price (in dollars per share) | 10.16 | [2] |
Option indexed to issuer's equity, shares (in shares) | 44 | |
2032D convertible senior notes [Member] | Minimum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 14.62 | |
Option indexed to issuers equity settlement proceeds | 0 | [1] |
2032D convertible senior notes [Member] | Maximum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 16.04 | |
Option indexed to issuers equity settlement proceeds | 244,000,000 | [1] |
2033E convertible senior notes [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuer's equity, strike price (in dollars per share) | 10.93 | [2] |
Option indexed to issuer's equity, shares (in shares) | 27 | |
2033E convertible senior notes [Member] | Minimum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 14.51 | |
Option indexed to issuers equity settlement proceeds | 0 | [1] |
2033E convertible senior notes [Member] | Maximum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 14.51 | |
Option indexed to issuers equity settlement proceeds | 98,000,000 | [1] |
2033F convertible senior note [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option indexed to issuer's equity, strike price (in dollars per share) | 10.93 | [2] |
Option indexed to issuer's equity, shares (in shares) | 27 | |
2033F convertible senior note [Member] | Minimum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 14.51 | |
Option indexed to issuers equity settlement proceeds | 0 | [1] |
2033F convertible senior note [Member] | Maximum [Member] | ' | |
Option Indexed to Issuer's Equity [Line Items] | ' | |
Option Indexed to Issuer's Equity, stated cap price (in dollars per share) | 14.51 | |
Option indexed to issuers equity settlement proceeds | 98,000,000 | [1] |
[1] | Settlement in cash on the respective expiration dates would result in us receiving an amount ranging from zero, if the market price per share of our common stock is at or below the respective low strike price, to the respective maximum amount if the market price per share of our common stock is at or above the respective high cap price. If share settlement were elected, the number of shares repurchased would be determined by the value of the capped calls at the time of settlement divided by the share price on the settlement date. Settlement of the capped calls prior to the expiration dates may be for an amount less than the maximum value at expiration. | |
[2] | Initial strike prices are subject to certain adjustments. |
Equity_Accumulated_Other_Compr
Equity - Accumulated Other Comprehensive Income (Loss) (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' | ' |
Accumulated other comprehensive income | ' | ' | $63 | ' |
Other comprehensive income before reclassifications | ' | ' | -1 | ' |
Amount reclassified out of accumulated other comprehensive income | ' | ' | -2 | ' |
Tax effects | ' | ' | -1 | ' |
Other comprehensive income (loss) | -9 | -4 | -4 | -1 |
Accumulated other comprehensive income | 59 | ' | 59 | ' |
Cumulative Foreign Currency Translation Adjustments [Member] | ' | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' | ' |
Accumulated other comprehensive income | ' | ' | 44 | ' |
Other comprehensive income before reclassifications | ' | ' | -4 | ' |
Amount reclassified out of accumulated other comprehensive income | ' | ' | 0 | ' |
Tax effects | ' | ' | 0 | ' |
Other comprehensive income (loss) | ' | ' | -4 | ' |
Accumulated other comprehensive income | 40 | ' | 40 | ' |
Gains (Losses) on Derivative Instruments, Net [Member] | ' | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' | ' |
Accumulated other comprehensive income | ' | ' | 21 | ' |
Other comprehensive income before reclassifications | ' | ' | -2 | ' |
Amount reclassified out of accumulated other comprehensive income | ' | ' | -1 | ' |
Tax effects | ' | ' | -1 | ' |
Other comprehensive income (loss) | ' | ' | -4 | ' |
Accumulated other comprehensive income | 17 | ' | 17 | ' |
Gains (Losses) on Investments, Net [Member] | ' | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' | ' |
Accumulated other comprehensive income | ' | ' | 0 | ' |
Other comprehensive income before reclassifications | ' | ' | 4 | ' |
Amount reclassified out of accumulated other comprehensive income | ' | ' | -2 | ' |
Tax effects | ' | ' | 0 | ' |
Other comprehensive income (loss) | ' | ' | 2 | ' |
Accumulated other comprehensive income | 2 | ' | 2 | ' |
Pension Liability Adjustments [Member] | ' | ' | ' | ' |
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] | ' | ' | ' | ' |
Accumulated other comprehensive income | ' | ' | -2 | ' |
Other comprehensive income before reclassifications | ' | ' | 1 | ' |
Amount reclassified out of accumulated other comprehensive income | ' | ' | 1 | ' |
Tax effects | ' | ' | 0 | ' |
Other comprehensive income (loss) | ' | ' | 2 | ' |
Accumulated other comprehensive income | $0 | ' | $0 | ' |
Equity_NCI_and_Consolidated_VI
Equity - NCI and Consolidated VIE disclosures (Details) (USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | ||||||||||||||||||||||||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Aug. 31, 2006 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | |||||
Nonsoftware License Arrangement with Photronics [Member] | Nonsoftware License Arrangement with Photronics [Member] | Nonsoftware License Arrangement with Photronics [Member] | Intel [Member] | Intel [Member] | Intel [Member] | Intel [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Other Consolidated Entities [Member] | Other Consolidated Entities [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Variable Interest Entity, Primary Beneficiary [Member] | Variable Interest Entity, Primary Beneficiary [Member] | |||||||||||
NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | Intel [Member] | Intel [Member] | Intel [Member] | Intel [Member] | Intel [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | IM Flash Technologies, LLC [Member] | MP Mask Technology Center, LLC [Member] | MP Mask Technology Center, LLC [Member] | ||||||||||||||||||
Collaborative Arrangement Process Design and Process Development [Member] | Collaborative Arrangement Process Design and Process Development [Member] | Collaborative Arrangement Process Design and Process Development [Member] | Collaborative Arrangement Process Design and Process Development [Member] | NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | NAND Flash [Member] | |||||||||||||||||||||||||
Variable Interest Entity [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
Noncontrolling interests in subsidiaries | $760 | ' | $760 | ' | $864 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $21 | $155 | $6 | $16 | $640 | [1] | ' | $640 | [1] | ' | $601 | [1] | $93 | [1] | $92 | [1] |
Variable interest entity, ownership percentage by noncontrolling owners (in ten thousandths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1.24% | 11.11% | ' | ' | 49.00% | [1] | ' | 49.00% | [1] | ' | 49.00% | [1] | 49.99% | [1] | 49.99% | [1] |
Variable interest entity, ownership percentage (in hundredths) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 51.00% | ' | 51.00% | ' | ' | 50.01% | ' | |||||
R&D expenses reduced by reimbursements from third party | 344 | 214 | 664 | 438 | ' | ' | ' | ' | -35 | -34 | -64 | -66 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
Net sales | 4,107 | 2,078 | 8,149 | 3,912 | ' | ' | ' | ' | ' | ' | ' | ' | 104 | 91 | 205 | 190 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
Trade Receivables | 2,548 | ' | 2,548 | ' | 2,069 | ' | ' | ' | ' | ' | ' | ' | 62 | ' | 62 | ' | 68 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
Distributions to, and contributions from, shareholders [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
Distributions to Micron from consolidated VIE's | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | 0 | 10 | 0 | ' | ' | ' | |||||
Distributions to noncontrolling interests from consolidated VIE's | ' | ' | 19 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 10 | 0 | 10 | 0 | ' | ' | ' | |||||
Micron contributions to consolidated VIE's | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 10 | 51 | 10 | ' | ' | ' | |||||
Cash received from noncontrolling interests | ' | ' | 49 | 10 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 10 | 49 | 10 | ' | ' | ' | |||||
Proceeds for entering into license agreement with Photronics | ' | ' | ' | ' | ' | 72 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
Term of license agreement with Photronics (in years) | ' | ' | ' | ' | ' | '10 years | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
Deferred income and other noncurrent liabilities related to license agreement with Photronics | ' | ' | ' | ' | ' | ' | $16 | $19 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||
[1] | Entity is a variable interest entity. |
Equity_Consolidated_VIE_Assets
Equity - Consolidated VIE Assets and Liabilities (Details) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 28, 2013 | Aug. 30, 2012 | ||
In Millions, unless otherwise specified | ||||||
Assets | ' | ' | ' | ' | ||
Cash and equivalents | $4,305 | $2,880 | $2,061 | $2,459 | ||
Receivables | 2,826 | 2,329 | ' | ' | ||
Inventories | 2,462 | 2,649 | ' | ' | ||
Other current assets | 199 | 276 | ' | ' | ||
Total current assets | 9,991 | 8,911 | ' | ' | ||
Property, plant and equipment, net | 7,859 | 7,626 | ' | ' | ||
Other noncurrent assets | 487 | 439 | ' | ' | ||
Total assets | 20,615 | 19,118 | ' | ' | ||
Liabilities | ' | ' | ' | ' | ||
Accounts payable and accrued expenses | 2,679 | 2,115 | ' | ' | ||
Deferred income | 251 | 243 | ' | ' | ||
Equipment purchase contracts | 145 | 182 | ' | ' | ||
Current debt | 2,230 | 1,585 | ' | ' | ||
Total current liabilities | 5,305 | 4,125 | ' | ' | ||
Long-term debt | 4,317 | 4,452 | ' | ' | ||
Other noncurrent liabilities | 858 | 535 | ' | ' | ||
Total liabilities | 10,480 | 9,112 | ' | ' | ||
Variable Interest Entity, Primary Beneficiary [Member] | IM Flash Technologies, LLC [Member] | ' | ' | ' | ' | ||
Assets | ' | ' | ' | ' | ||
Cash and equivalents | 112 | [1] | 62 | [1] | ' | ' |
Receivables | 70 | [1] | 76 | [1] | ' | ' |
Inventories | 47 | [1] | 49 | [1] | ' | ' |
Other current assets | 5 | [1] | 4 | [1] | ' | ' |
Total current assets | 234 | [1] | 191 | [1] | ' | ' |
Property, plant and equipment, net | 1,348 | [1] | 1,382 | [1] | ' | ' |
Other noncurrent assets | 42 | [1] | 46 | [1] | ' | ' |
Total assets | 1,624 | [1] | 1,619 | [1] | ' | ' |
Liabilities | ' | ' | ' | ' | ||
Accounts payable and accrued expenses | 93 | [1] | 88 | [1] | ' | ' |
Deferred income | 8 | [1] | 9 | [1] | ' | ' |
Equipment purchase contracts | 11 | [1] | 78 | [1] | ' | ' |
Current debt | 6 | [1] | 6 | [1] | ' | ' |
Total current liabilities | 118 | [1] | 181 | [1] | ' | ' |
Long-term debt | 10 | [1] | 13 | [1] | ' | ' |
Other noncurrent liabilities | 114 | [1] | 118 | [1] | ' | ' |
Total liabilities | 242 | [1] | 312 | [1] | ' | ' |
Variable Interest Entity, Primary Beneficiary [Member] | MP Mask Technology Center, LLC [Member] | ' | ' | ' | ' | ||
Assets | ' | ' | ' | ' | ||
Total current assets | 37 | [1] | 26 | [1] | ' | ' |
Noncurrent assets (primarily property, plant and equipment) | 209 | [1] | 182 | [1] | ' | ' |
Liabilities | ' | ' | ' | ' | ||
Total current liabilities | $40 | [1] | $25 | [1] | ' | ' |
[1] | Amounts exclude intercompany balances that were eliminated in our consolidated balance sheets. |
Equity_MMT_Share_Purchase_Deta
Equity - MMT Share Purchase (Details) (USD $) | 6 Months Ended | 3 Months Ended | 3 Months Ended | ||||||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Jul. 31, 2013 |
Noncontrolling Interests [Member] | Noncontrolling Interests [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | Elpida Acquisition [Member] | |||
Noncontrolling Interests [Member] | Additional Capital [Member] | Rexchip Electronics Corporation, now known as Micron Memory Taiwan Co., Ltd. [Member] | |||||||
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Noncontrolling interests, ownership percentage by noncontrolling owners (in ten thousandths) | ' | ' | ' | ' | 1.24% | 11.11% | ' | ' | 11.11% |
Minority interest decrease from purchase of interest, change in ownership percentage (in ten thousandths) | ' | ' | ' | ' | 9.87% | ' | ' | ' | ' |
Acquisition of noncontrolling interest in MMT | ($136) | $0 | ($167) | $0 | ($136) | ' | ($167) | $31 | ' |
Derivative_Instruments_Fair_Va
Derivative Instruments - Fair Values (Details) | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Millions, unless otherwise specified | USD ($) | USD ($) | Notes Payable, Other Payables [Member] | Notes Payable, Other Payables [Member] | Secured Debt 2 [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Not Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | Designated as Hedging Instrument [Member] | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | Notes Payable, Other Payables [Member] | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Convertible notes settlement obligations [Member] | Currency options [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Receivables [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Other noncurrent assets [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Current debt [Member] | Accounts payable and accrued expenses and current debt [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Other noncurrent liabilities [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | Cash Flow Hedging [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD ($) | Yen | Yen | Yen | Yen | Singapore dollar | Singapore dollar | Shekel | Shekel | Euro | Euro | USD ($) | USD ($) | New Taiwan dollar | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Convertible notes settlement obligations [Member] | Currency options [Member] | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Convertible notes settlement obligations [Member] | Currency options [Member] | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Currency options [Member] | Convertible notes settlement obligations [Member] | USD ($) | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Convertible notes settlement obligations [Member] | Currency options [Member] | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Currency options [Member] | Currency options [Member] | Currency options [Member] | Currency options [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | Accounts payable and accrued expenses [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
USD ($) | USD ($) | Reorganization obligation [Member] | Reorganization obligation [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Yen | Yen | Singapore dollar | Singapore dollar | Shekel | Shekel | Euro | Euro | USD ($) | USD ($) | USD ($) | New Taiwan dollar | Yen | Yen | Singapore dollar | Singapore dollar | Shekel | Shekel | Euro | Euro | USD ($) | USD ($) | USD ($) | New Taiwan dollar | Yen | Yen | Singapore dollar | Singapore dollar | Shekel | Shekel | Euro | Euro | USD ($) | USD ($) | New Taiwan dollar | USD ($) | Yen | Yen | Singapore dollar | Singapore dollar | Shekel | Shekel | Euro | Euro | USD ($) | USD ($) | USD ($) | New Taiwan dollar | Yen | Yen | Euro | Euro | USD ($) | USD ($) | Minimum [Member] | Maximum [Member] | Yen | Yen | USD ($) | USD ($) | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Forward Contracts [Member] | Interest Rate Swap [Member] | Interest Rate Swap [Member] | Currency options [Member] | Currency options [Member] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Less Than One Year From Balance Sheet Date [Member] | More Than One Year And Within Two Years From Balance Sheet Date [Member] | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | Yen | Yen | Euro | Euro | USD ($) | USD ($) | Yen | Yen | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
JPY (¥) | JPY (¥) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notional Disclosures [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notional Amount Outstanding | ' | ' | ' | ' | ' | $771 | [1] | $1,262 | [1] | ' | $321 | [1] | $336 | [1] | ¥ 20,000 | ¥ 10,000 | $321 | [1] | $218 | [1] | $66 | [1] | $78 | [1] | $8 | [1] | $217 | [1] | $55 | [1] | $62 | [1] | ' | $351 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $231 | $283 | ' | $8 | $6 | $2 | $6 | $218 | $250 | ' | ' | $3 | $21 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Notional amount of convertible notes settlement obligations (in shares) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 26 | [1] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Interest Rate Derivatives [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Long-term Debt, Gross | 6,547 | 6,037 | 666 | 635 | 273 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hedging designation allocation | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 20.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 80.00% | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative, Fair Value, Net [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Asset | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 1 | [2] | 2 | [2] | 0 | [2] | 1 | [2] | 1 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 1 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [2] | 0 | [3] | 3 | [3] | 0 | [3] | 3 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | 0 | [3] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value of Liability | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ($2) | [4] | ($6) | [4] | $0 | [4] | $0 | [4] | $0 | [4] | $0 | [4] | ($1) | [4] | $0 | [4] | ($1) | [4] | $0 | [4] | $0 | [4] | $0 | [4] | ($265) | [4] | ($271) | [4] | ($3) | [5] | $0 | [5] | ($3) | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | $0 | [5] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ($2) | [6] | ($3) | [6] | ($1) | [6] | ($1) | [6] | $0 | [6] | $0 | [6] | ($1) | [6] | $0 | [6] | $0 | [6] | ($2) | [6] | ||||||||||||||||||||||||||||||||||||||||||
Foreign Currency Cash Flow Hedges [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General maturity of non-designated currency forward contracts (in days) | ' | ' | ' | ' | ' | ' | ' | '35 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Approximate convertible notes settlement obligation period (in days) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
General maturity of hedge contracts (in days or months) | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | '12 months | ' | ' | ' | ' | ' | ' | '12 months | '18 months | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[1] | (1)Notional amounts of forward, option and interest rate swap contracts in U.S. dollars and convertible notes settlement obligations in millions of shares. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[2] | (2)B Included in receivables b other. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[3] | (3)B Included in other noncurrent assets. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[4] | (4)B Included in accounts payable and accrued expenses b other for forward, option and interest rate swap contracts and in current debt for convertible notes settlement obligations. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[5] | (5)B Included in other noncurrent liabilities. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
[6] | Included in accounts payable and accrued expenses b other. |
Derivative_Instruments_Hedging
Derivative Instruments - Hedging Relationship (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' | ' |
Derivative, Gain (Loss) on Derivative, Net | ' | ' | ($21) | ($173) |
Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months | 7 | ' | 7 | ' |
Not Designated as Hedging Instrument [Member] | Elpida Acquisition [Member] | ' | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' | ' |
Derivative, Gain (Loss) on Derivative, Net | ' | -120 | ' | -178 |
Designated as Hedging Instrument [Member] | Cash Flow Hedging [Member] | ' | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' | ' |
Derivative Instruments, Gain (Loss) Recognized in Other Comprehensive Income, Effective Portion | ' | -6 | -2 | -10 |
Convertible notes settlement obligations [Member] | Not Designated as Hedging Instrument [Member] | Other Non-Operating Income Expense Net [Member] | ' | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' | ' |
Derivative, Gain (Loss) on Derivative, Net | -15 | 0 | -52 | 0 |
Foreign Exchange Contract [Member] | Not Designated as Hedging Instrument [Member] | Other Non-Operating Income Expense Net [Member] | ' | ' | ' | ' |
Derivative Instruments, Gain (Loss) [Line Items] | ' | ' | ' | ' |
Derivative, Gain (Loss) on Derivative, Net | ($7) | ($122) | ($21) | ($173) |
Fair_Value_Measurements_Assets
Fair Value Measurements - Assets measured (Details) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | Not Designated as Hedging Instrument [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | Fair Value, Measurements, Recurring [Member] | ||
Convertible notes settlement obligations [Member] | Money market funds [Member] | Money market funds [Member] | Certificates of deposit [Member] | Certificates of deposit [Member] | Government securities [Member] | Government securities [Member] | Commercial paper [Member] | Commercial paper [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Asset-backed securities [Member] | Asset-backed securities [Member] | Marketable equity securities [Member] | Marketable equity securities [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 1 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 2 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | Level 3 [Member] | |||||
Money market funds [Member] | Money market funds [Member] | Certificates of deposit [Member] | Certificates of deposit [Member] | Government securities [Member] | Government securities [Member] | Commercial paper [Member] | Commercial paper [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Asset-backed securities [Member] | Asset-backed securities [Member] | Marketable equity securities [Member] | Marketable equity securities [Member] | Money market funds [Member] | Money market funds [Member] | Certificates of deposit [Member] | Certificates of deposit [Member] | Government securities [Member] | Government securities [Member] | Commercial paper [Member] | Commercial paper [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Asset-backed securities [Member] | Asset-backed securities [Member] | Marketable equity securities [Member] | Marketable equity securities [Member] | Money market funds [Member] | Money market funds [Member] | Certificates of deposit [Member] | Certificates of deposit [Member] | Government securities [Member] | Government securities [Member] | Commercial paper [Member] | Commercial paper [Member] | Corporate bonds [Member] | Corporate bonds [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Commercial Paper, Not Included with Cash and Cash Equivalents [Member] | Asset-backed securities [Member] | Asset-backed securities [Member] | Marketable equity securities [Member] | Marketable equity securities [Member] | ||||||||||||||||||||||||||||
Fair Value, Assets Measured on Recurring Basis, Financial Statement Captions [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash equivalents | ' | ' | ' | $1,223 | $1,261 | $1,137 | $1,188 | $81 | $38 | $5 | $0 | $0 | $35 | ' | ' | ' | ' | ' | ' | ' | ' | $1,137 | $1,188 | $1,137 | $1,188 | $0 | $0 | $0 | $0 | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | $86 | $73 | $0 | $0 | $81 | $38 | $5 | $0 | $0 | $35 | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' |
Short-term investments | 199 | 221 | ' | 199 | 221 | ' | ' | 10 | 9 | 39 | 72 | ' | ' | 124 | 112 | 23 | 26 | 3 | 2 | ' | ' | 0 | 0 | ' | ' | 0 | 0 | 0 | 0 | ' | ' | 0 | 0 | 0 | 0 | 0 | 0 | ' | ' | 199 | 221 | ' | ' | 10 | 9 | 39 | 72 | ' | ' | 124 | 112 | 23 | 26 | 3 | 2 | ' | ' | 0 | 0 | ' | ' | 0 | 0 | 0 | 0 | ' | ' | 0 | 0 | 0 | 0 | 0 | 0 | ' | ' |
Long-term marketable investments | 552 | 499 | ' | 552 | 499 | ' | ' | 2 | 0 | 97 | 96 | ' | ' | 332 | 302 | ' | ' | 120 | 95 | 1 | 6 | 1 | 6 | ' | ' | 0 | 0 | 0 | 0 | ' | ' | 0 | 0 | ' | ' | 0 | 0 | 1 | 6 | 551 | 493 | ' | ' | 2 | 0 | 97 | 96 | ' | ' | 332 | 302 | ' | ' | 120 | 95 | 0 | 0 | 0 | 0 | ' | ' | 0 | 0 | 0 | 0 | ' | ' | 0 | 0 | ' | ' | 0 | 0 | 0 | 0 |
Restricted cash | ' | ' | ' | 7 | 302 | ' | ' | 7 | 302 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 7 | 302 | ' | ' | 7 | 302 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' | 0 | 0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Total assets measured at fair value on a recurring basis | ' | ' | ' | $1,981 | $2,283 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $1,138 | $1,194 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $843 | $1,089 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | $0 | $0 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Approximate convertible notes settlement obligation period (in days) | ' | ' | '30 days | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Fair_Value_Measurements_Fair_a
Fair Value Measurements - Fair and Carrying Value (Details) (USD $) | Feb. 27, 2014 | Aug. 29, 2013 |
In Millions, unless otherwise specified | ||
Fair value and carrying value disclosure [Line Items] | ' | ' |
Long-term Debt, Gross | $6,547 | $6,037 |
Fair Value [Member] | Convertible Debt [Member] | Level 2 [Member] | ' | ' |
Fair value and carrying value disclosure [Line Items] | ' | ' |
Convertible notes | 5,693 | 4,167 |
Fair Value [Member] | Reorganization Obligation And Other Notes [Member] | Level 2 [Member] | ' | ' |
Fair value and carrying value disclosure [Line Items] | ' | ' |
Elpida creditor installment payments and other notes | 2,907 | 2,269 |
Carrying Value [Member] | Convertible Debt [Member] | ' | ' |
Fair value and carrying value disclosure [Line Items] | ' | ' |
Long-term Debt, Gross | 2,658 | 2,506 |
Carrying Value [Member] | Reorganization Obligation And Other Notes [Member] | ' | ' |
Fair value and carrying value disclosure [Line Items] | ' | ' |
Long-term Debt, Gross | $2,843 | $2,279 |
Equity_Plans_Share_Based_Compe
Equity Plans - Share Based Compensation (Details) (USD $) | 3 Months Ended | 6 Months Ended | |||
In Millions, except Per Share data, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 |
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | ' | ' | ' | ' | ' |
Number of shares of common stock reserved for issuance for stock options and restricted stock awards (in shares) | 123 | ' | 123 | ' | ' |
Number of shares subject to outstanding awards (in shares) | 66 | ' | 66 | ' | ' |
Number of shares available for future awards (in shares) | 57 | ' | 57 | ' | ' |
Number of stock options granted during the period (in shares) | 9 | 13 | 11 | 17 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Additional General Disclosures [Abstract] | ' | ' | ' | ' | ' |
Weighted-average grant-date fair values per share of options granted during period (in dollars per share) | $9.58 | $3.35 | $9.17 | $3.27 | ' |
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract] | ' | ' | ' | ' | ' |
Fair Value Assumptions, Method Used | ' | ' | 'Black-Scholes | ' | ' |
Average expected life (in years) | '4 years 9 months | '5 years 1 month | '4 years 9 months | '5 years 1 month | ' |
Weighted-average expected volatility (in hundredths) | 46.00% | 59.00% | 47.00% | 60.00% | ' |
Weighted-average risk-free interest rate (in thousandths) | 1.60% | 0.70% | 1.60% | 0.70% | ' |
Restricted Stock Awards activity | ' | ' | ' | ' | ' |
Number of Shares - Outstanding (in shares) | ' | ' | ' | ' | 12 |
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Roll Forward] | ' | ' | ' | ' | ' |
Weighted Average Grant Date Fair Value Per Share - Granted (in dollars per share) | $23.24 | $6.69 | $21.22 | $6.20 | ' |
Service-based awards [Member] | ' | ' | ' | ' | ' |
Restricted Stock Awards activity | ' | ' | ' | ' | ' |
Number of Shares - Granted (in shares) | 4 | 3 | 5 | 5 | ' |
Performance-based shares [Member] | ' | ' | ' | ' | ' |
Restricted Stock Awards activity | ' | ' | ' | ' | ' |
Number of Shares - Outstanding (in shares) | ' | ' | ' | ' | 1 |
Number of Shares - Granted (in shares) | 0 | 0 | 1 | 1 | ' |
Equity_Plans_Stockbased_compen
Equity Plans - Stock-based compensation expense (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation | $27 | $21 | $49 | $40 |
Employee Service Share-based Compensation, Aggregate Disclosures [Abstract] | ' | ' | ' | ' |
Total unrecognized compensation costs, net of estimated forfeitures, related to non-vested awards expected to be recognized | 295 | ' | 295 | ' |
Weighted average period that unrecognized compensation costs is expected to be recognized (in years) | ' | ' | '1 year 6 months | ' |
Stock Options [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation | 14 | 14 | 28 | 27 |
Restricted Stock Awards [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation | 13 | 7 | 21 | 13 |
Cost of Goods Sold [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation | 8 | 7 | 15 | 13 |
Selling, General and Administrative [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation | 13 | 9 | 24 | 18 |
Research and Development [Member] | ' | ' | ' | ' |
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] | ' | ' | ' | ' |
Stock-based compensation | $6 | $5 | $10 | $9 |
Restucture_and_Asset_Impairmen2
Restucture and Asset Impairments Restructure and Asset Impairments (Details) (USD $) | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | 12 Months Ended | 3 Months Ended | 6 Months Ended | 3 Months Ended | 6 Months Ended | |||||||||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Aug. 29, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Nov. 29, 2012 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Micron Technology Italia, Srl. [Member] | Micron Technology Italia, Srl. [Member] | Micron Technology Italia, Srl. [Member] | Micron Technology Italia, Srl. [Member] | Micron Technology Italia, Srl. [Member] | Transform [Member] | Transform [Member] | Transform [Member] | Transform [Member] | Transform [Member] | Other Restucturing Activities [Member] | Other Restucturing Activities [Member] | Other Restucturing Activities [Member] | Other Restucturing Activities [Member] | |||||
mm | mm | |||||||||||||||||
Restructuring Cost and Reserve [Line Items] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Loss (gain) on impairment of MIT assets | ' | ' | ' | ' | ($5) | $62 | ($5) | $62 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Gain on lease termination | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | -25 | 0 | -25 | ' | ' | ' | ' |
Restructure and asset impairments | 12 | 60 | 9 | 39 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | 17 | -2 | 14 | 2 |
Diameter of Wafer Used in Production | ' | ' | ' | ' | 200 | ' | 200 | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Value of consideration received | ' | ' | ' | ' | ' | ' | ' | ' | $35 | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Other_Operating_Income_Expense2
Other Operating (Income) Expense, Net (Details) (USD $) | 3 Months Ended | 6 Months Ended | 3 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 | Nov. 28, 2013 |
Rambus Settlement [Member] | |||||
Component Of Operating Other Income And Expense Net [Line Items] | ' | ' | ' | ' | ' |
Rambus settlement | $0 | $0 | $233 | $0 | $233 |
(Gain) loss on disposition of property, plant and equipment | 1 | -10 | 9 | -15 | ' |
Other | 0 | 2 | -4 | -1 | ' |
Other operating (income) expense, net | $1 | ($8) | $238 | ($16) | ' |
Other_NonOperating_Income_Expe2
Other Non-Operating Income (Expense), Net (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Component of Other Non-Operating Income (Expense), Net [Line Items] | ' | ' | ' | ' |
Loss on restructure of debt | ($80) | ($31) | ($155) | ($31) |
Adjustment to gain on acquisition of Elpida | -33 | 0 | -33 | 0 |
Gain (loss) from changes in currency exchange rates | -14 | -127 | -20 | -186 |
Other | 5 | -1 | 6 | -1 |
Other non-operating income (expense), net | -122 | -159 | -202 | -218 |
2014 convertible senior notes [Member] | ' | ' | ' | ' |
Component of Other Non-Operating Income (Expense), Net [Line Items] | ' | ' | ' | ' |
Loss on settlement for restructure of debt | ' | -31 | ' | ' |
Extinguishment of Debt, Principal Amount | ' | 464 | ' | ' |
Elpida Acquisition [Member] | ' | ' | ' | ' |
Component of Other Non-Operating Income (Expense), Net [Line Items] | ' | ' | ' | ' |
Adjustment to gain on acquisition of Elpida | -33 | ' | ' | ' |
Elpida Acquisition [Member] | Not Designated as Hedging Instrument [Member] | ' | ' | ' | ' |
Component of Other Non-Operating Income (Expense), Net [Line Items] | ' | ' | ' | ' |
Gain (loss) from changes in currency exchange rates | ' | ($120) | ' | ($178) |
Income_Taxes_Details_1
Income Taxes (Details 1) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Income tax expense (benefit) | $63 | ($9) | $143 | $4 |
Elpida Company [Member] | ' | ' | ' | ' |
Deferred foreign income tax provision | 55 | ' | 128 | ' |
Tax Benefits Resulting From Favorable Resolution Of Prior Period Tax Positions [Member] | ' | ' | ' | ' |
Income tax expense (benefit) | ' | -10 | ' | ' |
Tax Benefits Resulting From Favorable Change In Tax Law [Member] | ' | ' | ' | ' |
Income tax expense (benefit) | ' | ($9) | ' | ' |
Income_Taxes_Income_Tax_Holida
Income Taxes Income Tax Holiday (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Income Tax Holiday [Line Items] | ' | ' | ' | ' |
Tax benefit due to arrangements allowing computation of tax provision at rates below local statutory rates | $68 | $36 | $144 | $47 |
Tax benefit per diluted share due to arrangements allowing computation of tax provision at rates below local statutory rates (in dollars per share) | $0.06 | $0.04 | $0.12 | $0.05 |
Earnings_Per_Share_Potential_C
Earnings Per Share - Potential Common Shares Excluded in the Computation of Diluted Earnings Per Share Because They Would Have Been Antidilutive (Details) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] | ' | ' | ' | ' |
Antidilutive potential common shares that could dilute basic earnings per share in the future (in shares) | 45 | 384 | 41 | 384 |
Earnings_Per_Share_Details
Earnings Per Share (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, except Per Share data, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Earnings Per Share Reconciliation [Abstract] | ' | ' | ' | ' |
Net income (loss) available to Micron shareholders - Basic and Diluted | $731 | ($286) | $1,089 | ($561) |
Weighted Average Number of Shares Outstanding Reconciliation [Abstract] | ' | ' | ' | ' |
Weighted-average common shares outstanding - Basic (in shares) | 1,060 | 1,016 | 1,053 | 1,015 |
Net effect of dilutive equity awards and convertible notes (in shares) | 141 | 0 | 146 | 0 |
Weighted-average common shares outstanding - Diluted (in shares) | 1,201 | 1,016 | 1,199 | 1,015 |
Earnings (loss) per share: | ' | ' | ' | ' |
Basic (in dollars per share) | $0.69 | ($0.28) | $1.03 | ($0.55) |
Diluted (in dollars per share) | $0.61 | ($0.28) | $0.91 | ($0.55) |
Segment_Information_Details
Segment Information (Details) (USD $) | 3 Months Ended | 6 Months Ended | ||
In Millions, unless otherwise specified | Feb. 27, 2014 | Feb. 28, 2013 | Feb. 27, 2014 | Feb. 28, 2013 |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net sales | $4,107 | $2,078 | $8,149 | $3,912 |
Operating income (loss) | 869 | -23 | 1,420 | -120 |
DSG [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net sales | 1,888 | 756 | 3,673 | 1,356 |
Operating income (loss) | 520 | -46 | 952 | -158 |
WSG [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net sales | 910 | 213 | 1,964 | 476 |
Operating income (loss) | 185 | -87 | 361 | -151 |
NSG [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net sales | 902 | 713 | 1,708 | 1,330 |
Operating income (loss) | 77 | 64 | 172 | 77 |
ESG [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net sales | 365 | 282 | 731 | 560 |
Operating income (loss) | 59 | 65 | 125 | 143 |
All Other [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Net sales | 42 | 114 | 73 | 190 |
Operating income (loss) | 28 | -19 | 43 | -31 |
Unallocated [Member] | ' | ' | ' | ' |
Segment Reporting Information [Line Items] | ' | ' | ' | ' |
Operating income (loss) | $0 | $0 | ($233) | $0 |
Certain_Concentrations_Details
Certain Concentrations (Details) (Sales Revenue, Goods, Net [Member]) | 6 Months Ended | |
Feb. 27, 2014 | Feb. 28, 2013 | |
Product Concentration Risk [Member] | Computing (including desktop PCs, servers, notebooks and workstations) [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk, percentage of net sales (in hundreths) | 35.00% | 25.00% |
Product Concentration Risk [Member] | Mobile [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk, percentage of net sales (in hundreths) | 25.00% | 10.00% |
Product Concentration Risk [Member] | Consumer electronics [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk, percentage of net sales (in hundreths) | 15.00% | 20.00% |
Product Concentration Risk [Member] | Solid state drives [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk, percentage of net sales (in hundreths) | 10.00% | 15.00% |
Product Concentration Risk [Member] | Networking and storage [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk, percentage of net sales (in hundreths) | ' | 10.00% |
Customer Concentration Risk [Member] | Apple Inc. [Member] | ' | ' |
Concentration Risk [Line Items] | ' | ' |
Concentration risk, percentage of net sales (in hundreths) | 11.00% | ' |